Colgate-Palmolive (CL) 10-K/A21 Feb 182017 FY Annual report (amended)Financial data

Company Profile

Document and Entity Information

Document and Entity Information - USD ($) $ in Billions	12 Months Ended
Document and Entity Information - USD ($) $ in Billions	Dec. 31, 2017	Jan. 31, 2018	Jun. 30, 2017
Document and Entity Information [Abstract]
Entity Registrant Name	COLGATE PALMOLIVE CO
Entity Central Index Key	21,665
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Document Type	10-K/A
Document Period End Date	Dec. 31, 2017
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	FY
Amendment Flag	true
Amendment Description	This Amendment No. 1 on Form 10-K/A (the “Amendment”) amends the Annual Report on Form 10-K of Colgate-Palmolive Company for the fiscal year ended December 31, 2017, as filed with the Securities and Exchange Commission on February 15, 2018 (the “Original Filing”). This Amendment is being filed solely to reformat the conformed signature on the Report of Independent Registered Public Accounting Firm. Due to an inadvertent oversight in the EDGAR preparation process, the conformed signature was included, but not visible, in the Original Filing. In accordance with Rule 12b-15 of the Securities Exchange Act of 1934, as amended, this Amendment includes new certifications required by Sections 302 and 906 of the Sarbanes-Oxley Act of 2002, as amended, dated as of the filing date of this Amendment. In addition, the consent filed as Exhibit 23 to this Amendment is dated as of the filing date of this Amendment. No other changes were made to the Original Filing. For ease of reference, the entire Form 10-K, including all other exhibits filed therewith, is included with this Amendment.
Trading Symbol	CL
Entity Common Stock, Shares Outstanding		875,326,736
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Public Float			$ 65.1

Consolidated Statements of Inco

Consolidated Statements of Income - USD ($) $ in Millions	12 Months Ended
Consolidated Statements of Income - USD ($) $ in Millions	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Income Statement [Abstract]
Net sales	$ 15,454	$ 15,195	$ 16,034
Cost of sales	6,174	6,072	6,635
Gross profit	9,280	9,123	9,399
Selling, general and administrative expenses	5,497	5,249	5,464
Other (income) expense, net	194	37	62
Charge for Venezuela accounting change	0	0	1,084
Operating profit	3,589	3,837	2,789
Interest (income) expense, net	102	99	26
Income before income taxes	3,487	3,738	2,763
Provision for income taxes	1,313	1,152	1,215
Net income including noncontrolling interests	2,174	2,586	1,548
Less: Net income attributable to noncontrolling interests	150	145	164
Net income attributable to Colgate-Palmolive Company	$ 2,024	$ 2,441	$ 1,384
Earnings per common share, basic (in dollars per share)	$ 2.30	$ 2.74	$ 1.53
Earnings per common share, diluted (in dollars per share)	$ 2.28	$ 2.72	$ 1.52

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Statement of Comprehensive Income [Abstract]
Net income including noncontrolling interests	$ 2,174	$ 2,586	$ 1,548
Other comprehensive income (loss), net of tax:
Cumulative translation adjustments	302	(137)	(645)
Retirement plan and other retiree benefit adjustments	54	(109)	196
Gains (losses) on available-for-sale securities	0	(1)	(7)
Gains (losses) on cash flow hedges	(14)	5	2
Total Other comprehensive income (loss), net of tax	342	(242)	(454)
Total Comprehensive income including noncontrolling interests	2,516	2,344	1,094
Less: Net income attributable to noncontrolling interests	150	145	164
Less: Cumulative translation adjustments attributable to noncontrolling interests	17	(12)	(11)
Total Comprehensive income attributable to noncontrolling interests	167	133	153
Total Comprehensive income attributable to Colgate-Palmolive Company	$ 2,349	$ 2,211	$ 941

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2017	Dec. 31, 2016
Current Assets
Cash and cash equivalents	$ 1,535	$ 1,315
Receivables (net of allowances of $77 and $73, respectively)	1,480	1,411
Inventories	1,221	1,171
Other current assets	403	441
Total current assets	4,639	4,338
Property, plant and equipment, net	4,072	3,840
Goodwill	2,218	2,107
Other intangible assets, net	1,341	1,313
Deferred income taxes	188	301
Other assets	218	224
Total assets	12,676	12,123
Current Liabilities
Notes and loans payable	11	13
Current portion of long-term debt	0	0
Accounts payable	1,212	1,124
Accrued income taxes	354	441
Other accruals	1,831	1,727
Total current liabilities	3,408	3,305
Long-term debt	6,566	6,520
Deferred income taxes	204	246
Other liabilities	2,255	2,035
Total liabilities	12,433	12,106
Commitments and contingent liabilities
Shareholders’ Equity
Common stock, $1 par value (2,000,000,000 shares authorized, 1,465,706,360 shares issued)	1,466	1,466
Additional paid-in capital	1,984	1,691
Retained earnings	20,531	19,922
Accumulated other comprehensive income (loss)	(3,855)	(4,180)
Unearned compensation	(5)	(7)
Treasury stock, at cost	(20,181)	(19,135)
Total Colgate-Palmolive Company shareholders’ equity	(60)	(243)
Noncontrolling interests	303	260
Total equity	243	17
Total liabilities and equity	$ 12,676	$ 12,123

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Dec. 31, 2017	Dec. 31, 2016
Current Assets
Allowance for doubtful accounts receivable, current	$ 77	$ 73
Commitments and contingent liabilities
Shareholders’ Equity
Common Stock, Par Value (in dollars per share)	$ 1	$ 1
Common Stock, Shares Authorized (in shares)	2,000,000,000	2,000,000,000
Common Stock, Shares Issued (in shares)	1,465,706,360	1,465,706,360

Consolidated Statements of Chan

Consolidated Statements of Changes in Shareholders' Equity - USD ($) $ in Millions	Total	Common Stock	Additional Paid-In Capital	Unearned Compensation	Treasury Stock	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Noncontrolling Interests
Beginning balance at Dec. 31, 2014		$ 1,466	$ 1,236	$ (20)	$ (16,862)	$ 18,832	$ (3,507)	$ 240
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	$ 1,548					1,384		164
Other comprehensive income (loss), net of tax	(454)						(443)	(11)
Dividends						(1,355)		(138)
Stock-based compensation expense			125
Shares issued for stock options			90		243
Shares issued for restricted stock awards			(69)		69
Treasury stock acquired					(1,551)
Other			56	8	(1)
Ending balance at Dec. 31, 2015		1,466	1,438	(12)	(18,102)	18,861	(3,950)	255
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	2,586					2,441		145
Other comprehensive income (loss), net of tax	(242)						(230)	(12)
Dividends						(1,380)		(128)
Stock-based compensation expense			123
Shares issued for stock options			128		242
Shares issued for restricted stock awards			(60)		60
Treasury stock acquired					(1,335)
Other			62	5
Ending balance at Dec. 31, 2016	17	1,466	1,691	(7)	(19,135)	19,922	(4,180)	260
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	2,174					2,024		150
Other comprehensive income (loss), net of tax	342						325	17
Dividends						(1,405)		(124)
Stock-based compensation expense			127
Shares issued for stock options			197		313
Shares issued for restricted stock awards			(34)		34
Treasury stock acquired					(1,399)
Other			3	2	6	(10)
Ending balance at Dec. 31, 2017	$ 243	$ 1,466	$ 1,984	$ (5)	$ (20,181)	$ 20,531	$ (3,855)	$ 303

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Operating Activities
Net income including noncontrolling interests	$ 2,174	$ 2,586	$ 1,548
Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations:
Depreciation and amortization	475	443	449
Restructuring and termination benefits, net of cash	91	(9)	69
Venezuela remeasurement charges	0	0	34
Stock-based compensation expense	127	123	125
Gain on sale of land in Mexico	0	(97)	0
Gain on sale of South Pacific laundry detergent business	0	0	(187)
Charge for Venezuela accounting change	0	0	1,084
Charge for U.S. tax reform	275	0	0
Deferred income taxes	108	56	(51)
Voluntary benefit plan contributions	(81)	(53)	0
Cash effects of changes in:
Receivables	(15)	(17)	(75)
Inventories	(8)	(4)	(13)
Accounts payable and other accruals	(96)	100	(67)
Other non-current assets and liabilities	4	13	33
Net cash provided by operations	3,054	3,141	2,949
Investing Activities
Capital expenditures	(553)	(593)	(691)
Sale of property and non-core product lines	44	0	9
Purchases of marketable securities and investments	(347)	(336)	(742)
Proceeds from sale of marketable securities and investments	391	378	599
Proceeds from sale of land in Mexico	0	60	0
Proceeds from sale of South Pacific laundry detergent business	0	0	221
Payment for acquisitions, net of cash acquired	0	(5)	(13)
Reduction in cash due to Venezuela accounting change	0	0	(75)
Other	(6)	(3)	7
Net cash used in investing activities	(471)	(499)	(685)
Financing Activities
Principal payments on debt	(4,808)	(7,274)	(9,181)
Proceeds from issuance of debt	4,779	7,438	9,602
Dividends paid	(1,529)	(1,508)	(1,493)
Purchases of treasury shares	(1,399)	(1,335)	(1,551)
Proceeds from exercise of stock options	507	446	347
Net cash used in financing activities	(2,450)	(2,233)	(2,276)
Effect of exchange rate changes on Cash and cash equivalents	87	(64)	(107)
Net (decrease) increase in Cash and cash equivalents	220	345	(119)
Cash and cash equivalents at beginning of year	1,315	970	1,089
Cash and cash equivalents at end of year	1,535	1,315	970
Supplemental Cash Flow Information
Income taxes paid	1,037	932	1,259
Interest paid	$ 150	$ 162	$ 131

Nature of Operations

Nature of Operations	12 Months Ended
Nature of Operations	Dec. 31, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Operations	Nature of Operations The Company manufactures and markets a wide variety of products in the U.S. and around the world in two product segments: Oral, Personal and Home Care; and Pet Nutrition. Oral, Personal and Home Care products include toothpaste, toothbrushes and mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, laundry and dishwashing detergents, fabric conditioners, household cleaners and other similar items. These products are sold primarily to retail and wholesale customers and distributors worldwide. Pet Nutrition products include specialty pet nutrition products manufactured and marketed by Hill’s Pet Nutrition. The principal customers for Pet Nutrition products are authorized pet supply retailers and veterinarians. Many of the products from both product segments are also sold to e-commerce retailers. Principal global and regional trademarks include Colgate, Palmolive, Speed Stick, Lady Speed Stick, Softsoap, Irish Spring, Protex, Sorriso, Kolynos, elmex, Tom’s of Maine, Sanex, Ajax, Axion, Fabuloso, Soupline and Suavitel, as well as Hill’s Science Diet, Hill’s Prescription Diet and Hill ’ s Ideal Balance. The Company’s principal classes of products accounted for the following percentages of worldwide Net sales for the past three years: 2017 2016 2015 Oral Care 48 % 47 % 47 % Personal Care 19 % 20 % 20 % Home Care 18 % 18 % 19 % Pet Nutrition 15 % 15 % 14 % Total 100 % 100 % 100 %

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
Summary of Significant Accounting Policies	Dec. 31, 2017
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Principles of Consolidation The Consolidated Financial Statements include the accounts of Colgate-Palmolive Company and its majority-owned or controlled subsidiaries. Intercompany transactions and balances have been eliminated. The Company’s investments in consumer products companies with interests ranging between 20% and 50% , where the Company has significant influence over the investee, are accounted for using the equity method. Net income (loss) from such investments is recorded in Other (income) expense, net in the Consolidated Statements of Income. As of December 31, 2017 and 2016 , equity method investments included in Other assets in the Consolidated Balance Sheets were $42 and $38 , respectively. Unrelated third parties hold the remaining ownership interests in these investments. Investments with less than a 20% interest are accounted for using the cost method. Effective December 31, 2015, the Company concluded it no longer met the accounting criteria for consolidation of its Venezuelan subsidiary (“CP Venezuela”) and began accounting for CP Venezuela using the cost method of accounting. As a result, effective December 31, 2015, CP Venezuela’s net assets and operating results are no longer included in the Company’s Consolidated Financial Statements. See Note 14 , Venezuela for further information. Use of Estimates The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires management to use judgment and make estimates that affect the reported amounts of assets and liabilities and disclosure of contingent gains and losses at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The level of uncertainty in estimates and assumptions increases with the length of time until the underlying transactions are completed. As such, the most significant uncertainty in the Company’s assumptions and estimates involved in preparing the financial statements includes pension and other retiree benefit cost assumptions, stock-based compensation, asset impairments, uncertain tax positions, tax valuation allowances, legal and other contingency reserves, the provisional charge in 2017 related to U.S. tax reform (see Note 11 , Income Taxes ) and, prior to the deconsolidation of the Company’s Venezuelan operations, the selection of the exchange rate used to remeasure the financial statements of CP Venezuela (see Note 14 , Venezuela). Additionally, the Company uses available market information and other valuation methodologies in assessing the fair value of financial instruments and retirement plan assets. Judgment is required in interpreting market data to develop the estimates of fair value and, accordingly, changes in assumptions or the estimation methodologies may affect the fair value estimates. Actual results could ultimately differ from those estimates. Revenue Recognition Sales are recorded at the time products are shipped to trade customers and when risk of ownership transfers. Net sales reflect units shipped at selling list prices reduced by sales returns and the cost of current and continuing promotional programs. Current promotional programs, such as product listing allowances and co-operative advertising arrangements, are recorded in the period incurred. Continuing promotional programs are predominantly consumer coupons and volume-based sales incentive arrangements with trade customers. The redemption cost of consumer coupons is based on historical redemption experience and is recorded when coupons are distributed. Volume-based incentives offered to trade customers are based on the estimated cost of the program and are recorded as products are sold. Shipping and Handling Costs Shipping and handling costs are classified as Selling, general and administrative expenses and were $1,183 , $1,140 and $1,235 for the years ended December 31, 2017 , 2016 and 2015 , respectively. Marketing Costs The Company markets its products through advertising and other promotional activities. Advertising costs are included in Selling, general and administrative expenses and are expensed as incurred. Certain consumer and trade promotional programs, such as consumer coupons, are recorded as a reduction of sales. Cash and Cash Equivalents The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. Inventories The cost of approximately 75% of inventories is determined using the first-in, first-out (“FIFO”) method, which is stated at the lower of cost or net realizable value. The cost of all other inventories, in the U.S. and Mexico, is determined using the last-in, first-out (“LIFO”) method, which is stated at the lower of cost or market. Property, Plant and Equipment Land, buildings and machinery and equipment are stated at cost. Depreciation is provided, primarily using the straight-line method, over estimated useful lives ranging from 3 to 15 years for machinery and equipment and up to 40 years for buildings. Depreciation attributable to manufacturing operations is included in Cost of sales. The remaining component of depreciation is included in Selling, general and administrative expenses. Goodwill and Other Intangibles Goodwill and indefinite life intangible assets, such as the Company’s global brands, are subject to impairment tests at least annually. These tests were performed and did not result in an impairment charge. Other intangible assets with finite lives, such as local brands and trademarks, customer relationships and non-compete agreements, are amortized over their estimated useful lives, generally ranging from 5 to 40 years. Amortization expense related to intangible assets is included in Other (income) expense, net, which is included in Operating profit. Income Taxes The provision for income taxes is determined using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized based upon the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates that will be in effect at the time such differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. The Company uses a comprehensive model to recognize, measure, present and disclose in its financial statements uncertain tax positions that the Company has taken or expects to take on an income tax return. The Company recognizes interest expense and penalties related to unrecognized tax benefits within Provision for income taxes. Financial Instruments Derivative instruments are recorded as assets and liabilities at estimated fair value based on available market information. The Company’s derivative instruments that qualify for hedge accounting are designated as either fair value hedges, cash flow hedges or net investment hedges. For fair value hedges, changes in the fair value of the derivative, as well as the offsetting changes in the fair value of the hedged item, are recognized in earnings each period. For cash flow hedges, changes in the fair value of the derivative are recorded in Other comprehensive income (loss) and are recognized in earnings when the offsetting effect of the hedged item is also recognized in earnings. For hedges of the net investment in foreign subsidiaries, changes in the fair value of the derivative are recorded in Other comprehensive income (loss) to offset the change in the value of the net investment being hedged. Cash flows related to hedges are classified in the same category as the cash flows from the hedged item in the Consolidated Statements of Cash Flows. The Company may also enter into certain foreign currency and interest rate instruments that economically hedge certain of its risks but do not qualify for hedge accounting. Changes in fair value of these derivative instruments, based on quoted market prices, are recognized in earnings each period. The Company’s derivative instruments and other financial instruments are more fully described in Note 7 , Fair Value Measurements and Financial Instruments along with the related fair value measurement considerations. Stock-Based Compensation The Company recognizes the cost of employee services received in exchange for awards of equity instruments, such as stock options and restricted stock units, based on the fair value of those awards at the date of grant over the requisite service period. The Company uses the Black-Scholes-Merton ( “ Black-Scholes ” ) option pricing model to determine the fair value of stock option awards. Stock-based compensation plans, related expenses and assumptions used in the Black-Scholes option pricing model are more fully described in Note 8 , Capital Stock and Stock-Based Compensation Plans. Currency Translation The assets and liabilities of foreign subsidiaries, other than those operating in highly inflationary environments, are translated into U.S. dollars at year-end exchange rates with resulting translation gains and losses accumulated in a separate component of shareholders’ equity. Income and expense items are translated into U.S. dollars at average rates of exchange prevailing during the year. For subsidiaries operating in highly inflationary environments, local currency-denominated non-monetary assets, including inventories, goodwill and property, plant and equipment, are remeasured at their historical exchange rates, while local currency-denominated monetary assets and liabilities are remeasured at year-end exchange rates. Remeasurement adjustments for these operations are included in Net income attributable to Colgate-Palmolive Company. Prior to the deconsolidation of the Company’s Venezuelan operations in 2015, CP Venezuela was designated as hyper-inflationary and the functional currency for CP Venezuela was the U.S. dollar. See Note 14, Venezuela for further information. Currently, none of the Company’s subsidiaries operate in highly inflationary environments. Recent Accounting Pronouncements On August 28, 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2017-12, “Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities,” amending the eligibility criteria for hedged items and transactions to expand an entity’s ability to hedge nonfinancial and financial risk components. The new guidance eliminates the requirement to separately measure and present hedge ineffectiveness and aligns the presentation of hedge gains and losses with the underlying hedge item. The new guidance also simplifies the hedge documentation and hedge effectiveness assessment requirements. The new guidance is effective for the Company beginning on January 1, 2019, with early adoption permitted. The amended presentation and disclosure requirements must be adopted on a prospective basis, while any amendments to cash flow and net investment hedge relationships that exist on the date of adoption must be applied on a “modified retrospective” basis, meaning a cumulative effect adjustment to the opening balance of retained earnings as of the beginning of the year of adoption. While the Company is currently assessing the impact of the new standard on its Consolidated Financial Statements, this new guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements. On May 10, 2017, the FASB issued ASU No. 2017-09, “Compensation–Stock Compensation (Topic 718): Scope of Modification Accounting,” clarifying when a change to the terms or conditions of a stock-based payment award must be accounted for as a modification. The new guidance requires modification accounting if the fair value, vesting condition or the classification of the award is not the same immediately before and after a change to the terms and conditions of the award. The new guidance was effective for the Company on a prospective basis beginning on January 1, 2018. This new guidance is not expected to have an impact on the Company’s Consolidated Financial Statements as it is not the Company’s practice to change either the terms or conditions of stock-based payment awards once they are granted. On March 10, 2017, the FASB issued ASU No. 2017-07, “Compensation–Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost,” changing the presentation of the net periodic benefit cost on the Statement of Income and limiting the amount of net periodic benefit cost eligible for capitalization to assets. The new guidance permits only the service cost component of net periodic benefit cost to be eligible for capitalization. The new guidance also requires entities to present the service cost component of net periodic benefit cost together with compensation costs arising from services rendered by employees during the period. Other components of net periodic benefit cost, which include interest, expected return on assets, amortization of prior service costs and actuarial gains and losses, are required to be presented outside of Operating profit. The line item or items used to present the other components of net periodic benefit cost must be disclosed in the Notes to the Consolidated Financial Statements, if not separately described on the Statement of Income. The new presentation requirement is required to be adopted on a “full retrospective” basis, meaning the standard is applied to all of the periods presented in the financial statements, while the limitation on capitalization can only be adopted on a prospective basis. The new guidance was effective for the Company beginning on January 1, 2018. Had the standard been effective for the year ended December 31, 2017, full year Operating profit would have increased by approximately $120 with no impact on Net income attributable to Colgate-Palmolive Company. The Company anticipates that, as a result of the reclassification, full year Operating profit will increase in future periods by approximately $100 annually with no impact on Net income attributable to Colgate-Palmolive Company. On January 26, 2017, the FASB issued ASU No. 2017-04, “Intangibles–Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment,” eliminating the requirement to calculate the implied fair value, essentially eliminating step two from the goodwill impairment test. The new standard requires goodwill impairment to be based upon the results of step one of the impairment test, which is defined as the excess of the carrying value of a reporting unit over its fair value. The impairment charge will be limited to the amount of goodwill allocated to that reporting unit. The standard is effective for the Company on a prospective basis beginning on January 1, 2020, with early adoption permitted. This new guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements. On January 5, 2017, the FASB issued ASU No. 2017-01, “Business Combinations (Topic 805): Clarifying the Definition of a Business,” which provides additional guidance on evaluating whether transactions should be accounted for as acquisitions of assets or businesses. The guidance requires an entity to evaluate if substantially all of the fair value of the assets acquired is concentrated in a single identifiable asset or a group of similar identifiable assets. If this threshold is met, the new guidance would define this as an asset acquisition; otherwise, the entity then evaluates whether the asset meets the requirement that a business include, at a minimum, an input and substantive process that together significantly contribute to the ability to create outputs. The guidance was effective for the Company on a prospective basis beginning on January 1, 2018. This new guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements. On October 24, 2016, the FASB issued ASU No. 2016-16, “Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other than Inventory,” which eliminates the requirement to defer recognition of income taxes on intra-entity asset transfers until the asset is sold to an outside party. The new guidance requires the recognition of current and deferred income taxes on intra-entity transfers of assets other than inventory, such as intellectual property and property, plant and equipment, when the transfer occurs. As permitted, the Company early-adopted the new standard on a “modified retrospective” basis, meaning the standard was applied only to the most recent period presented in the financial statements, as of January 1, 2017. This new guidance did not have a material impact on the Company’s Consolidated Financial Statements. On August 26, 2016, the FASB issued ASU No. 2016-15, “Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments,” which clarifies how certain cash receipts and payments are to be presented in the statement of cash flows. The guidance was effective for the Company on January 1, 2018. This new guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements. On March 30, 2016, the FASB issued ASU No. 2016-09, “Compensation–Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting,” which amended accounting for income taxes related to stock-based compensation, the related classification in the statement of cash flows and share award forfeiture accounting. The new guidance was effective for the Company beginning on January 1, 2017. As required subsequent to the adoption of this new guidance, the Company recognized excess tax benefits of $47 (resulting from an increase in the fair value of an award from grant date to the vesting or exercise date, as applicable) in the Provision for income taxes as a discrete item during the year ended December 31, 2017 . These amounts may not necessarily be indicative of future amounts that may be recognized as any excess tax benefits from stock-based compensation recognized would be dependent on future stock price, employee exercise behavior and applicable tax rates. Prior to January 1, 2017, excess tax benefits were recognized in equity. As permitted, the Company elected to classify these excess tax benefits from stock-based compensation as an operating activity in the Statement of Cash Flows instead of as a financing activity on a prospective basis and did not retrospectively adjust prior periods. Also, as permitted by the new standard, the Company elected to account for forfeitures as they occur. On March 15, 2016, the FASB issued ASU No. 2016-07, “Investments–Equity Method and Joint Ventures (Topic 323): Simplifying the Transition to the Equity Method of Accounting,” which eliminated the requirement to retroactively adjust an investment that subsequently qualifies for equity method accounting (as a result of an increase in level of ownership interest or degree of influence) as if the equity method of accounting had been applied during all prior periods that the investment was held. The new standard requires that the investor add the cost of acquiring additional ownership interest in the investee to its current basis and prospectively apply the equity method of accounting. For an available-for-sale investment, any unrealized gains or losses should be recognized in earnings at the date the investment qualifies as an equity method investment. The new guidance was effective for the Company beginning on January 1, 2017, and did not have a material impact on the Company’s Consolidated Financial Statements. On February 25, 2016, the FASB issued its final standard on lease accounting, ASU No. 2016-02, “Leases (Topic 842),” which supersedes Topic 840, “Leases.” The new accounting standard requires the recognition of right-of-use assets and lease liabilities for all long-term leases, including operating leases, on the balance sheet. The new standard also provides additional guidance on the measurement of the right-of-use assets and lease liabilities and will require enhanced disclosures about the Company’s leasing arrangements. Under current accounting standards, substantially all of the Company’s leases are considered operating leases and, as such, are not recognized on the Consolidated Balance Sheet. This new standard is effective for the Company beginning on January 1, 2019, with early adoption permitted. The standard requires a “modified retrospective” adoption, meaning the standard is applied to leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements. The Company is currently assessing the impact of the new standard on its Consolidated Financial Statements. On January 5, 2016, the FASB issued ASU No. 2016-01, “Financial Instruments–Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities.” The updated guidance enhances the reporting model for financial instruments, which includes amendments to address aspects of recognition, measurement, presentation and disclosure. The amendment to the standard was effective for the Company beginning on January 1, 2018 and is not expected to have a material impact on the Company’s Consolidated Financial Statements. On July 22, 2015, the FASB issued ASU No. 2015-11, “Inventory (Topic 330): Simplifying the Measurement of Inventory,” which simplifies the subsequent measurement of inventories by replacing the lower of cost or market test with a lower of cost and net realizable value test. The guidance applies only to inventories for which cost is determined by methods other than LIFO and the retail inventory method. The new guidance was effective for the Company beginning on January 1, 2017. This new guidance did not have a material impact on the Company’s Consolidated Financial Statements. On May 28, 2014, the FASB and the International Accounting Standards Board issued their final converged standard on revenue recognition. The standard, issued as ASU No. 2014-09, “Revenue from Contracts with Customers (Topic 606)” by the FASB, provides a comprehensive revenue recognition model for all contracts with customers and supersedes current revenue recognition guidance. The revenue standard contains principles that an entity will apply to determine the measurement of revenue and timing of when it is recognized. The underlying principle is that an entity will recognize revenue to depict the transfer of goods or services to its customers at an amount that the entity expects to be entitled to in exchange for those goods or services. The new standard also includes enhanced disclosures. During 2016, the FASB issued several accounting updates (ASU No. 2016-08, 2016-10 and 2016-12) to clarify implementation guidance and correct unintended application of the guidance. The standard allows for either full retrospective adoption or modified retrospective adoption. The Company adopted the new standard on January 1, 2018, on a “modified retrospective” basis, which did not have a material impact on the Company’s Consolidated Financial Statements. Although the new standard resulted in changes to the Company’s revenue recognition accounting policy commencing on January 1, 2018, the Company does not expect it will have a material impact in future periods on its Consolidated Financial Statements. Reclassifications Certain prior year amounts have been reclassified to conform to the current year presentation.

Acquisitions and Divestitures

Acquisitions and Divestitures	12 Months Ended
Acquisitions and Divestitures	Dec. 31, 2017
Business Combinations [Abstract]
Acquisitions and Divestitures	Acquisitions and Divestitures Acquisitions In January 2018, the Company acquired all of the outstanding equity interests of Physicians Care Alliance, LLC and Elta MD Holdings, Inc., professional skin care businesses, for aggregate cash consideration of approximately $730 . Sale of Land in Mexico In September 2016, the Company’s Mexican subsidiary completed the sale to the United States of America of the Mexico City site on which its commercial operations, technology center and soap production facility were previously located and received $ 60 as the third and final installment of the sale price. The total sale price (including the third installment and the previously received first and second installments) was $ 120 . The Company recognized a pretax gain of $ 97 ($ 63 aftertax or $0.07 per diluted share) in the third quarter of 2016, net of costs primarily related to site preparation. Sale of Laundry Detergent Business in the South Pacific In August 2015, the Company completed the sale of its laundry detergent business in the South Pacific to Henkel AG & Co. KGaA for an aggregate purchase price of approximately 310 Australian dollars ($ 221 ) and recorded a pretax gain of $ 187 ($ 120 aftertax or $ 0.13 per diluted share) in Other (income) expense, net. The gain is net of charges related to the right-sizing of the Company’s South Pacific business, asset write-offs related to the divested laundry detergent business and other costs related to the sale. The funds from the sale were reinvested to expand the Global Growth and Efficiency Program (see Note 4, Restructuring and Related Implementation Changes).

Restructuring and Related Imple

Restructuring and Related Implementation Charges	12 Months Ended
Restructuring and Related Implementation Charges	Dec. 31, 2017
Restructuring and Related Activities [Abstract]
Restructuring and Related Implementation Charges	Restructuring and Related Implementation Charges In the fourth quarter of 2012, the Company commenced a restructuring program (the “Global Growth and Efficiency Program”) for sustained growth. The program was expanded in 2014 and expanded and extended in 2015. Building on the Company’s successful implementation of the program, on October 26, 2017 , the Board approved an expansion of the Global Growth and Efficiency Program and an extension of the program through December 31, 2019 to take advantage of additional opportunities to streamline the Company’s operations. Initiatives under the Global Growth and Efficiency Program continue to fit within the program’s three focus areas of expanding commercial hubs, extending shared business services and streamlining global functions and optimizing the global supply chain and facilities. Including the most recent expansion, cumulative pretax charges resulting from the Global Growth and Efficiency Program, once all phases are approved and implemented, are estimated to be in the range of $1,730 to $1,885 ( $1,280 to $1,380 aftertax). The Company anticipates that pretax charges for 2018 will approximate $100 to $175 ( $75 to $125 aftertax). It is expected that substantially all charges resulting from the Global Growth and Efficiency Program will be incurred by December 31, 2019. The pretax charges resulting from the Global Growth and Efficiency Program are currently estimated to be comprised of the following categories: Employee-Related Costs, including severance, pension and other termination benefits ( 50% ); asset-related costs, primarily Incremental Depreciation and Asset Impairments ( 10% ); and Other charges, which include contract termination costs, consisting primarily of related implementation charges resulting directly from exit activities ( 20% ) and the implementation of new strategies ( 20% ). Over the course of the Global Growth and Efficiency Program, it is currently estimated that approximately 80% of the charges will result in cash expenditures. The Company expects that the cumulative pretax charges, once all projects are approved and implemented, will relate to initiatives undertaken in North America ( 15% ), Europe ( 20% ), Latin America ( 5% ), Asia Pacific ( 5% ), Africa/Eurasia ( 5% ), Hill’s Pet Nutrition ( 10% ) and Corporate ( 40% ), which includes substantially all of the costs related to the implementation of new strategies, noted above, on a global basis. The Company expects that, when it has been fully implemented, the Global Growth and Efficiency Program will have contributed a net reduction of approximately 3,800 to 4,400 positions from the Company’s global employee workforce. For the years ended December 31, 2017 , 2016 and 2015 , restructuring and related implementation charges are reflected in the Consolidated Statements of Income as follows: 2017 2016 2015 Cost of sales $ 75 $ 46 $ 20 Selling, general and administrative expenses 89 77 64 Other (income) expense, net 169 105 170 Total Global Growth and Efficiency Program charges, pretax $ 333 $ 228 $ 254 Total Global Growth and Efficiency Program charges, aftertax $ 246 $ 168 $ 183 Restructuring and related implementation charges in the preceding table are recorded in the Corporate segment as these initiatives are predominantly centrally directed and controlled and are not included in internal measures of segment operating performance. Total charges incurred for the Global Growth and Efficiency Program relate to initiatives undertaken by the following reportable operating segments: Program-to-date 2017 2016 2015 Accumulated Charges North America 23 % 35 % 21 % 18 % Latin America 2 % 5 % 3 % 3 % Europe 21 % 12 % 14 % 22 % Asia Pacific 5 % 4 % 4 % 3 % Africa/Eurasia 3 % 14 % 5 % 6 % Hill ’ s Pet Nutrition 6 % 7 % 5 % 7 % Corporate 40 % 23 % 48 % 41 % Total 100 % 100 % 100 % 100 % Since the inception of the Global Growth and Efficiency Program in the fourth quarter of 2012, the Company has incurred cumulative pretax charges of $1,561 ( $1,153 aftertax) in connection with the implementation of various projects as follows: Cumulative Charges as of December 31, 2017 Employee-Related Costs $ 628 Incremental Depreciation 90 Asset Impairments 36 Other 807 Total $ 1,561 The majority of costs incurred since inception relate to the following projects: the implementation of the Company’s overall hubbing strategy; the extension of shared business services and streamlining of global functions; the consolidation of facilities; the closing of the Morristown, New Jersey personal care facility; the simplification and streamlining of the Company’s research and development capabilities and oral care supply chain, both in Europe; redesigning the European commercial organization; restructuring how the Company will provide future retirement benefits to substantially all of the U.S.-based employees participating in the Company’s defined benefit retirement plan by shifting them to the Company’s defined contribution plan; and the implementation of a Corporate efficiencies program. The following table summarizes the activity for the restructuring and related implementation charges, in the respective periods, discussed above and the related accruals: Employee-Related Costs Incremental Depreciation Asset Impairments Other Total Balance at January 1, 2015 $ 85 $ — $ — $ 107 $ 192 Charges 109 20 5 120 254 Cash payments (85 ) — — (94 ) (179 ) Charges against assets (17 ) (20 ) (5 ) — (42 ) Foreign exchange (8 ) — — (2 ) (10 ) Other — — — — — Balance at December 31, 2015 $ 84 $ — $ — $ 131 $ 215 Charges 61 9 20 138 228 Cash payments (84 ) — — (153 ) (237 ) Charges against assets (4 ) (9 ) (20 ) — (33 ) Foreign exchange (1 ) — — — (1 ) Other — — — 9 9 Balance at December 31, 2016 $ 56 $ — $ — $ 125 $ 181 Charges 163 10 9 151 333 Cash payments (74 ) — — (170 ) (244 ) Charges against assets (21 ) (10 ) (9 ) — (40 ) Foreign exchange 3 — — 1 4 Other — — — — — Balance at December 31, 2017 $ 127 $ — $ — $ 107 $ 234 Employee-Related Costs primarily include severance and other termination benefits and are calculated based on long-standing benefit practices, local statutory requirements and, in certain cases, voluntary termination arrangements. Employee-Related Costs also include pension and other retiree benefit enhancements amounting to $21 , $4 and $17 for the years ended December 31, 2017, 2016 and 2015, respectively, which are reflected as Charges against assets within Employee-Related Costs in the preceding table as the corresponding balance sheet amounts are reflected as a reduction of pension assets or an increase in pension and other retiree benefit liabilities (see Note 10 , Retirement Plans and Other Retiree Benefits). Incremental Depreciation is recorded to reflect changes in useful lives and estimated residual values for long-lived assets that will be taken out of service prior to the end of their normal service period. Asset Impairments are recorded to write down assets held for sale or disposal to their fair value based on amounts expected to be realized. Charges against assets within Asset Impairments are net of cash proceeds pertaining to the sale of certain assets. Other charges consist primarily of charges resulting directly from exit activities and the implementation of new strategies as a result of the Global Growth and Efficiency Program. These charges for the years ended December 31, 2017, 2016 and 2015 include third-party incremental costs related to the development and implementation of new business and strategic initiatives of $145 , $116 and $65 , respectively, and contract termination costs and charges resulting directly from exit activities of $6 , $21 and $8 , respectively. These charges were expensed as incurred. Also included in Other charges for the years ended December 31, 2017, 2016 and 2015 are other exit costs of $0 , $1 and $47 , respectively, related to the consolidation of facilities.

Goodwill and Other Intangible A

Goodwill and Other Intangible Assets	12 Months Ended
Goodwill and Other Intangible Assets	Dec. 31, 2017
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Other Intangible Assets	Goodwill and Other Intangible Assets The net carrying value of Goodwill as of December 31, 2017 and 2016 by segment was as follows: 2017 2016 Oral, Personal and Home Care North America $ 343 $ 336 Latin America 256 260 Europe 1,333 1,233 Asia Pacific 190 187 Africa/Eurasia 81 76 Total Oral, Personal and Home Care 2,203 2,092 Pet Nutrition 15 15 Total Goodwill $ 2,218 $ 2,107 The change in the amount of Goodwill in each year is primarily due to the impact of foreign currency translation. Other intangible assets as of December 31, 2017 and 2016 were comprised of the following: 2017 2016 Gross Carrying Amount Accumulated Amortization Net Gross Carrying Amount Accumulated Amortization Net Trademarks $ 547 $ (337 ) $ 210 $ 539 $ (317 ) $ 222 Other finite life intangible assets 249 (103 ) 146 231 (78 ) 153 Indefinite life intangible assets 985 — 985 938 — 938 Total Other intangible assets $ 1,781 $ (440 ) $ 1,341 $ 1,708 $ (395 ) $ 1,313 The changes in the net carrying amounts of Other intangible assets during 2017 , 2016 and 2015 were primarily due to amortization expense of $35 , $33 and $33 , respectively, as well as the impact of foreign currency translation. Annual estimated amortization expense for each of the next five years is expected to be approximately $35 .

Long-Term Debt and Credit Facil

Long-Term Debt and Credit Facilities	12 Months Ended
Long-Term Debt and Credit Facilities	Dec. 31, 2017
Debt Disclosure [Abstract]
Long-Term Debt and Credit Facilities	Long-Term Debt and Credit Facilities Long-term debt consisted of the following at December 31: Weighted Average Interest Rate Maturities 2017 2016 Notes 2.0% 2018 - 2078 $ 6,542 $ 6,225 Commercial paper 1.5% 2018 24 295 6,566 6,520 Less: Current portion of long-term debt — — Total $ 6,566 $ 6,520 The weighted-average interest rate on short-term borrowings of $11 in 2017 and $13 in 2016 included in Notes and loans payable in the Consolidated Balance Sheets as of December 31, 2017 and 2016 was 2.8% and 1.6% , respectively. The Company classifies commercial paper and notes maturing within the next twelve months as long-term debt when it has the intent and ability to refinance such obligations on a long-term basis. Excluding such obligations, scheduled maturities of long-term debt and capitalized leases outstanding as of December 31, 2017 , were as follows: Years Ended December 31, 2018 $ — 2019 1,097 2020 248 2021 298 2022 889 Thereafter 3,311 The Company has entered into interest rate swap agreements and foreign exchange contracts related to certain of these debt instruments. See Note 7, Fair Value Measurements and Financial Instruments for further information about the Company’s financial instruments. The Company’s debt issuances support its capital structure strategy objectives of funding its business and growth initiatives while minimizing its risk-adjusted cost of capital. During the fourth quarter of 2017, the Company issued $400 of five -year notes at a fixed rate of 2.25% . During the third quarter of 2017, the Company issued $500 of thirty -year notes at a fixed rate of 3.70% . The debt issuances in 2017 were under the Company’s shelf registration statement. Proceeds from the debt issuances in 2017 were used for general corporate purposes which included the retirement of commercial paper borrowings. At December 31, 2017 , the Company had access to unused domestic and foreign lines of credit of $ 2,949 (including under the facilities discussed below) and could also issue medium-term notes pursuant to an effective shelf registration statement. In November 2011, the Company entered into a five -year revolving credit facility with a capacity of $1,850 with a syndicate of banks. This facility was extended for an additional year in 2012 and again in 2013. In 2014, the Company entered into an amendment of this facility whereby the facility was extended for an additional year to November 2019 and the capacity of the facility was increased to $2,370 . In 2016, the facility was extended for an additional year to November 2020 . The Company also has the ability to draw $165 from a revolving credit facility that expires in November 2018 . Commitment fees related to the credit facilities are not material. Certain agreements with respect to the Company’s bank borrowings contain financial and other covenants as well as cross-default provisions. Noncompliance with these requirements could ultimately result in the acceleration of amounts owed. The Company is in full compliance with all such requirements and believes the likelihood of noncompliance is remote.

Fair Value Measurements and Fin

Fair Value Measurements and Financial Instruments	12 Months Ended
Fair Value Measurements and Financial Instruments	Dec. 31, 2017
Financial Instruments and Fair Value Measurements [Abstract]
Fair Value Measurements and Financial Instruments	Fair Value Measurements and Financial Instruments The Company uses available market information and other valuation methodologies in assessing the fair value of financial instruments. Judgment is required in interpreting market data to develop the estimates of fair value and, accordingly, changes in assumptions or the estimation methodologies may affect the fair value estimates. The Company is exposed to the risk of credit loss in the event of nonperformance by counterparties to financial instrument contracts; however, nonperformance is considered unlikely and any nonperformance is unlikely to be material, as it is the Company’s policy to contract only with diverse, credit-worthy counterparties based upon both strong credit ratings and other credit considerations. The Company is exposed to market risk from foreign currency exchange rates, interest rates and commodity price fluctuations. Volatility relating to these exposures is managed on a global basis by utilizing a number of techniques, including working capital management, sourcing strategies, selling price increases, selective borrowings in local currencies and entering into selective derivative instrument transactions, issued with standard features, in accordance with the Company’s treasury and risk management policies, which prohibit the use of derivatives for speculative purposes and leveraged derivatives for any purpose. It is the Company’s policy to enter into derivative instrument contracts with terms that match the underlying exposure being hedged. Hedge ineffectiveness, if any, is not material for any period presented. Provided below are details of the Company’s exposures by type of risk and derivative instruments by type of hedge designation. Valuation Considerations Assets and liabilities carried at fair value are classified as follows: Level 1: Based upon quoted market prices in active markets for identical assets or liabilities. Level 2: Based upon observable market-based inputs or unobservable inputs that are corroborated by market data. Level 3: Based upon unobservable inputs reflecting the reporting entity’s own assumptions. Foreign Exchange Risk As the Company markets its products in over 200 countries and territories, it is exposed to currency fluctuations related to manufacturing and selling its products in currencies other than the U.S. dollar. The Company manages its foreign currency exposures through a combination of cost containment measures, sourcing strategies, selling price increases and the hedging of certain costs in an effort to minimize the impact on earnings of foreign currency rate movements. The Company primarily utilizes foreign currency contracts, including forward and swap contracts, option contracts, foreign and local currency deposits and local currency borrowings to hedge portions of its foreign currency purchases, assets and liabilities arising in the normal course of business and the net investment in certain foreign subsidiaries. The duration of foreign currency contracts generally does not exceed 12 months and the contracts are valued using observable market rates (Level 2 valuation). Interest Rate Risk The Company manages its targeted mix of fixed and floating rate debt with debt issuances and by entering into interest rate swaps in order to mitigate fluctuations in earnings and cash flows that may result from interest rate volatility. The notional amount, interest payment and maturity date of the swaps generally match the principal, interest payment and maturity date of the related debt, and the swaps are valued using observable benchmark rates (Level 2 valuation). Commodity Price Risk The Company is exposed to price volatility related to raw materials used in production, such as resins, pulp, essential oils, tropical oils, tallow, poultry, corn and soybeans . The Company manages its raw material exposures through a combination of cost containment measures, sourcing strategies, ongoing productivity initiatives and the limited use of commodity hedging contracts. Futures contracts are used on a limited basis, primarily in the Hill’s Pet Nutrition segment, to manage volatility related to raw material inventory purchases of certain traded commodities, and these contracts are measured using quoted commodity exchange prices (Level 1 valuation). The duration of the commodity contracts generally does not exceed 12 months. Credit Risk The Company is exposed to the risk of credit loss in the event of nonperformance by counterparties to financial instrument contracts; however, nonperformance is considered unlikely and any nonperformance is unlikely to be material as it is the Company’s policy to contract with diverse, credit-worthy counterparties based upon both strong credit ratings and other credit considerations. The following table summarizes the fair value of the Company’s derivative instruments and other financial instruments at December 31, 2017 and December 31, 2016 : Assets Liabilities Account Fair Value Account Fair Value Designated derivative instruments 12/31/17 12/31/16 12/31/17 12/31/16 Interest rate swap contracts Other current assets $ — $ 1 Other accruals $ — $ — Interest rate swap contracts Other assets — 1 Other liabilities 7 — Foreign currency contracts Other current assets 25 29 Other accruals 20 4 Foreign currency contracts Other assets — 5 Other liabilities 46 — Commodity contracts Other current assets — — Other accruals — — Total designated $ 25 $ 36 $ 73 $ 4 Derivatives not designated Foreign currency contracts Other assets — — Other liabilities — — Total not designated $ — $ — $ — $ — Total derivative instruments $ 25 $ 36 $ 73 $ 4 Other financial instruments Marketable securities Other current assets $ 14 $ 23 Total other financial instruments $ 14 $ 23 The carrying amount of cash, cash equivalents, accounts receivable and short-term debt approximated fair value as of December 31, 2017 and 2016 . The estimated fair value of the Company’s long-term debt, including the current portion, as of December 31, 2017 and 2016 , was $6,799 and $6,717 , respectively, and the related carrying value was $6,566 and $6,520 , respectively. The estimated fair value of long-term debt was derived principally from quoted prices on the Company’s outstanding fixed-term notes (Level 2 valuation). Fair Value Hedges The Company has designated all interest rate swap contracts and certain foreign currency forward and option contracts as fair value hedges, for which the gain or loss on the derivative and the offsetting gain or loss on the hedged item are recognized in current earnings. The impact of foreign currency contracts is primarily recognized in Selling, general and administrative expenses and the impact of interest rate swap contracts is recognized in Interest (income) expense, net. Activity related to fair value hedges recorded during each period presented was as follows: 2017 2016 Foreign Currency Contracts Interest Rate Swaps Total Foreign Currency Contracts Interest Rate Swaps Total Notional Value at December 31, $ 1,231 $ 1,000 $ 2,231 $ 204 $ 1,250 $ 1,454 Gain (loss) on derivatives (7 ) (9 ) (16 ) 5 (5 ) — Gain (loss) on hedged items 7 9 16 (5 ) 5 — Cash Flow Hedges All of the Company’s commodity contracts and certain foreign currency forward contracts have been designated as cash flow hedges, for which the effective portion of the gain or loss is reported as a component of Other comprehensive income ( “ OCI ” ) and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. Activity related to cash flow hedges recorded during each period presented was as follows: 2017 2016 Foreign Currency Contracts Commodity Contracts Total Foreign Currency Contracts Commodity Contracts Total Notional Value at December 31, $ 702 $ — $ 702 $ 643 $ 7 $ 650 Gain (loss) recognized in OCI (25 ) — (25 ) 12 (1 ) 11 Gain (loss) reclassified into Cost of sales (3 ) — (3 ) 4 — 4 The net gain (loss) recognized in OCI for both foreign currency contracts and commodity contracts is generally expected to be recognized in Cost of sales within the next twelve months. Net Investment Hedges The Company has designated certain foreign currency forward and option contracts and certain foreign currency-denominated debt as net investment hedges, for which the gain or loss on the instrument is reported as a component of Cumulative translation adjustments within OCI, along with the offsetting gain or loss on the hedged items. Activity related to net investment hedges recorded during each period presented was as follows: 2017 2016 Foreign Currency Contracts Foreign Currency Debt Total Foreign Currency Contracts Foreign Currency Debt Total Notional Value at December 31, $ 478 $ 601 $ 1,079 $ 498 $ 1,118 $ 1,616 Gain (loss) on instruments (71 ) (112 ) (183 ) 22 35 57 Gain (loss) on hedged items 71 112 183 (25 ) (35 ) (60 ) Derivatives Not Designated as Hedging Instruments Derivatives not designated as hedging instruments include foreign currency contracts for which the gain or loss on the instrument is recognized in Other (income) expense, net for the twelve months ended December 31, 2017. During the second quarter of 2017, the Company de-designated foreign currency forward contracts previously designated as net investment hedges and entered into new derivative instruments with offsetting terms. Gains or losses on these de-designated derivatives were substantially offset by gains and losses on the new derivative instruments. Derivatives not designated as hedging instruments consisted of a cross-currency swap that served as an economic hedge of a foreign currency deposit, for which the gain or loss on the instrument and the offsetting gain or loss on the hedged item was recognized in Other (income) expense, net for the twelve months ended December 31, 2016. Activity related to these contracts during each period presented was as follows: 2017 2016 Foreign Currency Contracts Foreign Currency Contracts Notional Value at December 31, $ 3 $ 4 Gain (loss) on instruments — 5 Gain (loss) on hedged items — (5 ) Other Financial Instruments Other financial instruments are classified as Other current assets or Other assets. Included in Other current assets at December 31, 2017 are marketable securities, which consist of bank deposits of $14 with original maturities greater than 90 days carried at fair value (Level 1 valuation) and the current portion of bonds issued by the Argentinian government in the amount of $4 classified as held-to-maturity and carried at amortized cost. Through its subsidiary in Argentina, the Company has invested in U.S. dollar-linked devaluation-protected bonds and Argentinian peso-denominated bonds issued by the Argentinian government. As of December 31, 2017 and 2016 , the amortized cost of these bonds was $4 and $52 , respectively, and their approximate fair value was $4 and $64 , respectively (Level 2 valuation).

Capital Stock and Stock-Based C

Capital Stock and Stock-Based Compensation Plans	12 Months Ended
Capital Stock and Stock-Based Compensation Plans	Dec. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Capital Stock and Stock-Based Compensation Plans	Capital Stock and Stock-Based Compensation Plans Preference Stock The Company has the authority to issue 50,262,150 shares of preference stock. Stock Repurchases On February 19, 2015, the Board authorized the repurchase of shares of the Company’s common stock having an aggregate purchase price of up to $5,000 under a share repurchase program (the “2015 Program”), which replaced a previously authorized share repurchase program. The Company commenced repurchase of shares of the Company’s common stock under the 2015 Program beginning February 19, 2015. The Board also has authorized share repurchases on an ongoing basis to fulfill certain requirements of the Company’s compensation and benefit programs. The shares are repurchased from time to time in open market or privately negotiated transactions at the Company’s discretion, subject to market conditions, customary blackout periods and other factors. The Company repurchased its common stock at a cost of $ 1,399 during 2017 under the 2015 Program. The Company may use either authorized and unissued shares or treasury shares to meet share requirements resulting from the exercise of stock options and the vesting of restricted stock unit awards. A summary of common stock and treasury stock activity for the three years ended December 31, is as follows: Common Stock Outstanding Treasury Stock Balance, January 1, 2015 906,712,145 558,994,215 Common stock acquired (22,802,784 ) 22,802,784 Shares issued for stock options 7,394,839 (7,394,839 ) Shares issued for restricted stock units and other 1,434,318 (1,434,318 ) Balance, December 31, 2015 892,738,518 572,967,842 Common stock acquired (19,271,304 ) 19,271,304 Shares issued for stock options 8,536,639 (8,536,639 ) Shares issued for restricted stock units and other 1,105,110 (1,105,110 ) Balance, December 31, 2016 883,108,963 582,597,397 Common stock acquired (19,185,828 ) 19,185,828 Shares issued for stock options 9,670,988 (9,670,988 ) Shares issued for restricted stock units and other 1,106,995 (1,106,995 ) Balance, December 31, 2017 874,701,118 591,005,242 Stock-Based Compensation The Company recognizes the cost of employee services received in exchange for awards of equity instruments, such as stock options and restricted stock units, based on the fair value of those awards at the date of grant. The fair value of restricted stock units, generally based on market prices, is amortized on a straight-line basis over the requisite service period. The estimated fair value of stock options on the date of grant is amortized on a straight-line basis over the requisite service period for each separately vesting portion of the award. Awards to employees eligible for retirement prior to the award becoming fully vested are recognized as compensation cost from the grant date through the date that the employee first becomes eligible to retire and is no longer required to provide service to earn the award. The Company has one incentive compensation plan pursuant to which it issues restricted stock units and stock options to employees and shares of common stock and stock options to non-employee directors. The Personnel and Organization Committee of the Board of Directors, which is comprised entirely of independent directors, administers the incentive compensation plan. The total stock-based compensation expense charged against pretax income for this plan was $ 127 , $ 123 and $ 125 for the years ended December 31, 2017 , 2016 and 2015 , respectively. The total income tax benefit recognized on stock-based compensation was approximately $ 42 , $40 and $39 for the years ended December 31, 2017 , 2016 and 2015 , respectively. Stock-based compensation expense is recorded within Selling, general and administrative expenses in the Corporate segment as these amounts are not included in internal measures of segment operating performance. The Company uses the Black-Scholes option pricing model to determine the fair value of stock option awards. The weighted-average estimated fair value of stock options granted in the years ended December 31, 2017 , 2016 and 2015 was $ 8.37 , $ 8.10 and $ 7.25 , respectively. Fair value is estimated using the Black-Scholes option pricing model with the assumptions summarized in the following table: 2017 2016 2015 Expected term of options 4.5 years 4.5 years 4.5 years Expected volatility rate 16.0 % 16.7 % 17.6 % Risk-free interest rate 1.8 % 1.2 % 1.5 % Expected dividend yield 2.2 % 2.1 % 2.5 % The weighted-average expected term of options granted each year was determined with reference to historical exercise and post-vesting cancellation experience, the vesting period of the awards and the contractual term of the awards, among other factors. Expected volatility incorporates implied share-price volatility derived from exchange traded options on the Company’s common stock. The risk-free interest rate for the expected term of the option is based on the yield of a zero-coupon U.S. Treasury bond with a maturity period equal to the option’s expected term. Restricted Stock Units The Company grants restricted stock unit awards to officers and other employees, including long-term incentive awards. Under the Company’s long-term incentive plan, awards are granted following a three-year performance period. Awards vest at the end of the restriction period, which is generally three years from the date of grant. As of December 31, 2017 , approximately 9,870,000 shares of common stock were available for future restricted stock unit awards. A summary of restricted stock unit activity during 2017 is presented below: Shares (in thousands) Weighted Average Grant Date Fair Value Per Award Restricted stock units as of January 1, 2017 2,945 $ 66 Activity: Granted 916 74 Vested (1,057 ) 62 Forfeited (74 ) 67 Restricted stock units as of December 31, 2017 2,730 $ 70 As of December 31, 2017 , there was $ 52 of total unrecognized compensation expense related to unvested restricted stock unit awards, which will be recognized over a weighted-average period of 2.1 years. The total fair value of restricted stock units vested during the years ended December 31, 2017 , 2016 and 2015 was $ 66 , $ 61 and $ 70 , respectively. Stock Options The Company issues non-qualified stock options to non-employee directors, officers and other employees. Stock options generally have a contractual term of six years and vest over three years. As of December 31, 2017 , 20,997,000 shares of common stock were available for future stock option grants. A summary of stock option activity during 2017 is presented below: Shares (in thousands) Weighted Average Exercise Price Weighted Average Remaining Contractual Life (in years) Intrinsic Value of Unexercised In-the-Money Options Options outstanding, January 1, 2017 43,692 $ 61 Granted 7,798 73 Exercised (10,118 ) 53 Forfeited or expired (393 ) 68 Options outstanding, December 31, 2017 40,979 65 4 $ 420 Options exercisable, December 31, 2017 25,349 $ 62 3 $ 351 As of December 31, 2017 , there was $ 45 of total unrecognized compensation expense related to unvested options, which will be recognized over a weighted-average period of 1.5 years. The total intrinsic value of options exercised during the years ended December 31, 2017 , 2016 and 2015 was $ 201 , $ 221 and $ 200 , respectively. The benefits of tax deductions in excess of grant date fair value resulting from the exercise of stock options and vesting of restricted stock unit awards for the years ended December 31, 2017 , 2016 and 2015 were $ 47 , $ 59 and $ 55 , respectively. Through December 31, 2016 these amounts were recognized in equity and were reported as a financing cash flow. Effective January 1, 2017, as a result of the required adoption of ASU No. 2016-09, excess tax benefits from stock-based compensation have been recognized in the provision for income taxes as a discrete item in the quarterly period in which they occur and classified as an operating cash flow. Cash proceeds received from options exercised for the years ended December 31, 2017 , 2016 and 2015 were $ 507 , $ 386 and $ 299 , respectively.

Employee Stock Ownership Plan

Employee Stock Ownership Plan	12 Months Ended
Employee Stock Ownership Plan	Dec. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Employee Stock Ownership Plan	Employee Stock Ownership Plan In 1989, the Company expanded its Employee Stock Ownership Plan ( “ ESOP ” ) through the introduction of a leveraged ESOP that funds certain benefits for employees who have met eligibility requirements. As of December 31, 2017 and 2016 , there were 18,400,412 and 21,082,162 shares of common stock, respectively, outstanding and issued to the Company ’ s ESOP. During 2000, the ESOP entered into a loan agreement with the Company under which the benefits of the ESOP may be extended through 2035. As of December 31, 2017 , the ESOP had outstanding borrowings from the Company of $5 , which represents unearned compensation shown as a reduction in Shareholders’ equity. Dividends on stock held by the ESOP are paid to the ESOP trust and, together with cash contributions from the Company, are (a) used by the ESOP to repay principal and interest, (b) credited to participant accounts or (c) used for contributions to the Company’s defined contribution plans. Stock is allocated to participants based upon the ratio of the current year’s debt service to the sum of total outstanding principal and interest payments over the life of the debt. As of December 31, 2017 , 14,809,986 shares of common stock had been released and allocated to participant accounts and 3,590,426 shares of common stock were available for future allocation to participant accounts. Dividends on the stock used to repay principal and interest or credited to participant accounts are deductible for income tax purposes and, accordingly, are reflected net of their tax benefit in the Consolidated Statements of Changes in Shareholders’ Equity. Annual expense related to the ESOP was $0 in 2017 , 2016 and 2015 . The Company paid dividends on the shares held by the ESOP of $32 in 2017 , $35 in 2016 and $38 in 2015 . The Company contributed to the ESOP $0 in 2017 , 2016 and 2015 .

Retirement Plans and Other Reti

Retirement Plans and Other Retiree Benefits	12 Months Ended
Retirement Plans and Other Retiree Benefits	Dec. 31, 2017
Retirement Benefits [Abstract]
Retirement Plans and Other Retiree Benefits	Retirement Plans and Other Retiree Benefits Retirement Plans The Company and certain of its U.S. and overseas subsidiaries maintain defined benefit retirement plans. Benefits under these plans are based primarily on years of service and employees’ earnings. In the U.S., effective January 1, 2014, the Company provides virtually all future retirement benefits through the Company’s defined contribution plan. As a result, service after December 31, 2013 is not considered for participants in the Company’s principal U.S. defined benefit retirement plan. Participants in the Company’s principal U.S. defined benefit retirement plan whose retirement benefit was determined under the cash balance formula continue to earn interest credits on their vested balances as of December 31, 2013 but no longer receive pay credits. Participants whose retirement benefit was determined under the final average earnings formula or career average earnings formula continue to have their accrued benefit adjusted for pay increases until termination of employment. In the Company’s principal U.S. plans and certain funded overseas plans, funds are contributed to trusts in accordance with regulatory limits to provide for current service and for any unfunded projected benefit obligation over a reasonable period. The target asset allocation for the Company’s defined benefit plans is as follows: United States International Asset Category Equity securities 27 % 39 % Fixed income securities 53 % 41 % Real estate and other investments 20 % 20 % Total 100 % 100 % At December 31, 2017 the allocation of the Company’s plan assets and the level of valuation input, as applicable, for each major asset category were as follows: Level of Valuation Pension Plans United States International Other Retiree Benefit Plans Cash and cash equivalents Level 1 $ 21 $ 11 $ — U.S. common stocks Level 1 127 4 — International common stocks Level 1 — 3 — Pooled funds (1) Level 1 138 94 — Fixed income securities (2) Level 2 843 24 — Guaranteed investment contracts (3) Level 2 1 53 — 1,130 189 — Investments valued using NAV per share (4) Domestic, developed and emerging markets equity funds 350 189 — Fixed income funds (5) 122 167 — Hedge funds (6) 82 5 — Multi-Asset funds (7) 115 3 — Real estate funds (8) 38 22 — 707 386 — Other assets and liabilities, net (9) (25 ) — — Total Investments $ 1,812 $ 575 $ — At December 31, 2016 the allocation of the Company’s plan assets and the level of valuation input, as applicable, for each major asset category were as follows: Level of Valuation Pension Plans United States International Other Retiree Benefit Plans Cash and cash equivalents Level 1 $ 27 $ 13 $ — U.S. common stocks Level 1 127 3 — International common stocks Level 1 — 3 — Pooled funds (1) Level 1 134 84 — Fixed income securities (2) Level 2 767 22 — Guaranteed investment contracts (3) Level 2 1 49 — 1,056 174 — Investments valued using NAV per share (4) Domestic, developed and emerging markets equity funds 323 155 — Fixed income funds (5) 118 155 — Hedge funds (6) 96 3 — Multi-Asset funds (7) 52 3 — Real estate funds (8) 43 19 — 632 335 — Other assets and liabilities, net (9) (42 ) — — Total Investments $ 1,646 $ 509 $ — _______ (1) Pooled funds primarily invest in U.S. and foreign equity securities, debt and money market securities. (2) The fixed income securities are traded over the counter and certain of these securities lack daily pricing or liquidity and as such are classified as Level 2. As of December 31, 2017 and 2016, approximately 50% of the U.S. pension plan fixed income portfolio was invested in U.S. treasury or agency securities, with the remainder invested in other government bonds and corporate bonds. (3) The guaranteed investment contracts (“GICs”) represent contracts with insurance companies measured at the cash surrender value of each contract. The Level 2 valuation reflects that the cash surrender value is based principally on a referenced pool of investment funds with active redemption. (4) Investments that are measured at fair value using net asset value (“NAV”) per share as a practical expedient have not been classified in the fair value hierarchy. The NAV is based on the value of the underlying investments owned, minus its liabilities, divided by the number of shares outstanding. There are no unfunded commitments related to these investments. Redemption notice period primarily ranges from 0-3 months and redemption frequency windows range from daily to quarterly. (5) Fixed income funds primarily invest in U.S. government and investment grade corporate bonds. (6) Consists of investments in underlying hedge fund strategies that are primarily implemented through the use of long and short equity and fixed income securities and derivative instruments such as futures and options. (7) Multi-Asset funds primarily invest across a variety of asset classes, including global stocks and bonds, as well as alternative strategies. (8) Real estate is valued using the NAV per unit of funds that are invested in real estate property. The investment value of the real estate property is determined quarterly using independent market appraisals as determined by the investment manager. (9) This category primarily includes unsettled trades for investments purchased and sold and dividend receivables. Equity securities in the U.S. plans include investments in the Company’s common stock representing 7% of U.S. plan assets at December 31, 2017 and December 31, 2016 . No shares of the Company’s common stock were purchased or sold by the U.S. plans in 2017 or 2016 . The plans received dividends on the Company’s common stock of $3 in 2017 and 2016 . Other Retiree Benefits The Company and certain of its subsidiaries provide health care and life insurance benefits for retired employees to the extent not provided by government-sponsored plans. The Company uses a December 31 measurement date for its defined benefit and other retiree benefit plans. Summarized information for the Company’s defined benefit and other retiree benefit plans is as follows: Pension Plans Other Retiree Benefit Plans 2017 2016 2017 2016 2017 2016 United States International Change in Benefit Obligations Benefit obligations at beginning of year $ 2,298 $ 2,201 $ 800 $ 802 $ 923 $ 862 Service cost 1 1 16 16 13 13 Interest cost 94 105 22 25 40 43 Participants’ contributions — — 2 2 — — Acquisitions/plan amendments — — (6 ) 1 — — Actuarial loss (gain) 110 129 (11 ) 76 21 39 Foreign exchange impact — — 72 (47 ) 3 1 Termination benefits (1) 24 3 — — (3 ) 1 Curtailments and settlements — — (11 ) (37 ) — — Benefit payments (164 ) (141 ) (36 ) (36 ) (37 ) (36 ) Other — — (1 ) (2 ) — — Benefit obligations at end of year $ 2,363 $ 2,298 $ 847 $ 800 $ 960 $ 923 Change in Plan Assets Fair value of plan assets at beginning of year $ 1,646 $ 1,624 $ 509 $ 520 $ — $ 14 Actual return on plan assets 225 88 42 46 — 1 Company contributions 105 75 30 54 37 21 Participants’ contributions — — 2 2 — — Foreign exchange impact — — 40 (43 ) — — Settlements and acquisitions — — (11 ) (33 ) — — Benefit payments (164 ) (141 ) (36 ) (36 ) (37 ) (36 ) Other — — (1 ) (1 ) — — Fair value of plan assets at end of year $ 1,812 $ 1,646 $ 575 $ 509 $ — $ — Funded Status Benefit obligations at end of year $ 2,363 $ 2,298 $ 847 $ 800 $ 960 $ 923 Fair value of plan assets at end of year 1,812 1,646 575 509 — — Net amount recognized $ (551 ) $ (652 ) $ (272 ) $ (291 ) $ (960 ) $ (923 ) Amounts Recognized in Balance Sheet Noncurrent assets $ — $ — $ 22 $ 8 $ — $ — Current liabilities (24 ) (24 ) (13 ) (12 ) (44 ) (44 ) Noncurrent liabilities (527 ) (628 ) (281 ) (287 ) (916 ) (879 ) Net amount recognized $ (551 ) $ (652 ) $ (272 ) $ (291 ) $ (960 ) $ (923 ) Amounts Recognized in Accumulated Other Comprehensive Income (Loss) Actuarial loss $ 911 $ 962 $ 209 $ 254 $ 338 $ 330 Transition/prior service cost 1 2 1 5 (1 ) (2 ) $ 912 $ 964 $ 210 $ 259 $ 337 $ 328 Accumulated benefit obligation $ 2,293 $ 2,230 $ 787 $ 739 $ — $ — Pension Plans Other Retiree Benefit Plans 2017 2016 2017 2016 2017 2016 United States International Weighted-Average Assumptions Used to Determine Benefit Obligations Discount rate 3.73 % 4.27 % 2.53 % 2.59 % 3.80 % 4.41 % Long-term rate of return on plan assets 6.60 % 6.80 % 4.04 % 4.14 % 6.60 % 6.80 % Long-term rate of compensation increase 3.50 % 3.50 % 2.79 % 2.58 % 3.50 % — % ESOP growth rate — % — % — % — % 10.00 % 10.00 % Medical cost trend rate of increase — % — % — % — % 6.00 % 6.33 % _________ (1) Represents pension and other retiree benefit enhancements incurred in 2017 and 2016 pursuant to the Global Growth and Efficiency Program. The overall investment objective of the plans is to balance risk and return so that obligations to employees are met. The Company evaluates its long-term rate of return on plan assets on an annual basis. In determining the long-term rate of return, the Company considers the nature of the plans’ investments and the historical rates of return. The assumed rate of return as of December 31, 2017 for the U.S. plans was 6.60% . Average annual rates of return for the U.S. plans for the most recent 1-year, 5-year, 10-year, 15-year and 25-year periods were 14% , 8% , 6% , 8% , and 8% , respectively. Similar assessments were performed in determining rates of return on international pension plan assets to arrive at the Company’s 2017 weighted-average rate of return of 4.04% . The medical cost trend rate of increase assumed in measuring the expected cost of benefits is projected to decrease from 6.00% in 2018 to 4.75% by 2023 , remaining at 4.75% for the years thereafter. Changes in the assumed rate can have a significant effect on amounts reported. A 1% change in the assumed medical cost trend rate would have the following approximate effect: One percentage point Increase Decrease Accumulated postretirement benefit obligation $ 123 $ (100 ) Total of service and interest cost components 9 (7 ) Expected mortality is a key assumption in the measurement of pension and other postretirement benefit obligations. For the Company’s U.S. plans, this assumption was updated as of December 31, 2016 in order to reflect the Society of Actuaries’ updated mortality improvement scale published in October 2016. This resulted in a decrease of 1% and 2% to the benefit obligations for the Company’s U.S. pension plans and other postretirement benefits, respectively. This assumption was previously updated for the Company’s U.S. plans as of December 31, 2015 in order to reflect the Society of Actuaries’ mortality tables and mortality improvement scale published in October 2015 which resulted in a decrease of 1% and 2% to the benefit obligations for the Company’s U.S. pension plans and other postretirement benefits, respectively. Plans with projected benefit obligations in excess of plan assets and plans with accumulated benefit obligations in excess of plan assets as of December 31 consisted of the following: Years Ended December 31, 2017 2016 Benefit Obligation Exceeds Fair Value of Plan Assets Projected benefit obligation $ 2,834 $ 2,973 Fair value of plan assets 1,992 2,024 Accumulated benefit obligation 2,641 2,840 Fair value of plan assets 1,905 2,003 Summarized information regarding the net periodic benefit costs for the Company’s defined benefit and other retiree benefit plans is as follows: Pension Plans Other Retiree Benefit Plans 2017 2016 2015 2017 2016 2015 2017 2016 2015 United States International Components of Net Periodic Benefit Cost Service cost $ 1 $ 1 $ 2 $ 16 $ 16 $ 20 $ 13 $ 13 $ 14 Interest cost 94 105 100 22 25 28 40 43 44 Annual ESOP allocation — — — — — — — — — Expected return on plan assets (111 ) (109 ) (117 ) (22 ) (23 ) (28 ) — (1 ) (2 ) Amortization of transition and prior service costs (credits) — — — — — 2 — — — Amortization of actuarial loss 48 41 44 10 8 11 13 14 25 Net periodic benefit cost $ 32 $ 38 $ 29 $ 26 $ 26 $ 33 $ 66 $ 69 $ 81 Other postretirement charges 24 3 16 4 11 (1 ) (3 ) 1 1 Total pension cost $ 56 $ 41 $ 45 $ 30 $ 37 $ 32 $ 63 $ 70 $ 82 Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost Discount rate 4.27 % 4.93 % 4.24 % 2.59 % 3.17 % 3.06 % 4.41 % 4.97 % 4.36 % Long-term rate of return on plan assets 6.80 % 6.80 % 6.80 % 4.14 % 4.62 % 5.05 % 6.80 % 6.80 % 6.80 % Long-term rate of compensation increase 3.50 % 3.50 % 3.50 % 2.58 % 2.78 % 2.83 % — % — % — % ESOP growth rate — % — % — % — % — % — % 10.00 % 10.00 % 10.00 % Medical cost trend rate of increase — % — % — % — % — % — % 6.33 % 6.67 % 7.00 % Other postretirement charges in 2017 , 2016 and 2015 include pension and other benefit enhancements amounting to $21 , $4 and $17 respectively, incurred pursuant to the Global Growth and Efficiency Program. Other postretirement charges in 2017 and 2016 also includes charges of $4 and $ 11 , respectively, in part due to retirements under the Global Growth and Efficiency Program. The Company made voluntary contributions of $81 , $53 and $0 in 2017 , 2016 and 2015 , respectively, to its U.S. retirement plans. The estimated actuarial loss and the estimated transition/prior service cost for defined benefit and other retiree benefit plans that will be amortized from Accumulated other comprehensive income (loss) into net periodic benefit cost over the next fiscal year is as follows: Pension Plans Other Retiree Benefit Plans Net actuarial loss $ 54 $ 17 Net transition and prior service cost — — Expected Contributions and Benefit Payments Management’s best estimate of voluntary contributions the Company will make to its U.S. postretirement plans for the year ending December 31, 2018 is approximately $75 . Actual funding may differ from current estimates depending on the variability of the market value of the assets as compared to the obligation and other market or regulatory conditions. Total benefit payments to be paid to participants for the year ending December 31, 2018 from the Company’s assets are estimated to be approximately $82 . Total benefit payments expected to be paid to participants from plan assets, or directly from the Company’s assets to participants in unfunded plans, are as follows: Pension Plans Years Ended December 31, United States International Other Retiree Benefit Plans Total 2018 $ 137 $ 37 $ 45 $ 219 2019 141 35 46 222 2020 144 37 46 227 2021 143 38 47 228 2022 151 39 48 238 2023-2027 737 222 250 1,209

Income Taxes

Income Taxes	12 Months Ended
Income Taxes	Dec. 31, 2017
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The components of Income before income taxes are as follows for the years ended December 31: 2017 2016 2015 United States $ 1,072 $ 1,191 $ 1,118 International 2,415 2,547 1,645 Total Income before income taxes $ 3,487 $ 3,738 $ 2,763 The Provision for income taxes consists of the following for the years ended December 31: 2017 2016 2015 United States $ 338 $ 395 $ 376 International 975 757 839 Total Provision for income taxes $ 1,313 $ 1,152 $ 1,215 Temporary differences between accounting for financial statement purposes and accounting for tax purposes result in the current provision for taxes being higher (lower) than the total provision for income taxes as follows: 2017 2016 2015 Goodwill and intangible assets $ 135 $ 18 $ 3 Property, plant and equipment 84 (3 ) (25 ) Pension and other retiree benefits (192 ) — 36 Stock-based compensation (28 ) 15 11 Tax loss and tax credit carryforwards (4 ) 5 (4 ) Other, net (103 ) (106 ) 98 Total deferred tax benefit (provision) $ (108 ) $ (71 ) $ 119 The difference between the statutory U.S. federal income tax rate and the Company’s global effective tax rate as reflected in the Consolidated Statements of Income is as follows: Percentage of Income before income taxes 2017 2016 2015 Tax at United States statutory rate 35.0 % 35.0 % 35.0 % State income taxes, net of federal benefit 0.5 0.5 1.0 Earnings taxed at other than United States statutory rate (3.4 ) (2.7 ) (3.6 ) Charge for U.S. tax reform (1) 7.9 — — Excess tax benefits from stock-based compensation (2) (1.4 ) — — (Benefit) charge for foreign tax matters (3) — (0.8 ) 0.5 (Benefit) from Venezuela remeasurement (4) — (5.6 ) — Tax charge on incremental repatriation of foreign earnings (4) — 5.6 — Venezuela deconsolidation (5) — — 12.8 Other, net (0.9 ) (1.2 ) (1.7 ) Effective tax rate 37.7 % 30.8 % 44.0 % _________ (1) On December 22, 2017, the Tax Cuts and Jobs Act (the “TCJA” or “U.S. tax reform”) was enacted which, among other things, lowered the U.S. corporate income tax rate to 21% from 35% and established a modified territorial system requiring a mandatory deemed repatriation tax on undistributed earnings of foreign subsidiaries. Beginning in 2018, the TCJA also requires a minimum tax on certain future earnings generated by foreign subsidiaries while providing for future tax-free repatriation of such earnings through a 100% dividends-received deduction. In accordance with ASC 740, Income Taxes, and Staff Accounting Bulletin 118, the Company recognized a provisional charge in the fourth quarter of 2017 of $275 related to the TCJA based on its initial analysis using available information and estimates. The provisional charge is comprised of $451 related to the one-time deemed repatriation of accumulated earnings of foreign subsidiaries and related withholding taxes and $20 related primarily to the remeasurement of net deferred tax assets as a result of the reduction in the corporate income tax rate, which are offset by $196 of income taxes which had been previously provided for planned repatriations of undistributed earnings of foreign subsidiaries. As a result, applicable U.S. and foreign taxes have been provided on substantially all of the Company’s accumulated earnings of foreign subsidiaries previously considered indefinitely reinvested. Given the significant complexity of the TCJA, anticipated guidance from the U.S. Treasury about implementing the TCJA and the potential for additional guidance from the Securities and Exchange Commission (“SEC”) or the FASB related to the TCJA or additional information becoming available, the Company’s provisional charge may be adjusted during 2018 and is expected to be finalized no later than the fourth quarter of 2018. Other provisions of the TCJA that impact future tax years are still being assessed. (2) As a result of adopting ASU No. 2016-09 “Compensation–Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting,” effective January 1, 2017, the Company recognized excess tax benefits from stock-based compensation of $47 (resulting from an increase in the fair value of an award from the grant date to the vesting or exercise date, as applicable) in the Provision for income taxes as a discrete item during the year ended December 31, 2017. These amounts may not necessarily be indicative of future amounts that may be recognized as any excess tax benefits from stock-based compensation recognized would be dependent on future stock price, employee exercise behavior and applicable tax rates. Prior to January 1, 2017, excess tax benefits from stock-based compensation were recognized in equity. See Note 2, Summary of Significant Accounting Policies - Recent Accounting Pronouncements for additional information. (3) The benefit from a tax matter in 2016 relates to several Supreme Court and Administrative Court rulings in a foreign jurisdiction allowing certain tax deductions which had the effect of reversing prior decisions. The charge for a tax matter in 2015 relates to several Supreme Court rulings in a foreign jurisdiction disallowing certain tax deductions which had the effect of reversing prior decisions. (4) The effective tax rate in 2016 included a $210 U.S. income tax benefit recognized in the first quarter of 2016 principally related to changes in Venezuela’s foreign exchange regime implemented in March 2016. Although, effective December 31, 2015, the operating results of CP Venezuela are no longer included in the Company’s Consolidated Financial Statements, under current tax rules, the Company is required to continue including CP Venezuela’s results in its consolidated U.S. federal income tax return. In order to fully utilize the above mentioned $210 tax benefit in 2016, the Company repatriated an incremental $1,500 of earnings of foreign subsidiaries it previously considered indefinitely reinvested outside of the U.S., and accordingly, recorded a tax charge of $210 during the first quarter of 2016. (5) See Note 14, Venezuela. The components of deferred tax assets (liabilities) are as follows at December 31: 2017 2016 Deferred tax liabilities: Goodwill and intangible assets $ (311 ) $ (451 ) Property, plant and equipment (306 ) (380 ) Other (182 ) (202 ) (799 ) (1,033 ) Deferred tax assets: Pension and other retiree benefits 375 599 Tax loss and tax credit carryforwards 39 34 Accrued liabilities 197 246 Stock-based compensation 90 127 Other 82 82 783 1,088 Net deferred income taxes $ (16 ) $ 55 2017 2016 Deferred taxes included within: Assets: Deferred income taxes $ 188 $ 301 Liabilities: Deferred income taxes (204 ) (246 ) Net deferred income taxes $ (16 ) $ 55 In addition, net tax benefit of $37 in 2017 , net tax benefit of $85 in 2016 , and net tax expense of $78 in 2015 were recorded directly through equity. The net tax benefit in 2017 predominantly includes current and future tax impacts related to benefit plans. The amounts in 2016 and 2015 include current and future tax impacts related to employee equity compensation and benefit plans. The Company uses a comprehensive model to recognize, measure, present and disclose in its financial statements uncertain tax positions that the Company has taken or expects to take on an income tax return. Unrecognized tax benefits activity for the years ended December 31, 2017 , 2016 and 2015 is summarized below: 2017 2016 2015 Unrecognized tax benefits: Balance, January 1 $ 201 $ 186 $ 218 Increases as a result of tax positions taken during the current year 13 9 20 Decreases of tax positions taken during prior years (9 ) (45 ) (25 ) Increases of tax positions taken during prior years 15 71 61 Decreases as a result of settlements with taxing authorities and the expiration of statutes of limitations (15 ) (18 ) (79 ) Effect of foreign currency rate movements 9 (2 ) (9 ) Balance, December 31 $ 214 $ 201 $ 186 If all of the unrecognized tax benefits for 2017 above were recognized, approximately $205 would impact the effective tax rate and would result in a cash outflow of approximately $185 . Although it is possible that the amount of unrecognized benefits with respect to our uncertain tax positions will increase or decrease in the next 12 months, the Company does not expect material changes. The Company recognized approximately $11 , $2 and $2 of interest expense related to the above unrecognized tax benefits within income tax expense in 2017 , 2016 and 2015 , respectively. The Company had accrued interest of approximately $28 , $17 and $16 as of December 31, 2017 , 2016 and 2015 , respectively. The Company and its subsidiaries file U.S. federal income tax returns as well as income tax returns in many state and foreign jurisdictions. All U.S. federal income tax returns through December 31, 2011 have been audited by the IRS and there are limited matters which the Company plans to appeal for years 2010 through 2011, the settlement of which is not expected to have a material adverse effect on the Company’s results of operations, cash flows or financial condition. With a few exceptions, the Company is no longer subject to U.S. state and local income tax examinations for income tax returns through December 31, 2011. In addition, the Company has subsidiaries in various foreign jurisdictions that have statutes of limitations for tax audits generally ranging from three to six years.

Earnings Per Share

Earnings Per Share	12 Months Ended
Earnings Per Share	Dec. 31, 2017
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share For the years ended December 31, 2017 , 2016 and 2015 , earnings per share were as follows: 2017 2016 2015 Net income attributable to Colgate-Palmolive Company Shares (millions) Per Share Net income attributable to Colgate-Palmolive Company Shares (millions) Per Share Net income attributable to Colgate-Palmolive Company Shares (millions) Per Share Basic EPS $ 2,024 881.8 $ 2.30 $ 2,441 891.8 $ 2.74 $ 1,384 902.2 $ 1.53 Stock options and restricted stock units 6.0 6.6 7.5 Diluted EPS $ 2,024 887.8 $ 2.28 $ 2,441 898.4 $ 2.72 $ 1,384 909.7 $ 1.52 Basic earnings per common share is computed by dividing net income available for common stockholders by the weighted-average number of shares of common stock outstanding for the period. Diluted earnings per common share is computed using the treasury stock method on the basis of the weighted-average number of shares of common stock plus the dilutive effect of potential common shares outstanding during the period. Dilutive potential common shares include outstanding stock options and restricted stock units. As of December 31, 2017 , 2016 and 2015 , the average number of stock options that were anti-dilutive and not included in diluted earnings per share calculations were 11,056,725 , 3,187,485 and 3,228,359 , respectively. As of December 31, 2017 , 2016 and 2015 , the average number of restricted stock units that were anti-dilutive and not included in diluted earnings per share calculations were 91 , 2,693 and 120 , respectively.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
Commitments and Contingencies	Dec. 31, 2017
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Minimum rental commitments under noncancellable operating leases, primarily for office and warehouse facilities, are $188 in 2018, $163 in 2019, $143 in 2020, $106 in 2021, $93 in 2022 and $44 thereafter. Rental expense amounted to $211 in 2017 , $204 in 2016 and $214 in 2015 . Capital leases included in fixed assets, contingent rentals and sublease income are not significant. The Company has various contractual commitments to purchase raw, packaging and other materials totaling approximately $467 at December 31, 2017 . As a global company serving consumers in more than 200 countries and territories, the Company is routinely subject to a wide variety of legal proceedings. These include disputes relating to intellectual property, contracts, product liability, marketing, advertising, foreign exchange controls, antitrust and trade regulation, as well as labor and employment, pension, privacy, environmental and tax matters, and consumer class actions. Management proactively reviews and monitors the Company’s exposure to, and the impact of, environmental matters. The Company is party to various environmental matters and, as such, may be responsible for all or a portion of the cleanup, restoration and post-closure monitoring of several sites. The Company establishes accruals for loss contingencies when it has determined that a loss is probable and that the amount of loss, or range of loss, can be reasonably estimated. Any such accruals are adjusted thereafter as appropriate to reflect changes in circumstances. The Company also determines estimates of reasonably possible losses or ranges of reasonably possible losses in excess of related accrued liabilities, if any, when it has determined that a loss is reasonably possible and it is able to determine such estimates. For those matters disclosed below for which the amount of any potential losses can be reasonably estimated, the Company currently estimates that the aggregate range of reasonably possible losses in excess of any accrued liabilities is $ 0 to approximately $ 250 (based on current exchange rates). The estimates included in this amount are based on the Company’s analysis of currently available information and, as new information is obtained, these estimates may change. Due to the inherent subjectivity of the assessments and the unpredictability of outcomes of legal proceedings, any amounts accrued or included in this aggregate amount may not represent the ultimate loss to the Company. Thus, the Company’s exposure and ultimate losses may be higher or lower, and possibly significantly so, than the amounts accrued or the range disclosed above. Based on current knowledge, management does not believe that the ultimate resolution of loss contingencies arising from the matters discussed herein will have a material effect on the Company’s consolidated financial position or its ongoing results of operations or cash flows. However, in light of the inherent uncertainties noted above, an adverse outcome in one or more matters could be material to the Company’s results of operations or cash flows for any particular quarter or year. Brazilian Matters There are certain tax and civil proceedings outstanding, as described below, related to the Company ’ s 1995 acquisition of the Kolynos oral care business from Wyeth (the “ Seller ” ). The Brazilian internal revenue authority has disallowed interest deductions and foreign exchange losses taken by the Company’s Brazilian subsidiary for certain years in connection with the financing of the Kolynos acquisition. The tax assessments with interest, penalties and any court-mandated fees, at the current exchange rate, are approximately $165 . This amount includes additional assessments received from the Brazilian internal revenue authority in April 2016 relating to net operating loss carryforwards used by the Company’s Brazilian subsidiary to offset taxable income that had also been deducted from the authority’s original assessments. The Company has been disputing the disallowances by appealing the assessments since October 2001. Appeals are currently pending at the administrative level. In the event the Company is ultimately unsuccessful in its administrative appeals, further appeals are available within the Brazilian federal courts. In September 2015, the Company lost one of its appeals at the administrative level and filed a lawsuit in Brazilian federal court. In February 2017, the Company lost an additional administrative appeal and filed a similar action in Brazilian federal court. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the disallowances are without merit and that the Company should ultimately prevail. The Company is challenging these disallowances vigorously. In July 2002, the Brazilian Federal Public Attorney filed a civil action against the federal government of Brazil, Laboratorios Wyeth-Whitehall Ltda. (the Brazilian subsidiary of the Seller) and the Company, as represented by its Brazilian subsidiary, in the 6th. Lower Federal Court in the City of São Paulo, seeking to annul an April 2000 decision by the Brazilian Board of Tax Appeals that found in favor of the Seller’s Brazilian subsidiary on the issue of whether it had incurred taxable capital gains as a result of the divestiture of Kolynos. The action seeks to make the Company’s Brazilian subsidiary jointly and severally liable for any tax due from the Seller’s Brazilian subsidiary. The case has been pending since 2002, and the Lower Federal Court has not issued a decision. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the Company should ultimately prevail in this action. The Company is challenging this action vigorously. In December 2005, the Brazilian internal revenue authority issued to the Company’s Brazilian subsidiary a tax assessment with interest, penalties and any court-mandated fees of approximately $ 74 , at the current exchange rate, based on a claim that certain purchases of U.S. Treasury bills by the subsidiary and their subsequent disposition during the period 2000 to 2001 were subject to a tax on foreign exchange transactions. The Company had been disputing the assessment within the internal revenue authority’s administrative appeals process. However, in November 2015, the Superior Chamber of Administrative Tax Appeals denied the Company’s final administrative appeal and the Company has filed a lawsuit in the Brazilian federal court. In the event the Company is unsuccessful in this filing, further appeals are available within the Brazilian federal courts. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the tax assessment is without merit and that the Company should ultimately prevail. The Company is challenging this assessment vigorously. Competition Matters Certain of the Company’s subsidiaries have historically been subject to investigations, and, in some cases, fines by governmental authorities in a number of countries related to alleged competition law violations. Substantially all of these matters also involved other consumer goods companies and/or retail customers. The Company’s policy is to comply with antitrust and competition laws and, if a violation of any such laws is found, to take appropriate remedial action and to cooperate fully with any related governmental inquiry. The status of pending competition law matters as of December 31, 2017 is set forth below. ▪ In December 2014, the French competition law authority found that 13 consumer goods companies, including the Company’s French subsidiary, exchanged competitively sensitive information related to the French home care and personal care sectors, for which the Company’s French subsidiary was fined $57 . In addition, as a result of the Company’s acquisition of the Sanex personal care business in 2011 from Unilever N.V. and Unilever PLC (together with Unilever N.V., “Unilever”), pursuant to a Business and Share Sale and Purchase Agreement (the “Sale and Purchase Agreement”), the French competition law authority found that the Company’s French subsidiary, along with Hillshire Brands Company (formerly Sara Lee Corporation (“Sara Lee”)), were jointly and severally liable for fines of $25 assessed against Sara Lee’s French subsidiary. The Company is entitled to indemnification for this fine from Unilever as provided in the Sale and Purchase Agreement. The fines were confirmed by the Court of Appeal in October 2016. The Company is appealing the decision of the Court of Appeal on behalf of the Company and Sara Lee in the French Supreme Court. ▪ In July 2014, the Greek competition law authority issued a statement of objections alleging a restriction of parallel imports into Greece. The Company responded to this statement of objections. In July 2017, the Company received the decision from the Greek competition law authority in which the Company was fined $11 . The Company is appealing the decision to the Greek courts. Talcum Powder Matters The Company has been named as a defendant in civil actions alleging that certain talcum powder products that were sold prior to 1996 were contaminated with asbestos. Most of these actions involve a number of co-defendants from a variety of different industries, including suppliers of asbestos and manufacturers of products that, unlike the Company’s products, were designed to contain asbestos. As of December 31, 2017 , there were 193 individual cases pending against the Company in state and federal courts throug hout the United States as compared to 115 cases as of December 31, 2016. During the year ended December 31, 2017 , 132 ne w cases were filed and 54 cases were resolved by voluntary dismissal, appeal in the Company’s favor or settlement. The value of settlements in the years presented was not material, either individually or in the aggregate, to each such period’s results of operations. The Company believes that a significant portion of its costs incurred in defending and resolving these claims will be covered by insurance policies issued by several primary and excess insurance carriers, subject to deductibles, exclusions, retentions and policy limits. While the Company and its legal counsel believe that these cases are without merit and intend to challenge them vigorously, there can be no assurances regarding the ultimate resolution of these matters. Since the amount of any potential losses from these cases currently cannot be reasonably estimated, the range of reasonably possible losses in excess of accrued liabilities disclosed above does not include any amount relating to these cases. N8 The Company was a defendant in a lawsuit that was brought in Utah federal court by N8 Medical, Inc. (“N8 Medical”), Brigham Young University (“BYU”) and N8 Pharmaceuticals, Inc. (“N8 Pharma”). The complaint, originally filed in November 2013, alleged breach of contract and other torts arising out of the Company’s evaluation of a technology owned by BYU and licensed, at various times, to Ceragenix Pharmaceuticals, Inc., now in bankruptcy, N8 Medical and N8 Pharma. In 2016, the Company resolved the claims brought by BYU and N8 Medical. These claims were each resolved in an amount that is not material to the Company’s results of operations. In the first quarter of 2017, the court dismissed the claims of N8 Pharma and, in the third quarter of 2017, N8 Pharma appealed the decision. ERISA Matter In June 2016, a putative class action claiming that residual annuity payments made to certain participants in the Colgate-Palmolive Company Employees’ Retirement Income Plan (the “Plan”) did not comply with the Employee Retirement Income Security Act was filed against the Plan, the Company and certain individuals in the United States District Court for the Southern District of New York. This action has been certified as a class action. The relief sought includes recalculation of benefits, pre- and post-judgment interest and attorneys’ fees. The Company is contesting this action vigorously. Since the amount of any potential loss from this case currently cannot be reasonably estimated, the range of reasonably possible losses in excess of accrued liabilities disclosed above does not include any amount relating to the case.

Venezuela

Venezuela	12 Months Ended
Venezuela	Dec. 31, 2017
Foreign Currency [Abstract]
Venezuela	Venezuela Effective December 31, 2015, the Company concluded it no longer met the accounting criteria for consolidation of CP Venezuela and began accounting for CP Venezuela using the cost method of accounting. As such, effective December 31, 2015, the Company’s Consolidated Balance Sheet no longer includes the assets and liabilities of CP Venezuela. As a result of this change in accounting, the Company recorded an aftertax charge of $1,058 ( $1,084 pretax) or $1.16 per diluted share in 2015. The charge primarily consists of an impairment of the Company’s investment in CP Venezuela of $952 , which includes intercompany receivables from CP Venezuela, and $111 related to the reclassification of cumulative translation losses. Prior periods have not been restated and CP Venezuela’s Net sales, Operating profit and Net income are included in the Company’s Consolidated Statements of Income through December 31, 2015. Since January 1, 2016, under the cost method of accounting, the Company no longer includes the local operating results of CP Venezuela in its Consolidated Financial Statements and includes income relating to CP Venezuela only to the extent it receives cash for sales of inventory to CP Venezuela or for dividends or royalties remitted by CP Venezuela, all of which have been immaterial. Although CP Venezuela’s local operating results are no longer included in the Company’s Consolidated Financial Statements for accounting purposes, under current tax rules, the Company is required to continue including CP Venezuela in its consolidated U.S. federal income tax return. In the first quarter of 2016, provision for income taxes included a $210 U.S. income tax benefit principally related to changes in Venezuela’s foreign exchange regime implemented in March 2016. See Note 11, Income Taxes for additional details. Prior to the change in accounting, CP Venezuela’s functional currency was the U.S. dollar since Venezuela had been designated hyper-inflationary and, as such, Venezuelan currency fluctuations were reported in income. The Company remeasured the financial statements of CP Venezuela at the end of each month at the rate at which it expected to remit future dividends which, based on the advice of legal counsel, was the SICAD rate (formerly known as the SICAD I rate). During the year ended December 31, 2015, the Company incurred pretax losses of $34 ( $22 aftertax or $0.02 per diluted common share) related to the remeasurement of CP Venezuela’s local currency-denominated net monetary assets at the quarter-end SICAD rate for the second and third quarters of 2015. The SICAD rate did not revalue during the fourth quarter of 2015 and was 13.50 bolivares per dollar as of December 31, 2015. Included in the remeasurement losses during 2015 were charges related to the devaluation-protected bonds issued by the Venezuelan government and held by CP Venezuela. Because the official exchange rate remained at 6.30 bolivares per dollar, the devaluation-protected bonds did not revalue at the SICAD rate but remained at the official exchange rate, resulting in an impairment in the fair value of the bonds.

Segment Information

Segment Information	12 Months Ended
Segment Information	Dec. 31, 2017
Segment Reporting [Abstract]
Segment Information	Segment Information The Company operates in two product segments: Oral, Personal and Home Care; and Pet Nutrition. The operations of the Oral, Personal and Home Care product segment are managed geographically in five reportable operating segments: North America, Latin America, Europe, Asia Pacific and Africa/Eurasia. The Company evaluates segment performance based on several factors, including Operating profit. The Company uses Operating profit as a measure of operating segment performance because it excludes the impact of Corporate-driven decisions related to interest expense and income taxes. The accounting policies of the operating segments are generally the same as those described in Note 2, Summary of Significant Accounting Policies. Intercompany sales have been eliminated. Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs, restructuring and related implementation costs and gains and losses on sales of non-core product lines and assets. The Company reports these items within Corporate operations as they relate to Corporate-based responsibilities and decisions and are not included in the internal measures of segment operating performance used by the Company to measure the underlying performance of the operating segments. Approximately 75% of the Company’s Net sales are generated from markets outside the U.S., with approximately 50% of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe). Oral, Personal and Home Care sales to Wal-Mart Stores, Inc. and its affiliates represent approximately 11% of the Company’s Net sales in 2017. No other customer represents more than 10% of Net sales. In 2017, Corporate Operating profit (loss) includes charges of $333 resulting from the Global Growth and Efficiency Program. In 2016, Corporate Operating profit (loss) includes charges of $228 resulting from the Global Growth and Efficiency Program and $17 for a litigation matter and a gain of $97 on the sale of land in Mexico. In 2015, Corporate Operating profit (loss) included charges of $1,084 related to the deconsolidation of the Company’s Venezuelan operations, $254 related to the Global Growth and Efficiency Program, $34 related to the remeasurement of CP Venezuela’s local currency-denominated net monetary assets as a result of effective devaluations and $14 for a litigation matter and a gain of $187 on the sale of the Company’s laundry detergent business in the South Pacific. 2017 2016 2015 Net sales Oral, Personal and Home Care North America (1) $ 3,117 $ 3,183 $ 3,149 Latin America 3,887 3,650 4,327 Europe 2,394 2,342 2,411 Asia Pacific 2,781 2,796 2,937 Africa/Eurasia 983 960 998 Total Oral, Personal and Home Care 13,162 12,931 13,822 Pet Nutrition (2) 2,292 2,264 2,212 Total Net sales $ 15,454 $ 15,195 $ 16,034 _________ (1) Net sales in the U.S. for Oral, Personal and Home Care were $2,865 , $2,932 and $2,896 in 2017 , 2016 and 2015 , respectively. (2) Net sales in the U.S. for Pet Nutrition were $1,246 , $1,243 and $1,223 in 2017 , 2016 and 2015 , respectively. 2017 2016 2015 Operating profit Oral, Personal and Home Care North America $ 986 $ 1,030 $ 974 Latin America 1,162 1,132 1,209 Europe 599 579 615 Asia Pacific 841 887 888 Africa/Eurasia 179 186 178 Total Oral, Personal and Home Care 3,767 3,814 3,864 Pet Nutrition 653 653 612 Corporate (831 ) (630 ) (1,687 ) Total Operating profit $ 3,589 $ 3,837 $ 2,789 2017 2016 2015 Capital expenditures Oral, Personal and Home Care North America $ 74 $ 151 $ 207 Latin America 127 94 110 Europe 63 51 40 Asia Pacific 125 120 121 Africa/Eurasia 13 17 12 Total Oral, Personal and Home Care 402 433 490 Pet Nutrition 33 38 34 Corporate 118 122 167 Total Capital expenditures $ 553 $ 593 $ 691 2017 2016 2015 Depreciation and amortization Oral, Personal and Home Care North America $ 58 $ 54 $ 47 Latin America 82 76 88 Europe 74 64 67 Asia Pacific 101 96 99 Africa/Eurasia 8 7 8 Total Oral, Personal and Home Care 323 297 309 Pet Nutrition 53 53 52 Corporate 99 93 88 Total Depreciation and amortization $ 475 $ 443 $ 449 2017 2016 2015 Identifiable assets Oral, Personal and Home Care North America $ 2,608 $ 2,685 $ 2,622 Latin America 2,423 2,314 2,314 Europe 3,781 3,554 3,308 Asia Pacific 2,244 2,006 2,031 Africa/Eurasia 544 499 476 Total Oral, Personal and Home Care 11,600 11,058 10,751 Pet Nutrition 1,026 1,009 1,006 Corporate (1) 50 56 178 Total Identifiable assets (2) $ 12,676 $ 12,123 $ 11,935 ____________ (1) In 2017 , Corporate identifiable assets primarily consist of derivative instruments ( 5% ) and investments in equity securities ( 86% ). In 2016 , Corporate identifiable assets primarily consist of derivative instruments ( 24% ) and investments in equity securities ( 68% ). In 2015 , Corporate identifiable assets primarily consist of derivative instruments ( 76% ) and investments in equity securities ( 23% ). (2) Long-lived assets in the U.S., primarily property, plant and equipment and goodwill and other intangibles represented approximately one-third of total long-lived assets of $ 7,908 , $7,642 and $7,420 in 2017 , 2016 and 2015 , respectively.

Supplemental Income Statement I

Supplemental Income Statement Information	12 Months Ended
Supplemental Income Statement Information	Dec. 31, 2017
Supplemental Income Statement Elements [Abstract]
Supplemental Income Statement Information	Supplemental Income Statement Information Other (income) expense, net 2017 2016 2015 Global Growth and Efficiency Program $ 169 $ 105 $ 170 Amortization of intangible assets 35 33 33 Gain on sale of land in Mexico — (97 ) — Charges for litigation matters — 17 14 Venezuela remeasurement charges — — 34 Gain on sale of South Pacific laundry detergent business — — (187 ) Equity income (11 ) (10 ) (8 ) Other, net 1 (11 ) 6 Total Other (income) expense, net $ 194 $ 37 $ 62 Interest (income) expense, net 2017 2016 2015 Interest incurred $ 156 $ 155 $ 139 Interest capitalized (3 ) (6 ) (6 ) Interest income (51 ) (50 ) (107 ) Total Interest (income) expense, net $ 102 $ 99 $ 26 2017 2016 2015 Research and development $ 285 $ 289 $ 274 Advertising $ 1,573 $ 1,428 $ 1,491

Supplemental Balance Sheet Info

Supplemental Balance Sheet Information	12 Months Ended
Supplemental Balance Sheet Information	Dec. 31, 2017
Balance Sheet Related Disclosures [Abstract]
Supplemental Balance Sheet Information	Supplemental Balance Sheet Information Inventories by major class are as follows at December 31: Inventories 2017 2016 Raw materials and supplies $ 267 $ 266 Work-in-process 42 42 Finished goods 912 863 Total Inventories $ 1,221 $ 1,171 Inventories valued under LIFO amounted to $289 and $278 at December 31, 2017 and 2016 , respectively. The excess of current cost over LIFO cost at the end of each year was $63 and $30 , respectively. The liquidations of LIFO inventory quantities had no material effect on income in 2017 , 2016 and 2015 . Property, plant and equipment, net 2017 2016 Land $ 159 $ 147 Buildings 1,655 1,544 Manufacturing machinery and equipment 5,165 4,971 Other equipment 1,481 1,280 8,460 7,942 Accumulated depreciation (4,388 ) (4,102 ) Total Property, plant and equipment, net $ 4,072 $ 3,840 Other accruals 2017 2016 Accrued advertising and coupon redemption $ 510 $ 491 Accrued payroll and employee benefits 325 309 Accrued taxes other than income taxes 123 112 Restructuring accrual 181 112 Pension and other retiree benefits 81 80 Accrued interest 34 29 Derivatives 20 4 Other 557 590 Total Other accruals $ 1,831 $ 1,727 Other liabilities 2017 2016 Pension and other retiree benefits $ 1,724 $ 1,794 Restructuring accrual 53 69 Other 478 172 Total Other liabilities $ 2,255 $ 2,035

Supplemental Other Comprehensiv

Supplemental Other Comprehensive Income (Loss) Information	12 Months Ended
Supplemental Other Comprehensive Income (Loss) Information	Dec. 31, 2017
Equity [Abstract]
Supplemental Other Comprehensive Income (Loss) Information	Supplemental Other Comprehensive Income (Loss) Information Other comprehensive income (loss) components attributable to Colgate-Palmolive Company before tax and net of tax during the years ended December 31 were as follows: 2017 2016 2015 Pre-tax Net of Tax Pre-tax Net of Tax Pre-tax Net of Tax Cumulative translation adjustments $ 218 $ 285 $ (97 ) $ (125 ) $ (721 ) $ (745 ) Reclassification due to Venezuela deconsolidation (1) — — — — 111 111 Cumulative translation adjustments 218 285 (97 ) (125 ) (610 ) (634 ) Pension and other benefits: Net actuarial gain (loss), prior service costs and settlements during the period 21 9 (231 ) (152 ) 182 115 Amortization of net actuarial loss, transition and prior service costs (2) 71 45 63 43 82 52 Reclassification due to Venezuela deconsolidation (1) — — — — 44 29 Retirement Plan and other retiree benefit adjustments 92 54 (168 ) (109 ) 308 196 Available-for-sale securities: Unrealized gains (losses) on available- for-sale securities (3) — — — — (18 ) (12 ) Reclassification of (gains) losses into net earnings on available- for-sale securities (4) — — (1 ) (1 ) 14 11 Reclassification due to Venezuela deconsolidation (1) — — — — (10 ) (6 ) Gains (losses) on available-for-sale securities — — (1 ) (1 ) (14 ) (7 ) Cash flow hedges: Unrealized gains (losses) on cash flow hedges (25 ) (16 ) 11 8 18 12 Reclassification of (gains) losses into net earnings on cash flow hedges (5) 3 2 (4 ) (3 ) (16 ) (10 ) Gains (losses) on cash flow hedges (22 ) (14 ) 7 5 2 2 Total Other comprehensive income (loss) $ 288 $ 325 $ (259 ) $ (230 ) $ (314 ) $ (443 ) _________ (1) Represents reclassifications from Accumulated other comprehensive income (loss) due to the deconsolidation of the Company’s Venezuelan operations. Cumulative translation, net actuarial gain (loss) and unrealized gains (losses) on available-for-sale securities were reclassified into the Charge for Venezuela accounting change on the Consolidated Statement of Income. (2) These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 10 , Retirement Plans and Other Retiree Benefits for additional details. (3) For the year ended December 31, 2015 , these amounts included pretax net losses of $50 related to the remeasurement of the bolivar-denominated fixed interest rate bonds and the devaluation-protected bonds in Venezuela. (4) Represents reclassification of losses on the Venezuela bonds into Other (income) expense, net due to an impairment in the fair value of the bonds as a result of the effective devaluations in the second and third quarters of 2015. (5) These (gains) losses are reclassified into Cost of sales. See Note 7 , Fair Value Measurements and Financial Instruments for additional details. There were no tax impacts on Other comprehensive income (loss) attributable to Noncontrolling interests. Accumulated Other Comprehensive Income (Loss) Accumulated other comprehensive income (loss) is comprised of cumulative foreign currency translation gains and losses, unrecognized pension and other retiree benefit costs, unrealized gains and losses from derivative instruments designated as cash flow hedges and unrealized gains and losses on available-for-sale securities. At December 31, 2017 and 2016 , Accumulated other comprehensive income (loss) consisted primarily of aftertax unrecognized pension and other retiree benefit costs of $923 and $977 , respectively, and cumulative foreign currency translation adjustments of $2,927 and $3,212 , respectively. Foreign currency translation adjustments in 2017 primarily reflect gains from the Euro. In 2016 , foreign currency translation adjustments primarily reflect losses from the Mexican peso and the Euro, partially offset by gains from the Brazilian real.

Quarterly Financial Data (Unaud

Quarterly Financial Data (Unaudited)	12 Months Ended
Quarterly Financial Data (Unaudited)	Dec. 31, 2017
Quarterly Financial Data [Abstract]
Quarterly Financial Data (Unaudited)	Quarterly Financial Data (Unaudited) Total First Quarter Second Quarter Third Quarter Fourth Quarter 2017 Net sales $ 15,454 $ 3,762 $ 3,826 $ 3,974 $ 3,892 Gross profit 9,280 (1) 2,269 (3) 2,300 (5) 2,383 (7) 2,328 (9) Net income including noncontrolling interests 2,174 (2) 611 (4) 560 (6) 650 (8) 353 (10) Net income attributable to Colgate-Palmolive Company 2,024 (2) 570 (4) 524 (6) 607 (8) 323 (10) Earnings per common share: Basic 2.30 (2) 0.64 (4) 0.59 (6) 0.69 (8) 0.37 (10) Diluted 2.28 (2) 0.64 (4) 0.59 (6) 0.68 (8) 0.37 (10) 2016 Net sales $ 15,195 $ 3,762 $ 3,845 $ 3,867 $ 3,721 Gross profit 9,123 (11) 2,248 (13) 2,304 (16) 2,324 (18) 2,247 (20) Net income including noncontrolling interests 2,586 (12) 574 (14) 638 (17) 746 (19) 628 (21) Net income attributable to Colgate-Palmolive Company 2,441 (12) 533 (14) (15) 600 (17) 702 (19) 606 (21) Earnings per common share: Basic 2.74 (12) 0.60 (14) 0.67 (17) 0.79 (19) 0.68 (21) Diluted 2.72 (12) 0.59 (14) 0.67 (17) 0.78 (19) 0.68 (21) ____________ Note: Basic and diluted earnings per share are computed independently for each quarter and the year-to-date period presented. Accordingly, the sum of the quarterly earnings per common share may not necessarily equal the earnings per share for the year-to-date period. (1) Gross profit for the full year of 2017 includes $75 of charges related to the Global Growth and Efficiency Program. (2) Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the full year of 2017 include $246 of aftertax charges related to the Global Growth and Efficiency Program and a $275 charge related to U.S. tax reform. (3) Gross profit for the first quarter of 2017 includes $14 of charges related to the Global Growth and Efficiency Program. (4) Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the first quarter of 2017 include $31 of aftertax charges related to the Global Growth and Efficiency Program. (5) Gross profit for the second quarter of 2017 includes $21 of charges related to the Global Growth and Efficiency Program. (6) Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the second quarter of 2017 include $115 of aftertax charges related to the Global Growth and Efficiency Program. (7) Gross profit for the third quarter of 2017 includes $16 of charges related to the Global Growth and Efficiency Program. (8) Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the third quarter of 2017 include $39 of aftertax charges related to the Global Growth and Efficiency Program. (9) Gross profit for the fourth quarter of 2017 includes $24 of charges related to the Global Growth and Efficiency Program. (10) Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the fourth quarter of 2017 include $61 of aftertax charges related to the Global Growth and Efficiency Program and a $275 charge related to U.S. tax reform. (11) Gross profit for the full year of 2016 includes $46 of charges related to the Global Growth and Efficiency Program. (12) Net income including noncontrolling interests for the full year of 2016 includes $169 of aftertax charges related to the Global Growth and Efficiency Program. Net income attributable to Colgate-Palmolive Company and Earnings per common share for the full year of 2016 include $168 of aftertax charges related to the Global Growth and Efficiency Program, a $63 aftertax gain on the sale of land in Mexico, $11 of aftertax charges for a litigation matter and $35 of benefits from tax matters. (13) Gross profit for the first quarter of 2016 includes $8 of charges related to the Global Growth and Efficiency Program. (14) Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the first quarter of 2016 include $38 of aftertax charges related to the Global Growth and Efficiency Program. (15) In the first quarter of 2016, provision for income taxes included a $210 U.S. income tax benefit principally related to changes in Venezuela’s foreign exchange regime implemented in March 2016. In order to fully utilize the above mentioned $210 tax benefit in 2016, the Company repatriated an incremental $1,500 of earnings of foreign subsidiaries it previously considered indefinitely reinvested outside of the U.S., and accordingly, recorded a tax charge of $210 during the first quarter of 2016. See Note 11, Income Taxes. (16) Gross profit for the second quarter of 2016 includes $12 of charges related to the Global Growth and Efficiency Program. (17) Net income including noncontrolling interests for the second quarter of 2016 includes $45 of aftertax charges related to the Global Growth and Efficiency Program. Net income attributable to Colgate-Palmolive Company and Earnings per common share for the second quarter of 2016 include $44 of aftertax charges related to the Global Growth and Efficiency Program and a $13 benefit from a tax matter. (18) Gross profit for the third quarter of 2016 includes $11 of charges related to the Global Growth and Efficiency Program. (19) Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the third quarter of 2016 include $32 of aftertax charges related to the Global Growth and Efficiency Program, a $63 aftertax gain on the sale of land in Mexico, a $4 aftertax charge for a litigation matter and $22 of benefits from tax matters. (20) Gross profit for the fourth quarter of 2016 includes $15 of charges related to the Global Growth and Efficiency Program. (21) Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the fourth quarter of 2016 include $54 of aftertax charges related to the Global Growth and Efficiency Program and a $7 aftertax charge for a litigation matter.

Schedule II - Valuation and Qua

Schedule II - Valuation and Qualifying Accounts	12 Months Ended
Schedule II - Valuation and Qualifying Accounts	Dec. 31, 2017
Valuation and Qualifying Accounts [Abstract]
SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS	COLGATE-PALMOLIVE COMPANY SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Dollars in Millions) Additions Balance at Beginning of Period Charged to Costs and Expenses Other Deductions Balance at End of Period Year Ended December 31, 2017 Allowance for doubtful accounts and estimated returns $ 73 $ 8 $ — $ 4 $ 77 Valuation allowance for deferred tax assets $ — $ 9 $ — $ — $ 9 Year Ended December 31, 2016 Allowance for doubtful accounts and estimated returns $ 59 $ 18 $ — $ 4 $ 73 Valuation allowance for deferred tax assets $ — $ — $ — $ — $ — Year Ended December 31, 2015 Allowance for doubtful accounts and estimated returns $ 54 $ 7 $ — $ 2 $ 59 Valuation allowance for deferred tax assets $ — $ — $ — $ — $ —

Summary of Significant Accoun28

Summary of Significant Accounting Policies (Policies)	12 Months Ended
Summary of Significant Accounting Policies (Policies)	Dec. 31, 2017
Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation The Consolidated Financial Statements include the accounts of Colgate-Palmolive Company and its majority-owned or controlled subsidiaries. Intercompany transactions and balances have been eliminated. The Company’s investments in consumer products companies with interests ranging between 20% and 50% , where the Company has significant influence over the investee, are accounted for using the equity method. Net income (loss) from such investments is recorded in Other (income) expense, net in the Consolidated Statements of Income. As of December 31, 2017 and 2016 , equity method investments included in Other assets in the Consolidated Balance Sheets were $42 and $38 , respectively. Unrelated third parties hold the remaining ownership interests in these investments. Investments with less than a 20% interest are accounted for using the cost method. Effective December 31, 2015, the Company concluded it no longer met the accounting criteria for consolidation of its Venezuelan subsidiary (“CP Venezuela”) and began accounting for CP Venezuela using the cost method of accounting. As a result, effective December 31, 2015, CP Venezuela’s net assets and operating results are no longer included in the Company’s Consolidated Financial Statements. See Note 14 , Venezuela for further information.
Use of Estimates	Use of Estimates The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires management to use judgment and make estimates that affect the reported amounts of assets and liabilities and disclosure of contingent gains and losses at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The level of uncertainty in estimates and assumptions increases with the length of time until the underlying transactions are completed. As such, the most significant uncertainty in the Company’s assumptions and estimates involved in preparing the financial statements includes pension and other retiree benefit cost assumptions, stock-based compensation, asset impairments, uncertain tax positions, tax valuation allowances, legal and other contingency reserves, the provisional charge in 2017 related to U.S. tax reform (see Note 11 , Income Taxes ) and, prior to the deconsolidation of the Company’s Venezuelan operations, the selection of the exchange rate used to remeasure the financial statements of CP Venezuela (see Note 14 , Venezuela). Additionally, the Company uses available market information and other valuation methodologies in assessing the fair value of financial instruments and retirement plan assets. Judgment is required in interpreting market data to develop the estimates of fair value and, accordingly, changes in assumptions or the estimation methodologies may affect the fair value estimates. Actual results could ultimately differ from those estimates.
Revenue Recognition	Revenue Recognition Sales are recorded at the time products are shipped to trade customers and when risk of ownership transfers. Net sales reflect units shipped at selling list prices reduced by sales returns and the cost of current and continuing promotional programs. Current promotional programs, such as product listing allowances and co-operative advertising arrangements, are recorded in the period incurred. Continuing promotional programs are predominantly consumer coupons and volume-based sales incentive arrangements with trade customers. The redemption cost of consumer coupons is based on historical redemption experience and is recorded when coupons are distributed. Volume-based incentives offered to trade customers are based on the estimated cost of the program and are recorded as products are sold.
Shipping and Handling Costs	Shipping and Handling Costs Shipping and handling costs are classified as Selling, general and administrative expenses and were $1,183 , $1,140 and $1,235 for the years ended December 31, 2017 , 2016 and 2015 , respectively.
Marketing Costs	Marketing Costs The Company markets its products through advertising and other promotional activities. Advertising costs are included in Selling, general and administrative expenses and are expensed as incurred. Certain consumer and trade promotional programs, such as consumer coupons, are recorded as a reduction of sales.
Cash and Cash equivalents	Cash and Cash Equivalents The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents.
Inventories	Inventories The cost of approximately 75% of inventories is determined using the first-in, first-out (“FIFO”) method, which is stated at the lower of cost or net realizable value. The cost of all other inventories, in the U.S. and Mexico, is determined using the last-in, first-out (“LIFO”) method, which is stated at the lower of cost or market.
Property, Plant and Equipment	Property, Plant and Equipment Land, buildings and machinery and equipment are stated at cost. Depreciation is provided, primarily using the straight-line method, over estimated useful lives ranging from 3 to 15 years for machinery and equipment and up to 40 years for buildings. Depreciation attributable to manufacturing operations is included in Cost of sales. The remaining component of depreciation is included in Selling, general and administrative expenses.
Goodwill and Other Intangibles	Goodwill and Other Intangibles Goodwill and indefinite life intangible assets, such as the Company’s global brands, are subject to impairment tests at least annually. These tests were performed and did not result in an impairment charge. Other intangible assets with finite lives, such as local brands and trademarks, customer relationships and non-compete agreements, are amortized over their estimated useful lives, generally ranging from 5 to 40 years. Amortization expense related to intangible assets is included in Other (income) expense, net, which is included in Operating profit.
Income Taxes	Income Taxes The provision for income taxes is determined using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized based upon the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates that will be in effect at the time such differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. The Company uses a comprehensive model to recognize, measure, present and disclose in its financial statements uncertain tax positions that the Company has taken or expects to take on an income tax return. The Company recognizes interest expense and penalties related to unrecognized tax benefits within Provision for income taxes.
Financial Instruments	Financial Instruments Derivative instruments are recorded as assets and liabilities at estimated fair value based on available market information. The Company’s derivative instruments that qualify for hedge accounting are designated as either fair value hedges, cash flow hedges or net investment hedges. For fair value hedges, changes in the fair value of the derivative, as well as the offsetting changes in the fair value of the hedged item, are recognized in earnings each period. For cash flow hedges, changes in the fair value of the derivative are recorded in Other comprehensive income (loss) and are recognized in earnings when the offsetting effect of the hedged item is also recognized in earnings. For hedges of the net investment in foreign subsidiaries, changes in the fair value of the derivative are recorded in Other comprehensive income (loss) to offset the change in the value of the net investment being hedged. Cash flows related to hedges are classified in the same category as the cash flows from the hedged item in the Consolidated Statements of Cash Flows. The Company may also enter into certain foreign currency and interest rate instruments that economically hedge certain of its risks but do not qualify for hedge accounting. Changes in fair value of these derivative instruments, based on quoted market prices, are recognized in earnings each period. The Company’s derivative instruments and other financial instruments are more fully described in Note 7 , Fair Value Measurements and Financial Instruments along with the related fair value measurement considerations.
Stock-Based Compensation	Stock-Based Compensation The Company recognizes the cost of employee services received in exchange for awards of equity instruments, such as stock options and restricted stock units, based on the fair value of those awards at the date of grant over the requisite service period. The Company uses the Black-Scholes-Merton ( “ Black-Scholes ” ) option pricing model to determine the fair value of stock option awards. Stock-based compensation plans, related expenses and assumptions used in the Black-Scholes option pricing model are more fully described in Note 8 , Capital Stock and Stock-Based Compensation Plans.
Currency Translation	Currency Translation The assets and liabilities of foreign subsidiaries, other than those operating in highly inflationary environments, are translated into U.S. dollars at year-end exchange rates with resulting translation gains and losses accumulated in a separate component of shareholders’ equity. Income and expense items are translated into U.S. dollars at average rates of exchange prevailing during the year. For subsidiaries operating in highly inflationary environments, local currency-denominated non-monetary assets, including inventories, goodwill and property, plant and equipment, are remeasured at their historical exchange rates, while local currency-denominated monetary assets and liabilities are remeasured at year-end exchange rates. Remeasurement adjustments for these operations are included in Net income attributable to Colgate-Palmolive Company. Prior to the deconsolidation of the Company’s Venezuelan operations in 2015, CP Venezuela was designated as hyper-inflationary and the functional currency for CP Venezuela was the U.S. dollar. See Note 14, Venezuela for further information.
Recent Accounting Pronouncements	Recent Accounting Pronouncements On August 28, 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2017-12, “Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities,” amending the eligibility criteria for hedged items and transactions to expand an entity’s ability to hedge nonfinancial and financial risk components. The new guidance eliminates the requirement to separately measure and present hedge ineffectiveness and aligns the presentation of hedge gains and losses with the underlying hedge item. The new guidance also simplifies the hedge documentation and hedge effectiveness assessment requirements. The new guidance is effective for the Company beginning on January 1, 2019, with early adoption permitted. The amended presentation and disclosure requirements must be adopted on a prospective basis, while any amendments to cash flow and net investment hedge relationships that exist on the date of adoption must be applied on a “modified retrospective” basis, meaning a cumulative effect adjustment to the opening balance of retained earnings as of the beginning of the year of adoption. While the Company is currently assessing the impact of the new standard on its Consolidated Financial Statements, this new guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements. On May 10, 2017, the FASB issued ASU No. 2017-09, “Compensation–Stock Compensation (Topic 718): Scope of Modification Accounting,” clarifying when a change to the terms or conditions of a stock-based payment award must be accounted for as a modification. The new guidance requires modification accounting if the fair value, vesting condition or the classification of the award is not the same immediately before and after a change to the terms and conditions of the award. The new guidance was effective for the Company on a prospective basis beginning on January 1, 2018. This new guidance is not expected to have an impact on the Company’s Consolidated Financial Statements as it is not the Company’s practice to change either the terms or conditions of stock-based payment awards once they are granted. On March 10, 2017, the FASB issued ASU No. 2017-07, “Compensation–Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost,” changing the presentation of the net periodic benefit cost on the Statement of Income and limiting the amount of net periodic benefit cost eligible for capitalization to assets. The new guidance permits only the service cost component of net periodic benefit cost to be eligible for capitalization. The new guidance also requires entities to present the service cost component of net periodic benefit cost together with compensation costs arising from services rendered by employees during the period. Other components of net periodic benefit cost, which include interest, expected return on assets, amortization of prior service costs and actuarial gains and losses, are required to be presented outside of Operating profit. The line item or items used to present the other components of net periodic benefit cost must be disclosed in the Notes to the Consolidated Financial Statements, if not separately described on the Statement of Income. The new presentation requirement is required to be adopted on a “full retrospective” basis, meaning the standard is applied to all of the periods presented in the financial statements, while the limitation on capitalization can only be adopted on a prospective basis. The new guidance was effective for the Company beginning on January 1, 2018. Had the standard been effective for the year ended December 31, 2017, full year Operating profit would have increased by approximately $120 with no impact on Net income attributable to Colgate-Palmolive Company. The Company anticipates that, as a result of the reclassification, full year Operating profit will increase in future periods by approximately $100 annually with no impact on Net income attributable to Colgate-Palmolive Company. On January 26, 2017, the FASB issued ASU No. 2017-04, “Intangibles–Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment,” eliminating the requirement to calculate the implied fair value, essentially eliminating step two from the goodwill impairment test. The new standard requires goodwill impairment to be based upon the results of step one of the impairment test, which is defined as the excess of the carrying value of a reporting unit over its fair value. The impairment charge will be limited to the amount of goodwill allocated to that reporting unit. The standard is effective for the Company on a prospective basis beginning on January 1, 2020, with early adoption permitted. This new guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements. On January 5, 2017, the FASB issued ASU No. 2017-01, “Business Combinations (Topic 805): Clarifying the Definition of a Business,” which provides additional guidance on evaluating whether transactions should be accounted for as acquisitions of assets or businesses. The guidance requires an entity to evaluate if substantially all of the fair value of the assets acquired is concentrated in a single identifiable asset or a group of similar identifiable assets. If this threshold is met, the new guidance would define this as an asset acquisition; otherwise, the entity then evaluates whether the asset meets the requirement that a business include, at a minimum, an input and substantive process that together significantly contribute to the ability to create outputs. The guidance was effective for the Company on a prospective basis beginning on January 1, 2018. This new guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements. On October 24, 2016, the FASB issued ASU No. 2016-16, “Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other than Inventory,” which eliminates the requirement to defer recognition of income taxes on intra-entity asset transfers until the asset is sold to an outside party. The new guidance requires the recognition of current and deferred income taxes on intra-entity transfers of assets other than inventory, such as intellectual property and property, plant and equipment, when the transfer occurs. As permitted, the Company early-adopted the new standard on a “modified retrospective” basis, meaning the standard was applied only to the most recent period presented in the financial statements, as of January 1, 2017. This new guidance did not have a material impact on the Company’s Consolidated Financial Statements. On August 26, 2016, the FASB issued ASU No. 2016-15, “Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments,” which clarifies how certain cash receipts and payments are to be presented in the statement of cash flows. The guidance was effective for the Company on January 1, 2018. This new guidance is not expected to have a material impact on the Company’s Consolidated Financial Statements. On March 30, 2016, the FASB issued ASU No. 2016-09, “Compensation–Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting,” which amended accounting for income taxes related to stock-based compensation, the related classification in the statement of cash flows and share award forfeiture accounting. The new guidance was effective for the Company beginning on January 1, 2017. As required subsequent to the adoption of this new guidance, the Company recognized excess tax benefits of $47 (resulting from an increase in the fair value of an award from grant date to the vesting or exercise date, as applicable) in the Provision for income taxes as a discrete item during the year ended December 31, 2017 . These amounts may not necessarily be indicative of future amounts that may be recognized as any excess tax benefits from stock-based compensation recognized would be dependent on future stock price, employee exercise behavior and applicable tax rates. Prior to January 1, 2017, excess tax benefits were recognized in equity. As permitted, the Company elected to classify these excess tax benefits from stock-based compensation as an operating activity in the Statement of Cash Flows instead of as a financing activity on a prospective basis and did not retrospectively adjust prior periods. Also, as permitted by the new standard, the Company elected to account for forfeitures as they occur. On March 15, 2016, the FASB issued ASU No. 2016-07, “Investments–Equity Method and Joint Ventures (Topic 323): Simplifying the Transition to the Equity Method of Accounting,” which eliminated the requirement to retroactively adjust an investment that subsequently qualifies for equity method accounting (as a result of an increase in level of ownership interest or degree of influence) as if the equity method of accounting had been applied during all prior periods that the investment was held. The new standard requires that the investor add the cost of acquiring additional ownership interest in the investee to its current basis and prospectively apply the equity method of accounting. For an available-for-sale investment, any unrealized gains or losses should be recognized in earnings at the date the investment qualifies as an equity method investment. The new guidance was effective for the Company beginning on January 1, 2017, and did not have a material impact on the Company’s Consolidated Financial Statements. On February 25, 2016, the FASB issued its final standard on lease accounting, ASU No. 2016-02, “Leases (Topic 842),” which supersedes Topic 840, “Leases.” The new accounting standard requires the recognition of right-of-use assets and lease liabilities for all long-term leases, including operating leases, on the balance sheet. The new standard also provides additional guidance on the measurement of the right-of-use assets and lease liabilities and will require enhanced disclosures about the Company’s leasing arrangements. Under current accounting standards, substantially all of the Company’s leases are considered operating leases and, as such, are not recognized on the Consolidated Balance Sheet. This new standard is effective for the Company beginning on January 1, 2019, with early adoption permitted. The standard requires a “modified retrospective” adoption, meaning the standard is applied to leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements. The Company is currently assessing the impact of the new standard on its Consolidated Financial Statements. On January 5, 2016, the FASB issued ASU No. 2016-01, “Financial Instruments–Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities.” The updated guidance enhances the reporting model for financial instruments, which includes amendments to address aspects of recognition, measurement, presentation and disclosure. The amendment to the standard was effective for the Company beginning on January 1, 2018 and is not expected to have a material impact on the Company’s Consolidated Financial Statements. On July 22, 2015, the FASB issued ASU No. 2015-11, “Inventory (Topic 330): Simplifying the Measurement of Inventory,” which simplifies the subsequent measurement of inventories by replacing the lower of cost or market test with a lower of cost and net realizable value test. The guidance applies only to inventories for which cost is determined by methods other than LIFO and the retail inventory method. The new guidance was effective for the Company beginning on January 1, 2017. This new guidance did not have a material impact on the Company’s Consolidated Financial Statements. On May 28, 2014, the FASB and the International Accounting Standards Board issued their final converged standard on revenue recognition. The standard, issued as ASU No. 2014-09, “Revenue from Contracts with Customers (Topic 606)” by the FASB, provides a comprehensive revenue recognition model for all contracts with customers and supersedes current revenue recognition guidance. The revenue standard contains principles that an entity will apply to determine the measurement of revenue and timing of when it is recognized. The underlying principle is that an entity will recognize revenue to depict the transfer of goods or services to its customers at an amount that the entity expects to be entitled to in exchange for those goods or services. The new standard also includes enhanced disclosures. During 2016, the FASB issued several accounting updates (ASU No. 2016-08, 2016-10 and 2016-12) to clarify implementation guidance and correct unintended application of the guidance. The standard allows for either full retrospective adoption or modified retrospective adoption. The Company adopted the new standard on January 1, 2018, on a “modified retrospective” basis, which did not have a material impact on the Company’s Consolidated Financial Statements. Although the new standard resulted in changes to the Company’s revenue recognition accounting policy commencing on January 1, 2018, the Company does not expect it will have a material impact in future periods on its Consolidated Financial Statements.
Reclassifications	Reclassifications Certain prior year amounts have been reclassified to conform to the current year presentation.

Nature of Operations (Tables)

Nature of Operations (Tables)	12 Months Ended
Nature of Operations (Tables)	Dec. 31, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Percentage of worldwide sales	The Company’s principal classes of products accounted for the following percentages of worldwide Net sales for the past three years: 2017 2016 2015 Oral Care 48 % 47 % 47 % Personal Care 19 % 20 % 20 % Home Care 18 % 18 % 19 % Pet Nutrition 15 % 15 % 14 % Total 100 % 100 % 100 %

Restructuring and Related Imp30

Restructuring and Related Implementation Charges (Tables)	12 Months Ended
Restructuring and Related Implementation Charges (Tables)	Dec. 31, 2017
Restructuring and Related Activities [Abstract]
Schedule of Restructuring and Related Costs	For the years ended December 31, 2017 , 2016 and 2015 , restructuring and related implementation charges are reflected in the Consolidated Statements of Income as follows: 2017 2016 2015 Cost of sales $ 75 $ 46 $ 20 Selling, general and administrative expenses 89 77 64 Other (income) expense, net 169 105 170 Total Global Growth and Efficiency Program charges, pretax $ 333 $ 228 $ 254 Total Global Growth and Efficiency Program charges, aftertax $ 246 $ 168 $ 183
Schedule of Percent of Total Restructuring Charges Related To Segment for the period	Total charges incurred for the Global Growth and Efficiency Program relate to initiatives undertaken by the following reportable operating segments: Program-to-date 2017 2016 2015 Accumulated Charges North America 23 % 35 % 21 % 18 % Latin America 2 % 5 % 3 % 3 % Europe 21 % 12 % 14 % 22 % Asia Pacific 5 % 4 % 4 % 3 % Africa/Eurasia 3 % 14 % 5 % 6 % Hill ’ s Pet Nutrition 6 % 7 % 5 % 7 % Corporate 40 % 23 % 48 % 41 % Total 100 % 100 % 100 % 100 %
Schedule of Restructuring and Related Costs Incurred to Date	Since the inception of the Global Growth and Efficiency Program in the fourth quarter of 2012, the Company has incurred cumulative pretax charges of $1,561 ( $1,153 aftertax) in connection with the implementation of various projects as follows: Cumulative Charges as of December 31, 2017 Employee-Related Costs $ 628 Incremental Depreciation 90 Asset Impairments 36 Other 807 Total $ 1,561
Schedule of Restructuring Reserve by Type of Cost	The following table summarizes the activity for the restructuring and related implementation charges, in the respective periods, discussed above and the related accruals: Employee-Related Costs Incremental Depreciation Asset Impairments Other Total Balance at January 1, 2015 $ 85 $ — $ — $ 107 $ 192 Charges 109 20 5 120 254 Cash payments (85 ) — — (94 ) (179 ) Charges against assets (17 ) (20 ) (5 ) — (42 ) Foreign exchange (8 ) — — (2 ) (10 ) Other — — — — — Balance at December 31, 2015 $ 84 $ — $ — $ 131 $ 215 Charges 61 9 20 138 228 Cash payments (84 ) — — (153 ) (237 ) Charges against assets (4 ) (9 ) (20 ) — (33 ) Foreign exchange (1 ) — — — (1 ) Other — — — 9 9 Balance at December 31, 2016 $ 56 $ — $ — $ 125 $ 181 Charges 163 10 9 151 333 Cash payments (74 ) — — (170 ) (244 ) Charges against assets (21 ) (10 ) (9 ) — (40 ) Foreign exchange 3 — — 1 4 Other — — — — — Balance at December 31, 2017 $ 127 $ — $ — $ 107 $ 234

Goodwill and Other Intangible31

Goodwill and Other Intangible Assets (Tables)	12 Months Ended
Goodwill and Other Intangible Assets (Tables)	Dec. 31, 2017
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The net carrying value of Goodwill as of December 31, 2017 and 2016 by segment was as follows: 2017 2016 Oral, Personal and Home Care North America $ 343 $ 336 Latin America 256 260 Europe 1,333 1,233 Asia Pacific 190 187 Africa/Eurasia 81 76 Total Oral, Personal and Home Care 2,203 2,092 Pet Nutrition 15 15 Total Goodwill $ 2,218 $ 2,107
Schedule Of Finite And Indefinite Lived Intangible Assets By Major Class	Other intangible assets as of December 31, 2017 and 2016 were comprised of the following: 2017 2016 Gross Carrying Amount Accumulated Amortization Net Gross Carrying Amount Accumulated Amortization Net Trademarks $ 547 $ (337 ) $ 210 $ 539 $ (317 ) $ 222 Other finite life intangible assets 249 (103 ) 146 231 (78 ) 153 Indefinite life intangible assets 985 — 985 938 — 938 Total Other intangible assets $ 1,781 $ (440 ) $ 1,341 $ 1,708 $ (395 ) $ 1,313

Long-Term Debt and Credit Fac32

Long-Term Debt and Credit Facilities (Tables)	12 Months Ended
Long-Term Debt and Credit Facilities (Tables)	Dec. 31, 2017
Debt Disclosure [Abstract]
Schedule of Long-term Debt Instruments	Long-term debt consisted of the following at December 31: Weighted Average Interest Rate Maturities 2017 2016 Notes 2.0% 2018 - 2078 $ 6,542 $ 6,225 Commercial paper 1.5% 2018 24 295 6,566 6,520 Less: Current portion of long-term debt — — Total $ 6,566 $ 6,520
Schedule of Maturities of Long-term Debt	Excluding such obligations, scheduled maturities of long-term debt and capitalized leases outstanding as of December 31, 2017 , were as follows: Years Ended December 31, 2018 $ — 2019 1,097 2020 248 2021 298 2022 889 Thereafter 3,311

Fair Value Measurements and F33

Fair Value Measurements and Financial Instruments (Tables)	12 Months Ended
Fair Value Measurements and Financial Instruments (Tables)	Dec. 31, 2017
Financial Instruments and Fair Value Measurements [Abstract]
Schedule of Derivative Instruments	The following table summarizes the fair value of the Company’s derivative instruments and other financial instruments at December 31, 2017 and December 31, 2016 : Assets Liabilities Account Fair Value Account Fair Value Designated derivative instruments 12/31/17 12/31/16 12/31/17 12/31/16 Interest rate swap contracts Other current assets $ — $ 1 Other accruals $ — $ — Interest rate swap contracts Other assets — 1 Other liabilities 7 — Foreign currency contracts Other current assets 25 29 Other accruals 20 4 Foreign currency contracts Other assets — 5 Other liabilities 46 — Commodity contracts Other current assets — — Other accruals — — Total designated $ 25 $ 36 $ 73 $ 4 Derivatives not designated Foreign currency contracts Other assets — — Other liabilities — — Total not designated $ — $ — $ — $ — Total derivative instruments $ 25 $ 36 $ 73 $ 4 Other financial instruments Marketable securities Other current assets $ 14 $ 23 Total other financial instruments $ 14 $ 23
Activity related to fair value hedges	Activity related to fair value hedges recorded during each period presented was as follows: 2017 2016 Foreign Currency Contracts Interest Rate Swaps Total Foreign Currency Contracts Interest Rate Swaps Total Notional Value at December 31, $ 1,231 $ 1,000 $ 2,231 $ 204 $ 1,250 $ 1,454 Gain (loss) on derivatives (7 ) (9 ) (16 ) 5 (5 ) — Gain (loss) on hedged items 7 9 16 (5 ) 5 —
Activity related to cash flow hedges	Activity related to cash flow hedges recorded during each period presented was as follows: 2017 2016 Foreign Currency Contracts Commodity Contracts Total Foreign Currency Contracts Commodity Contracts Total Notional Value at December 31, $ 702 $ — $ 702 $ 643 $ 7 $ 650 Gain (loss) recognized in OCI (25 ) — (25 ) 12 (1 ) 11 Gain (loss) reclassified into Cost of sales (3 ) — (3 ) 4 — 4
Activity related to net investment hedges	Activity related to net investment hedges recorded during each period presented was as follows: 2017 2016 Foreign Currency Contracts Foreign Currency Debt Total Foreign Currency Contracts Foreign Currency Debt Total Notional Value at December 31, $ 478 $ 601 $ 1,079 $ 498 $ 1,118 $ 1,616 Gain (loss) on instruments (71 ) (112 ) (183 ) 22 35 57 Gain (loss) on hedged items 71 112 183 (25 ) (35 ) (60 )
Activity related to derivatives not designated as hedging instruments	Activity related to these contracts during each period presented was as follows: 2017 2016 Foreign Currency Contracts Foreign Currency Contracts Notional Value at December 31, $ 3 $ 4 Gain (loss) on instruments — 5 Gain (loss) on hedged items — (5 )

Capital Stock and Stock-Based34

Capital Stock and Stock-Based Compensation Plans (Tables)	12 Months Ended
Capital Stock and Stock-Based Compensation Plans (Tables)	Dec. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule Of Common And Treasury Stock Activity	A summary of common stock and treasury stock activity for the three years ended December 31, is as follows: Common Stock Outstanding Treasury Stock Balance, January 1, 2015 906,712,145 558,994,215 Common stock acquired (22,802,784 ) 22,802,784 Shares issued for stock options 7,394,839 (7,394,839 ) Shares issued for restricted stock units and other 1,434,318 (1,434,318 ) Balance, December 31, 2015 892,738,518 572,967,842 Common stock acquired (19,271,304 ) 19,271,304 Shares issued for stock options 8,536,639 (8,536,639 ) Shares issued for restricted stock units and other 1,105,110 (1,105,110 ) Balance, December 31, 2016 883,108,963 582,597,397 Common stock acquired (19,185,828 ) 19,185,828 Shares issued for stock options 9,670,988 (9,670,988 ) Shares issued for restricted stock units and other 1,106,995 (1,106,995 ) Balance, December 31, 2017 874,701,118 591,005,242
Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions	Fair value is estimated using the Black-Scholes option pricing model with the assumptions summarized in the following table: 2017 2016 2015 Expected term of options 4.5 years 4.5 years 4.5 years Expected volatility rate 16.0 % 16.7 % 17.6 % Risk-free interest rate 1.8 % 1.2 % 1.5 % Expected dividend yield 2.2 % 2.1 % 2.5 %
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity	A summary of restricted stock unit activity during 2017 is presented below: Shares (in thousands) Weighted Average Grant Date Fair Value Per Award Restricted stock units as of January 1, 2017 2,945 $ 66 Activity: Granted 916 74 Vested (1,057 ) 62 Forfeited (74 ) 67 Restricted stock units as of December 31, 2017 2,730 $ 70
Schedule of Share-based Compensation, Stock Options, Activity	A summary of stock option activity during 2017 is presented below: Shares (in thousands) Weighted Average Exercise Price Weighted Average Remaining Contractual Life (in years) Intrinsic Value of Unexercised In-the-Money Options Options outstanding, January 1, 2017 43,692 $ 61 Granted 7,798 73 Exercised (10,118 ) 53 Forfeited or expired (393 ) 68 Options outstanding, December 31, 2017 40,979 65 4 $ 420 Options exercisable, December 31, 2017 25,349 $ 62 3 $ 351

Retirement Plans and Other Re35

Retirement Plans and Other Retiree Benefits (Tables)	12 Months Ended
Retirement Plans and Other Retiree Benefits (Tables)	Dec. 31, 2017
Retirement Benefits [Abstract]
Schedule of Allocation of Plan Assets	The target asset allocation for the Company’s defined benefit plans is as follows: United States International Asset Category Equity securities 27 % 39 % Fixed income securities 53 % 41 % Real estate and other investments 20 % 20 % Total 100 % 100 % At December 31, 2017 the allocation of the Company’s plan assets and the level of valuation input, as applicable, for each major asset category were as follows: Level of Valuation Pension Plans United States International Other Retiree Benefit Plans Cash and cash equivalents Level 1 $ 21 $ 11 $ — U.S. common stocks Level 1 127 4 — International common stocks Level 1 — 3 — Pooled funds (1) Level 1 138 94 — Fixed income securities (2) Level 2 843 24 — Guaranteed investment contracts (3) Level 2 1 53 — 1,130 189 — Investments valued using NAV per share (4) Domestic, developed and emerging markets equity funds 350 189 — Fixed income funds (5) 122 167 — Hedge funds (6) 82 5 — Multi-Asset funds (7) 115 3 — Real estate funds (8) 38 22 — 707 386 — Other assets and liabilities, net (9) (25 ) — — Total Investments $ 1,812 $ 575 $ — At December 31, 2016 the allocation of the Company’s plan assets and the level of valuation input, as applicable, for each major asset category were as follows: Level of Valuation Pension Plans United States International Other Retiree Benefit Plans Cash and cash equivalents Level 1 $ 27 $ 13 $ — U.S. common stocks Level 1 127 3 — International common stocks Level 1 — 3 — Pooled funds (1) Level 1 134 84 — Fixed income securities (2) Level 2 767 22 — Guaranteed investment contracts (3) Level 2 1 49 — 1,056 174 — Investments valued using NAV per share (4) Domestic, developed and emerging markets equity funds 323 155 — Fixed income funds (5) 118 155 — Hedge funds (6) 96 3 — Multi-Asset funds (7) 52 3 — Real estate funds (8) 43 19 — 632 335 — Other assets and liabilities, net (9) (42 ) — — Total Investments $ 1,646 $ 509 $ — _______ (1) Pooled funds primarily invest in U.S. and foreign equity securities, debt and money market securities. (2) The fixed income securities are traded over the counter and certain of these securities lack daily pricing or liquidity and as such are classified as Level 2. As of December 31, 2017 and 2016, approximately 50% of the U.S. pension plan fixed income portfolio was invested in U.S. treasury or agency securities, with the remainder invested in other government bonds and corporate bonds. (3) The guaranteed investment contracts (“GICs”) represent contracts with insurance companies measured at the cash surrender value of each contract. The Level 2 valuation reflects that the cash surrender value is based principally on a referenced pool of investment funds with active redemption. (4) Investments that are measured at fair value using net asset value (“NAV”) per share as a practical expedient have not been classified in the fair value hierarchy. The NAV is based on the value of the underlying investments owned, minus its liabilities, divided by the number of shares outstanding. There are no unfunded commitments related to these investments. Redemption notice period primarily ranges from 0-3 months and redemption frequency windows range from daily to quarterly. (5) Fixed income funds primarily invest in U.S. government and investment grade corporate bonds. (6) Consists of investments in underlying hedge fund strategies that are primarily implemented through the use of long and short equity and fixed income securities and derivative instruments such as futures and options. (7) Multi-Asset funds primarily invest across a variety of asset classes, including global stocks and bonds, as well as alternative strategies. (8) Real estate is valued using the NAV per unit of funds that are invested in real estate property. The investment value of the real estate property is determined quarterly using independent market appraisals as determined by the investment manager. (9) This category primarily includes unsettled trades for investments purchased and sold and dividend receivables.
Defined benefit plans disclosures	The Company uses a December 31 measurement date for its defined benefit and other retiree benefit plans. Summarized information for the Company’s defined benefit and other retiree benefit plans is as follows: Pension Plans Other Retiree Benefit Plans 2017 2016 2017 2016 2017 2016 United States International Change in Benefit Obligations Benefit obligations at beginning of year $ 2,298 $ 2,201 $ 800 $ 802 $ 923 $ 862 Service cost 1 1 16 16 13 13 Interest cost 94 105 22 25 40 43 Participants’ contributions — — 2 2 — — Acquisitions/plan amendments — — (6 ) 1 — — Actuarial loss (gain) 110 129 (11 ) 76 21 39 Foreign exchange impact — — 72 (47 ) 3 1 Termination benefits (1) 24 3 — — (3 ) 1 Curtailments and settlements — — (11 ) (37 ) — — Benefit payments (164 ) (141 ) (36 ) (36 ) (37 ) (36 ) Other — — (1 ) (2 ) — — Benefit obligations at end of year $ 2,363 $ 2,298 $ 847 $ 800 $ 960 $ 923 Change in Plan Assets Fair value of plan assets at beginning of year $ 1,646 $ 1,624 $ 509 $ 520 $ — $ 14 Actual return on plan assets 225 88 42 46 — 1 Company contributions 105 75 30 54 37 21 Participants’ contributions — — 2 2 — — Foreign exchange impact — — 40 (43 ) — — Settlements and acquisitions — — (11 ) (33 ) — — Benefit payments (164 ) (141 ) (36 ) (36 ) (37 ) (36 ) Other — — (1 ) (1 ) — — Fair value of plan assets at end of year $ 1,812 $ 1,646 $ 575 $ 509 $ — $ — Funded Status Benefit obligations at end of year $ 2,363 $ 2,298 $ 847 $ 800 $ 960 $ 923 Fair value of plan assets at end of year 1,812 1,646 575 509 — — Net amount recognized $ (551 ) $ (652 ) $ (272 ) $ (291 ) $ (960 ) $ (923 ) Amounts Recognized in Balance Sheet Noncurrent assets $ — $ — $ 22 $ 8 $ — $ — Current liabilities (24 ) (24 ) (13 ) (12 ) (44 ) (44 ) Noncurrent liabilities (527 ) (628 ) (281 ) (287 ) (916 ) (879 ) Net amount recognized $ (551 ) $ (652 ) $ (272 ) $ (291 ) $ (960 ) $ (923 ) Amounts Recognized in Accumulated Other Comprehensive Income (Loss) Actuarial loss $ 911 $ 962 $ 209 $ 254 $ 338 $ 330 Transition/prior service cost 1 2 1 5 (1 ) (2 ) $ 912 $ 964 $ 210 $ 259 $ 337 $ 328 Accumulated benefit obligation $ 2,293 $ 2,230 $ 787 $ 739 $ — $ — Pension Plans Other Retiree Benefit Plans 2017 2016 2017 2016 2017 2016 United States International Weighted-Average Assumptions Used to Determine Benefit Obligations Discount rate 3.73 % 4.27 % 2.53 % 2.59 % 3.80 % 4.41 % Long-term rate of return on plan assets 6.60 % 6.80 % 4.04 % 4.14 % 6.60 % 6.80 % Long-term rate of compensation increase 3.50 % 3.50 % 2.79 % 2.58 % 3.50 % — % ESOP growth rate — % — % — % — % 10.00 % 10.00 % Medical cost trend rate of increase — % — % — % — % 6.00 % 6.33 % _________ (1) Represents pension and other retiree benefit enhancements incurred in 2017 and 2016 pursuant to the Global Growth and Efficiency Program.
Schedule of Effect of One-Percentage-Point Change in Assumed Health Care Cost Trend Rates	A 1% change in the assumed medical cost trend rate would have the following approximate effect: One percentage point Increase Decrease Accumulated postretirement benefit obligation $ 123 $ (100 ) Total of service and interest cost components 9 (7 )
Schedule of Accumulated Benefit Obligations in Excess of Fair Value of Plan Assets	Plans with projected benefit obligations in excess of plan assets and plans with accumulated benefit obligations in excess of plan assets as of December 31 consisted of the following: Years Ended December 31, 2017 2016 Benefit Obligation Exceeds Fair Value of Plan Assets Projected benefit obligation $ 2,834 $ 2,973 Fair value of plan assets 1,992 2,024 Accumulated benefit obligation 2,641 2,840 Fair value of plan assets 1,905 2,003
Schedule of Net Benefit Costs	Summarized information regarding the net periodic benefit costs for the Company’s defined benefit and other retiree benefit plans is as follows: Pension Plans Other Retiree Benefit Plans 2017 2016 2015 2017 2016 2015 2017 2016 2015 United States International Components of Net Periodic Benefit Cost Service cost $ 1 $ 1 $ 2 $ 16 $ 16 $ 20 $ 13 $ 13 $ 14 Interest cost 94 105 100 22 25 28 40 43 44 Annual ESOP allocation — — — — — — — — — Expected return on plan assets (111 ) (109 ) (117 ) (22 ) (23 ) (28 ) — (1 ) (2 ) Amortization of transition and prior service costs (credits) — — — — — 2 — — — Amortization of actuarial loss 48 41 44 10 8 11 13 14 25 Net periodic benefit cost $ 32 $ 38 $ 29 $ 26 $ 26 $ 33 $ 66 $ 69 $ 81 Other postretirement charges 24 3 16 4 11 (1 ) (3 ) 1 1 Total pension cost $ 56 $ 41 $ 45 $ 30 $ 37 $ 32 $ 63 $ 70 $ 82 Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost Discount rate 4.27 % 4.93 % 4.24 % 2.59 % 3.17 % 3.06 % 4.41 % 4.97 % 4.36 % Long-term rate of return on plan assets 6.80 % 6.80 % 6.80 % 4.14 % 4.62 % 5.05 % 6.80 % 6.80 % 6.80 % Long-term rate of compensation increase 3.50 % 3.50 % 3.50 % 2.58 % 2.78 % 2.83 % — % — % — % ESOP growth rate — % — % — % — % — % — % 10.00 % 10.00 % 10.00 % Medical cost trend rate of increase — % — % — % — % — % — % 6.33 % 6.67 % 7.00 %
Schedule of Amounts in Accumulated Other Comprehensive Income (Loss) to be Recognized over Next Fiscal Year	The estimated actuarial loss and the estimated transition/prior service cost for defined benefit and other retiree benefit plans that will be amortized from Accumulated other comprehensive income (loss) into net periodic benefit cost over the next fiscal year is as follows: Pension Plans Other Retiree Benefit Plans Net actuarial loss $ 54 $ 17 Net transition and prior service cost — —
Schedule of Expected Benefit Payments	Total benefit payments expected to be paid to participants from plan assets, or directly from the Company’s assets to participants in unfunded plans, are as follows: Pension Plans Years Ended December 31, United States International Other Retiree Benefit Plans Total 2018 $ 137 $ 37 $ 45 $ 219 2019 141 35 46 222 2020 144 37 46 227 2021 143 38 47 228 2022 151 39 48 238 2023-2027 737 222 250 1,209

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
Income Taxes (Tables)	Dec. 31, 2017
Income Tax Disclosure [Abstract]
Components of income before income taxes	The components of Income before income taxes are as follows for the years ended December 31: 2017 2016 2015 United States $ 1,072 $ 1,191 $ 1,118 International 2,415 2,547 1,645 Total Income before income taxes $ 3,487 $ 3,738 $ 2,763
Provision for income taxes	The Provision for income taxes consists of the following for the years ended December 31: 2017 2016 2015 United States $ 338 $ 395 $ 376 International 975 757 839 Total Provision for income taxes $ 1,313 $ 1,152 $ 1,215
Schedule of components of deferred income tax benefit	Temporary differences between accounting for financial statement purposes and accounting for tax purposes result in the current provision for taxes being higher (lower) than the total provision for income taxes as follows: 2017 2016 2015 Goodwill and intangible assets $ 135 $ 18 $ 3 Property, plant and equipment 84 (3 ) (25 ) Pension and other retiree benefits (192 ) — 36 Stock-based compensation (28 ) 15 11 Tax loss and tax credit carryforwards (4 ) 5 (4 ) Other, net (103 ) (106 ) 98 Total deferred tax benefit (provision) $ (108 ) $ (71 ) $ 119
Effective tax rate reconciliation	The difference between the statutory U.S. federal income tax rate and the Company’s global effective tax rate as reflected in the Consolidated Statements of Income is as follows: Percentage of Income before income taxes 2017 2016 2015 Tax at United States statutory rate 35.0 % 35.0 % 35.0 % State income taxes, net of federal benefit 0.5 0.5 1.0 Earnings taxed at other than United States statutory rate (3.4 ) (2.7 ) (3.6 ) Charge for U.S. tax reform (1) 7.9 — — Excess tax benefits from stock-based compensation (2) (1.4 ) — — (Benefit) charge for foreign tax matters (3) — (0.8 ) 0.5 (Benefit) from Venezuela remeasurement (4) — (5.6 ) — Tax charge on incremental repatriation of foreign earnings (4) — 5.6 — Venezuela deconsolidation (5) — — 12.8 Other, net (0.9 ) (1.2 ) (1.7 ) Effective tax rate 37.7 % 30.8 % 44.0 % _________ (1) On December 22, 2017, the Tax Cuts and Jobs Act (the “TCJA” or “U.S. tax reform”) was enacted which, among other things, lowered the U.S. corporate income tax rate to 21% from 35% and established a modified territorial system requiring a mandatory deemed repatriation tax on undistributed earnings of foreign subsidiaries. Beginning in 2018, the TCJA also requires a minimum tax on certain future earnings generated by foreign subsidiaries while providing for future tax-free repatriation of such earnings through a 100% dividends-received deduction. In accordance with ASC 740, Income Taxes, and Staff Accounting Bulletin 118, the Company recognized a provisional charge in the fourth quarter of 2017 of $275 related to the TCJA based on its initial analysis using available information and estimates. The provisional charge is comprised of $451 related to the one-time deemed repatriation of accumulated earnings of foreign subsidiaries and related withholding taxes and $20 related primarily to the remeasurement of net deferred tax assets as a result of the reduction in the corporate income tax rate, which are offset by $196 of income taxes which had been previously provided for planned repatriations of undistributed earnings of foreign subsidiaries. As a result, applicable U.S. and foreign taxes have been provided on substantially all of the Company’s accumulated earnings of foreign subsidiaries previously considered indefinitely reinvested. Given the significant complexity of the TCJA, anticipated guidance from the U.S. Treasury about implementing the TCJA and the potential for additional guidance from the Securities and Exchange Commission (“SEC”) or the FASB related to the TCJA or additional information becoming available, the Company’s provisional charge may be adjusted during 2018 and is expected to be finalized no later than the fourth quarter of 2018. Other provisions of the TCJA that impact future tax years are still being assessed. (2) As a result of adopting ASU No. 2016-09 “Compensation–Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting,” effective January 1, 2017, the Company recognized excess tax benefits from stock-based compensation of $47 (resulting from an increase in the fair value of an award from the grant date to the vesting or exercise date, as applicable) in the Provision for income taxes as a discrete item during the year ended December 31, 2017. These amounts may not necessarily be indicative of future amounts that may be recognized as any excess tax benefits from stock-based compensation recognized would be dependent on future stock price, employee exercise behavior and applicable tax rates. Prior to January 1, 2017, excess tax benefits from stock-based compensation were recognized in equity. See Note 2, Summary of Significant Accounting Policies - Recent Accounting Pronouncements for additional information. (3) The benefit from a tax matter in 2016 relates to several Supreme Court and Administrative Court rulings in a foreign jurisdiction allowing certain tax deductions which had the effect of reversing prior decisions. The charge for a tax matter in 2015 relates to several Supreme Court rulings in a foreign jurisdiction disallowing certain tax deductions which had the effect of reversing prior decisions. (4) The effective tax rate in 2016 included a $210 U.S. income tax benefit recognized in the first quarter of 2016 principally related to changes in Venezuela’s foreign exchange regime implemented in March 2016. Although, effective December 31, 2015, the operating results of CP Venezuela are no longer included in the Company’s Consolidated Financial Statements, under current tax rules, the Company is required to continue including CP Venezuela’s results in its consolidated U.S. federal income tax return. In order to fully utilize the above mentioned $210 tax benefit in 2016, the Company repatriated an incremental $1,500 of earnings of foreign subsidiaries it previously considered indefinitely reinvested outside of the U.S., and accordingly, recorded a tax charge of $210 during the first quarter of 2016. (5) See Note 14, Venezuela.
Components of deferred tax assets (liabilities)	The components of deferred tax assets (liabilities) are as follows at December 31: 2017 2016 Deferred tax liabilities: Goodwill and intangible assets $ (311 ) $ (451 ) Property, plant and equipment (306 ) (380 ) Other (182 ) (202 ) (799 ) (1,033 ) Deferred tax assets: Pension and other retiree benefits 375 599 Tax loss and tax credit carryforwards 39 34 Accrued liabilities 197 246 Stock-based compensation 90 127 Other 82 82 783 1,088 Net deferred income taxes $ (16 ) $ 55 2017 2016 Deferred taxes included within: Assets: Deferred income taxes $ 188 $ 301 Liabilities: Deferred income taxes (204 ) (246 ) Net deferred income taxes $ (16 ) $ 55
Unrecognized tax benefits activity	Unrecognized tax benefits activity for the years ended December 31, 2017 , 2016 and 2015 is summarized below: 2017 2016 2015 Unrecognized tax benefits: Balance, January 1 $ 201 $ 186 $ 218 Increases as a result of tax positions taken during the current year 13 9 20 Decreases of tax positions taken during prior years (9 ) (45 ) (25 ) Increases of tax positions taken during prior years 15 71 61 Decreases as a result of settlements with taxing authorities and the expiration of statutes of limitations (15 ) (18 ) (79 ) Effect of foreign currency rate movements 9 (2 ) (9 ) Balance, December 31 $ 214 $ 201 $ 186

Earnings Per Share (Tables)

Earnings Per Share (Tables)	12 Months Ended
Earnings Per Share (Tables)	Dec. 31, 2017
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	For the years ended December 31, 2017 , 2016 and 2015 , earnings per share were as follows: 2017 2016 2015 Net income attributable to Colgate-Palmolive Company Shares (millions) Per Share Net income attributable to Colgate-Palmolive Company Shares (millions) Per Share Net income attributable to Colgate-Palmolive Company Shares (millions) Per Share Basic EPS $ 2,024 881.8 $ 2.30 $ 2,441 891.8 $ 2.74 $ 1,384 902.2 $ 1.53 Stock options and restricted stock units 6.0 6.6 7.5 Diluted EPS $ 2,024 887.8 $ 2.28 $ 2,441 898.4 $ 2.72 $ 1,384 909.7 $ 1.52

Segment Information (Tables)

Segment Information (Tables)	12 Months Ended
Segment Information (Tables)	Dec. 31, 2017
Segment Reporting [Abstract]
Schedule of Segment Reporting Information, by Segment	2017 2016 2015 Net sales Oral, Personal and Home Care North America (1) $ 3,117 $ 3,183 $ 3,149 Latin America 3,887 3,650 4,327 Europe 2,394 2,342 2,411 Asia Pacific 2,781 2,796 2,937 Africa/Eurasia 983 960 998 Total Oral, Personal and Home Care 13,162 12,931 13,822 Pet Nutrition (2) 2,292 2,264 2,212 Total Net sales $ 15,454 $ 15,195 $ 16,034 _________ (1) Net sales in the U.S. for Oral, Personal and Home Care were $2,865 , $2,932 and $2,896 in 2017 , 2016 and 2015 , respectively. (2) Net sales in the U.S. for Pet Nutrition were $1,246 , $1,243 and $1,223 in 2017 , 2016 and 2015 , respectively. 2017 2016 2015 Operating profit Oral, Personal and Home Care North America $ 986 $ 1,030 $ 974 Latin America 1,162 1,132 1,209 Europe 599 579 615 Asia Pacific 841 887 888 Africa/Eurasia 179 186 178 Total Oral, Personal and Home Care 3,767 3,814 3,864 Pet Nutrition 653 653 612 Corporate (831 ) (630 ) (1,687 ) Total Operating profit $ 3,589 $ 3,837 $ 2,789 2017 2016 2015 Capital expenditures Oral, Personal and Home Care North America $ 74 $ 151 $ 207 Latin America 127 94 110 Europe 63 51 40 Asia Pacific 125 120 121 Africa/Eurasia 13 17 12 Total Oral, Personal and Home Care 402 433 490 Pet Nutrition 33 38 34 Corporate 118 122 167 Total Capital expenditures $ 553 $ 593 $ 691 2017 2016 2015 Depreciation and amortization Oral, Personal and Home Care North America $ 58 $ 54 $ 47 Latin America 82 76 88 Europe 74 64 67 Asia Pacific 101 96 99 Africa/Eurasia 8 7 8 Total Oral, Personal and Home Care 323 297 309 Pet Nutrition 53 53 52 Corporate 99 93 88 Total Depreciation and amortization $ 475 $ 443 $ 449 2017 2016 2015 Identifiable assets Oral, Personal and Home Care North America $ 2,608 $ 2,685 $ 2,622 Latin America 2,423 2,314 2,314 Europe 3,781 3,554 3,308 Asia Pacific 2,244 2,006 2,031 Africa/Eurasia 544 499 476 Total Oral, Personal and Home Care 11,600 11,058 10,751 Pet Nutrition 1,026 1,009 1,006 Corporate (1) 50 56 178 Total Identifiable assets (2) $ 12,676 $ 12,123 $ 11,935 ____________ (1) In 2017 , Corporate identifiable assets primarily consist of derivative instruments ( 5% ) and investments in equity securities ( 86% ). In 2016 , Corporate identifiable assets primarily consist of derivative instruments ( 24% ) and investments in equity securities ( 68% ). In 2015 , Corporate identifiable assets primarily consist of derivative instruments ( 76% ) and investments in equity securities ( 23% ). (2) Long-lived assets in the U.S., primarily property, plant and equipment and goodwill and other intangibles represented approximately one-third of total long-lived assets of $ 7,908 , $7,642 and $7,420 in 2017 , 2016 and 2015 , respectively.

Supplemental Income Statement39

Supplemental Income Statement Information (Tables)	12 Months Ended
Supplemental Income Statement Information (Tables)	Dec. 31, 2017
Supplemental Income Statement Elements [Abstract]
Other (income) expense, net	Other (income) expense, net 2017 2016 2015 Global Growth and Efficiency Program $ 169 $ 105 $ 170 Amortization of intangible assets 35 33 33 Gain on sale of land in Mexico — (97 ) — Charges for litigation matters — 17 14 Venezuela remeasurement charges — — 34 Gain on sale of South Pacific laundry detergent business — — (187 ) Equity income (11 ) (10 ) (8 ) Other, net 1 (11 ) 6 Total Other (income) expense, net $ 194 $ 37 $ 62
Interest expense, net	Interest (income) expense, net 2017 2016 2015 Interest incurred $ 156 $ 155 $ 139 Interest capitalized (3 ) (6 ) (6 ) Interest income (51 ) (50 ) (107 ) Total Interest (income) expense, net $ 102 $ 99 $ 26
Research and development and Advertising	2017 2016 2015 Research and development $ 285 $ 289 $ 274 Advertising $ 1,573 $ 1,428 $ 1,491

Supplemental Balance Sheet In40

Supplemental Balance Sheet Information (Tables)	12 Months Ended
Supplemental Balance Sheet Information (Tables)	Dec. 31, 2017
Balance Sheet Related Disclosures [Abstract]
Schedule of Inventory, Current	Inventories by major class are as follows at December 31: Inventories 2017 2016 Raw materials and supplies $ 267 $ 266 Work-in-process 42 42 Finished goods 912 863 Total Inventories $ 1,221 $ 1,171
Property, Plant and Equipment	Property, plant and equipment, net 2017 2016 Land $ 159 $ 147 Buildings 1,655 1,544 Manufacturing machinery and equipment 5,165 4,971 Other equipment 1,481 1,280 8,460 7,942 Accumulated depreciation (4,388 ) (4,102 ) Total Property, plant and equipment, net $ 4,072 $ 3,840
Other accruals	Other accruals 2017 2016 Accrued advertising and coupon redemption $ 510 $ 491 Accrued payroll and employee benefits 325 309 Accrued taxes other than income taxes 123 112 Restructuring accrual 181 112 Pension and other retiree benefits 81 80 Accrued interest 34 29 Derivatives 20 4 Other 557 590 Total Other accruals $ 1,831 $ 1,727
Other liabilities	Other liabilities 2017 2016 Pension and other retiree benefits $ 1,724 $ 1,794 Restructuring accrual 53 69 Other 478 172 Total Other liabilities $ 2,255 $ 2,035

Supplemental Other Comprehens41

Supplemental Other Comprehensive Income (Loss) Information (Tables)	12 Months Ended
	Dec. 31, 2017
Equity [Abstract]
Schedule of Comprehensive Income (Loss)	Other comprehensive income (loss) components attributable to Colgate-Palmolive Company before tax and net of tax during the years ended December 31 were as follows: 2017 2016 2015 Pre-tax Net of Tax Pre-tax Net of Tax Pre-tax Net of Tax Cumulative translation adjustments $ 218 $ 285 $ (97 ) $ (125 ) $ (721 ) $ (745 ) Reclassification due to Venezuela deconsolidation (1) — — — — 111 111 Cumulative translation adjustments 218 285 (97 ) (125 ) (610 ) (634 ) Pension and other benefits: Net actuarial gain (loss), prior service costs and settlements during the period 21 9 (231 ) (152 ) 182 115 Amortization of net actuarial loss, transition and prior service costs (2) 71 45 63 43 82 52 Reclassification due to Venezuela deconsolidation (1) — — — — 44 29 Retirement Plan and other retiree benefit adjustments 92 54 (168 ) (109 ) 308 196 Available-for-sale securities: Unrealized gains (losses) on available- for-sale securities (3) — — — — (18 ) (12 ) Reclassification of (gains) losses into net earnings on available- for-sale securities (4) — — (1 ) (1 ) 14 11 Reclassification due to Venezuela deconsolidation (1) — — — — (10 ) (6 ) Gains (losses) on available-for-sale securities — — (1 ) (1 ) (14 ) (7 ) Cash flow hedges: Unrealized gains (losses) on cash flow hedges (25 ) (16 ) 11 8 18 12 Reclassification of (gains) losses into net earnings on cash flow hedges (5) 3 2 (4 ) (3 ) (16 ) (10 ) Gains (losses) on cash flow hedges (22 ) (14 ) 7 5 2 2 Total Other comprehensive income (loss) $ 288 $ 325 $ (259 ) $ (230 ) $ (314 ) $ (443 ) _________ (1) Represents reclassifications from Accumulated other comprehensive income (loss) due to the deconsolidation of the Company’s Venezuelan operations. Cumulative translation, net actuarial gain (loss) and unrealized gains (losses) on available-for-sale securities were reclassified into the Charge for Venezuela accounting change on the Consolidated Statement of Income. (2) These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 10 , Retirement Plans and Other Retiree Benefits for additional details. (3) For the year ended December 31, 2015 , these amounts included pretax net losses of $50 related to the remeasurement of the bolivar-denominated fixed interest rate bonds and the devaluation-protected bonds in Venezuela. (4) Represents reclassification of losses on the Venezuela bonds into Other (income) expense, net due to an impairment in the fair value of the bonds as a result of the effective devaluations in the second and third quarters of 2015. (5) These (gains) losses are reclassified into Cost of sales. See Note 7 , Fair Value Measurements and Financial Instruments for additional details.

Quarterly Financial Data (Una42

Quarterly Financial Data (Unaudited) (Tables)	12 Months Ended
Quarterly Financial Data (Unaudited) (Tables)	Dec. 31, 2017
Quarterly Financial Data [Abstract]
Schedule of Quarterly Financial Information	Total First Quarter Second Quarter Third Quarter Fourth Quarter 2017 Net sales $ 15,454 $ 3,762 $ 3,826 $ 3,974 $ 3,892 Gross profit 9,280 (1) 2,269 (3) 2,300 (5) 2,383 (7) 2,328 (9) Net income including noncontrolling interests 2,174 (2) 611 (4) 560 (6) 650 (8) 353 (10) Net income attributable to Colgate-Palmolive Company 2,024 (2) 570 (4) 524 (6) 607 (8) 323 (10) Earnings per common share: Basic 2.30 (2) 0.64 (4) 0.59 (6) 0.69 (8) 0.37 (10) Diluted 2.28 (2) 0.64 (4) 0.59 (6) 0.68 (8) 0.37 (10) 2016 Net sales $ 15,195 $ 3,762 $ 3,845 $ 3,867 $ 3,721 Gross profit 9,123 (11) 2,248 (13) 2,304 (16) 2,324 (18) 2,247 (20) Net income including noncontrolling interests 2,586 (12) 574 (14) 638 (17) 746 (19) 628 (21) Net income attributable to Colgate-Palmolive Company 2,441 (12) 533 (14) (15) 600 (17) 702 (19) 606 (21) Earnings per common share: Basic 2.74 (12) 0.60 (14) 0.67 (17) 0.79 (19) 0.68 (21) Diluted 2.72 (12) 0.59 (14) 0.67 (17) 0.78 (19) 0.68 (21) ____________ Note: Basic and diluted earnings per share are computed independently for each quarter and the year-to-date period presented. Accordingly, the sum of the quarterly earnings per common share may not necessarily equal the earnings per share for the year-to-date period. (1) Gross profit for the full year of 2017 includes $75 of charges related to the Global Growth and Efficiency Program. (2) Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the full year of 2017 include $246 of aftertax charges related to the Global Growth and Efficiency Program and a $275 charge related to U.S. tax reform. (3) Gross profit for the first quarter of 2017 includes $14 of charges related to the Global Growth and Efficiency Program. (4) Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the first quarter of 2017 include $31 of aftertax charges related to the Global Growth and Efficiency Program. (5) Gross profit for the second quarter of 2017 includes $21 of charges related to the Global Growth and Efficiency Program. (6) Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the second quarter of 2017 include $115 of aftertax charges related to the Global Growth and Efficiency Program. (7) Gross profit for the third quarter of 2017 includes $16 of charges related to the Global Growth and Efficiency Program. (8) Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the third quarter of 2017 include $39 of aftertax charges related to the Global Growth and Efficiency Program. (9) Gross profit for the fourth quarter of 2017 includes $24 of charges related to the Global Growth and Efficiency Program. (10) Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the fourth quarter of 2017 include $61 of aftertax charges related to the Global Growth and Efficiency Program and a $275 charge related to U.S. tax reform. (11) Gross profit for the full year of 2016 includes $46 of charges related to the Global Growth and Efficiency Program. (12) Net income including noncontrolling interests for the full year of 2016 includes $169 of aftertax charges related to the Global Growth and Efficiency Program. Net income attributable to Colgate-Palmolive Company and Earnings per common share for the full year of 2016 include $168 of aftertax charges related to the Global Growth and Efficiency Program, a $63 aftertax gain on the sale of land in Mexico, $11 of aftertax charges for a litigation matter and $35 of benefits from tax matters. (13) Gross profit for the first quarter of 2016 includes $8 of charges related to the Global Growth and Efficiency Program. (14) Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the first quarter of 2016 include $38 of aftertax charges related to the Global Growth and Efficiency Program. (15) In the first quarter of 2016, provision for income taxes included a $210 U.S. income tax benefit principally related to changes in Venezuela’s foreign exchange regime implemented in March 2016. In order to fully utilize the above mentioned $210 tax benefit in 2016, the Company repatriated an incremental $1,500 of earnings of foreign subsidiaries it previously considered indefinitely reinvested outside of the U.S., and accordingly, recorded a tax charge of $210 during the first quarter of 2016. See Note 11, Income Taxes. (16) Gross profit for the second quarter of 2016 includes $12 of charges related to the Global Growth and Efficiency Program. (17) Net income including noncontrolling interests for the second quarter of 2016 includes $45 of aftertax charges related to the Global Growth and Efficiency Program. Net income attributable to Colgate-Palmolive Company and Earnings per common share for the second quarter of 2016 include $44 of aftertax charges related to the Global Growth and Efficiency Program and a $13 benefit from a tax matter. (18) Gross profit for the third quarter of 2016 includes $11 of charges related to the Global Growth and Efficiency Program. (19) Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the third quarter of 2016 include $32 of aftertax charges related to the Global Growth and Efficiency Program, a $63 aftertax gain on the sale of land in Mexico, a $4 aftertax charge for a litigation matter and $22 of benefits from tax matters. (20) Gross profit for the fourth quarter of 2016 includes $15 of charges related to the Global Growth and Efficiency Program. (21) Net income including noncontrolling interests, Net income attributable to Colgate-Palmolive Company and Earnings per common share for the fourth quarter of 2016 include $54 of aftertax charges related to the Global Growth and Efficiency Program and a $7 aftertax charge for a litigation matter.

Nature of Operations (Details)

Nature of Operations (Details) - business_segment	12 Months Ended
Nature of Operations (Details) - business_segment	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of product segments (in segments)	2
Entity-Wide Information, Revenue from External Customer [Line Items]
Percentage of worldwide sales	100.00%	100.00%	100.00%
Oral Care
Entity-Wide Information, Revenue from External Customer [Line Items]
Percentage of worldwide sales	48.00%	47.00%	47.00%
Personal Care
Entity-Wide Information, Revenue from External Customer [Line Items]
Percentage of worldwide sales	19.00%	20.00%	20.00%
Home Care
Entity-Wide Information, Revenue from External Customer [Line Items]
Percentage of worldwide sales	18.00%	18.00%	19.00%
Pet Nutrition
Entity-Wide Information, Revenue from External Customer [Line Items]
Percentage of worldwide sales	15.00%	15.00%	14.00%

Summary of Significant Accoun44

Summary of Significant Accounting Policies - Principles of Consolidation, Shipping and Handling Costs, Inventories, & Property, Plant, and Equipment (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Principles of Consolidation [Abstract]
Investments accounted for using the equity method, minimum interest	20.00%
Investments accounted for using the equity method, maximum interest	50.00%
Equity method investments included in other assets	$ 42	$ 38
Investments accounted for using the cost method, maximum interest	20.00%
Shipping and Handling Costs [Abstract]
Shipping and handling costs classified as Selling, general and administrative expenses	$ 1,183	$ 1,140	$ 1,235
Inventories [Abstract]
Approximate percentage of inventories determined using the first-in, first-out (FIFO) method	75.00%
Minimum \| Machinery and equipment
Property, Plant and Equipment [Line Items]
Estimated useful life	3 years
Maximum \| Machinery and equipment
Property, Plant and Equipment [Line Items]
Estimated useful life	15 years
Maximum \| Buildings
Property, Plant and Equipment [Line Items]
Estimated useful life	40 years

Summary of Significant Accoun45

Summary of Significant Accounting Policies - Goodwill and Other Intangibles (Details) - Local Brands, Trademarks, Customer Relationships, and Non-Compete Agreements	12 Months Ended
	Dec. 31, 2017
Minimum
Finite-Lived Intangible Assets [Line Items]
Estimated useful life of finite-lived intangible assets	5 years
Maximum
Finite-Lived Intangible Assets [Line Items]
Estimated useful life of finite-lived intangible assets	40 years

Summary of Significant Accoun46

Summary of Significant Accounting Policies - Recent Accounting Pronouncements (Details) - USD ($) $ in Millions

3 Months Ended

12 Months Ended

Dec. 31, 2017

Sep. 30, 2017

Jun. 30, 2017

Mar. 31, 2017

Dec. 31, 2016

Sep. 30, 2016

Jun. 30, 2016

Mar. 31, 2016

Dec. 31, 2018

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2015

New Accounting Pronouncements or Change in Accounting Principle [Line Items]

Operating profit

$ 3,589

$ 3,837

$ 2,789

Net income

$ 323

$ 607

$ 524

$ 570

$ 606

$ 702

$ 600

$ 533

2,024

$ 2,441

$ 1,384

Maximum

New Accounting Pronouncements or Change in Accounting Principle [Line Items]

Excess tax benefits recognized

Accounting Standards Update 2017-07 | Scenario, Forecast

New Accounting Pronouncements or Change in Accounting Principle [Line Items]

Operating profit

$ 100

Net income

$ 0

Accounting Standards Update 2017-07 | Pro Forma

New Accounting Pronouncements or Change in Accounting Principle [Line Items]

Operating profit

120

Net income

$ 0

Acquisitions and Divestitures -

Acquisitions and Divestitures - Acquisitions (Details) $ in Millions	1 Months Ended
	Jan. 31, 2018USD ($)
Subsequent Event \| PCA Skin and Elta MD
Business Acquisition [Line Items]
Payments to acquire business	$ 730

Acquisitions and Divestitures48

Acquisitions and Divestitures - Divestitures (Details) $ / shares in Units, AUD in Millions, $ in Millions	1 Months Ended			3 Months Ended	12 Months Ended
	Sep. 30, 2016USD ($)	Aug. 31, 2015USD ($)$ / shares	Aug. 31, 2015AUD	Sep. 30, 2016USD ($)$ / shares	Dec. 31, 2017USD ($)	Dec. 31, 2016USD ($)	Dec. 31, 2015USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from sale of land					$ 0	$ 60	$ 0
Gain on sale of land in Mexico					0	97	0
Proceeds from sale of business					0	0	221
Gain on sale of business					$ 0	0	$ 187
MEXICO
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from sale of land	$ 120
Gain on sale of land in Mexico				$ 97		97
Aftertax gain on sale of land				$ 63		$ 63
Impact of aftertax gain on sale per common share, diluted (in dollars per share) \| $ / shares				$ 0.07
MEXICO \| Third Installment
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from sale of land	$ 60
Europe South Pacific \| Laundry Detergent Business
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Impact of aftertax gain on sale per common share, diluted (in dollars per share) \| $ / shares		$ 0.13
Proceeds from sale of business		$ 221	AUD 310
Gain on sale of business		187
Aftertax gain on sale business		$ 120

Restructuring and Related Imp49

Restructuring and Related Implementation Charges - Narrative (Details) $ in Millions	12 Months Ended
	Dec. 31, 2017USD ($)employees	Dec. 31, 2016USD ($)	Dec. 31, 2015USD ($)
Restructuring Cost and Reserve [Line Items]
Total Global Growth and Efficiency Program charges, pretax	$ 169	$ 105	$ 170
Global Growth and Efficiency Program
Restructuring Cost and Reserve [Line Items]
Expected percent of total charges resulting in cash expenditure	80.00%
Pretax charges related to the Restructuring Program to date	$ 1,561
Restructuring and related cost incurred cost to date after tax	1,153
Charges against assets	(40)	(33)	(42)
Total Global Growth and Efficiency Program charges, pretax	$ 333	228	254
Global Growth and Efficiency Program \| Pet Nutrition
Restructuring Cost and Reserve [Line Items]
Expected percent of total restructuring charges related to segment for the duration of the program	10.00%
Global Growth and Efficiency Program \| Corporate
Restructuring Cost and Reserve [Line Items]
Expected percent of total restructuring charges related to segment for the duration of the program	40.00%
Global Growth and Efficiency Program \| North America
Restructuring Cost and Reserve [Line Items]
Expected percent of total restructuring charges related to segment for the duration of the program	15.00%
Global Growth and Efficiency Program \| Europe
Restructuring Cost and Reserve [Line Items]
Expected percent of total restructuring charges related to segment for the duration of the program	20.00%
Global Growth and Efficiency Program \| Latin America
Restructuring Cost and Reserve [Line Items]
Expected percent of total restructuring charges related to segment for the duration of the program	5.00%
Global Growth and Efficiency Program \| Asia Pacific
Restructuring Cost and Reserve [Line Items]
Expected percent of total restructuring charges related to segment for the duration of the program	5.00%
Global Growth and Efficiency Program \| Africa/Eurasia
Restructuring Cost and Reserve [Line Items]
Expected percent of total restructuring charges related to segment for the duration of the program	5.00%
Global Growth and Efficiency Program \| Employee-Related Costs
Restructuring Cost and Reserve [Line Items]
Estimated percent of total cumulative pretax charges of implementing restructuring program by category	50.00%
Pretax charges related to the Restructuring Program to date	$ 628
Charges against assets	(21)	(4)	(17)
Total Global Growth and Efficiency Program charges, pretax	$ 163	61	109
Global Growth and Efficiency Program \| Incremental Depreciation And Asset Impairment
Restructuring Cost and Reserve [Line Items]
Estimated percent of total cumulative pretax charges of implementing restructuring program by category	10.00%
Global Growth and Efficiency Program \| Charges Resulting Directly From Exit Activities
Restructuring Cost and Reserve [Line Items]
Estimated percent of total cumulative pretax charges of implementing restructuring program by category	20.00%
Global Growth and Efficiency Program \| Implementation Of New Strategies
Restructuring Cost and Reserve [Line Items]
Estimated percent of total cumulative pretax charges of implementing restructuring program by category	20.00%
Global Growth and Efficiency Program \| Third party Incremental Cost
Restructuring Cost and Reserve [Line Items]
Total Global Growth and Efficiency Program charges, pretax	$ 145	116	65
Global Growth and Efficiency Program \| Contract Termination
Restructuring Cost and Reserve [Line Items]
Total Global Growth and Efficiency Program charges, pretax	6	21	8
Global Growth and Efficiency Program \| Land and Building
Restructuring Cost and Reserve [Line Items]
Total Global Growth and Efficiency Program charges, pretax	0	$ 1	$ 47
Global Growth and Efficiency Program \| Minimum \| Expected Completion Date 2019
Restructuring Cost and Reserve [Line Items]
Restructuring program expected cost before tax	1,730
Restructuring program total expected cost after tax	1,280
Restructuring program expected cost, upcoming fiscal year, before tax	100
Restructuring program expected cost, upcoming fiscal year, after tax	$ 75
Restructuring and related cost, expected number of positions eliminated (in positions) \| employees	3,800
Global Growth and Efficiency Program \| Maximum \| Expected Completion Date 2019
Restructuring Cost and Reserve [Line Items]
Restructuring program expected cost before tax	$ 1,885
Restructuring program total expected cost after tax	1,380
Restructuring program expected cost, upcoming fiscal year, before tax	175
Restructuring program expected cost, upcoming fiscal year, after tax	$ 125
Restructuring and related cost, expected number of positions eliminated (in positions) \| employees	4,400

Restructuring and Related Imp50

Restructuring and Related Implementation Charges - Summary of Restructuring and Related Costs (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Restructuring Cost and Reserve [Line Items]
Total Global Growth and Efficiency Program charges, pretax									$ 169	$ 105	$ 170
Global Growth and Efficiency Program
Restructuring Cost and Reserve [Line Items]
Total Global Growth and Efficiency Program charges, pretax									333	228	254
Total Global Growth and Efficiency Program charges, aftertax	$ 61	$ 39	$ 115	$ 31	$ 54	$ 32	$ 44	$ 38	246	168	183
Global Growth and Efficiency Program \| Cost of sales
Restructuring Cost and Reserve [Line Items]
Total Global Growth and Efficiency Program charges, pretax	$ 24	$ 16	$ 21	$ 14	$ 15	$ 11	$ 12	$ 8	75	46	20
Global Growth and Efficiency Program \| Selling, general and administrative expenses
Restructuring Cost and Reserve [Line Items]
Total Global Growth and Efficiency Program charges, pretax									89	77	64
Global Growth and Efficiency Program \| Other (income) expense, net
Restructuring Cost and Reserve [Line Items]
Total Global Growth and Efficiency Program charges, pretax									$ 169	$ 105	$ 170

Restructuring and Related Imp51

Restructuring and Related Implementation Charges - Restructuring Charges Incurred, by Segment (Details) - Global Growth and Efficiency Program	12 Months Ended			63 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2017
Restructuring Cost and Reserve [Line Items]
Percent of total restructuring charges related to segment	100.00%	100.00%	100.00%
Percent of restructuring charges related to segment, program-to-date accumulated charges				100.00%
Pet Nutrition
Restructuring Cost and Reserve [Line Items]
Percent of total restructuring charges related to segment	6.00%	7.00%	5.00%
Percent of restructuring charges related to segment, program-to-date accumulated charges				7.00%
Corporate
Restructuring Cost and Reserve [Line Items]
Percent of total restructuring charges related to segment	40.00%	23.00%	48.00%
Percent of restructuring charges related to segment, program-to-date accumulated charges				41.00%
North America
Restructuring Cost and Reserve [Line Items]
Percent of total restructuring charges related to segment	23.00%	35.00%	21.00%
Percent of restructuring charges related to segment, program-to-date accumulated charges				18.00%
Latin America
Restructuring Cost and Reserve [Line Items]
Percent of total restructuring charges related to segment	2.00%	5.00%	3.00%
Percent of restructuring charges related to segment, program-to-date accumulated charges				3.00%
Europe
Restructuring Cost and Reserve [Line Items]
Percent of total restructuring charges related to segment	21.00%	12.00%	14.00%
Percent of restructuring charges related to segment, program-to-date accumulated charges				22.00%
Asia Pacific
Restructuring Cost and Reserve [Line Items]
Percent of total restructuring charges related to segment	5.00%	4.00%	4.00%
Percent of restructuring charges related to segment, program-to-date accumulated charges				3.00%
Africa/Eurasia
Restructuring Cost and Reserve [Line Items]
Percent of total restructuring charges related to segment	3.00%	14.00%	5.00%
Percent of restructuring charges related to segment, program-to-date accumulated charges				6.00%

Restructuring and Related Imp52

Restructuring and Related Implementation Charges - Summary of Restructuring Charges, Cumulative to Date (Details) - Global Growth and Efficiency Program $ in Millions	Dec. 31, 2017USD ($)
Restructuring Cost and Reserve [Line Items]
Pretax charges related to the Restructuring Program to date	$ 1,561
Employee-Related Costs
Restructuring Cost and Reserve [Line Items]
Pretax charges related to the Restructuring Program to date	628
Incremental Depreciation
Restructuring Cost and Reserve [Line Items]
Pretax charges related to the Restructuring Program to date	90
Asset Impairments
Restructuring Cost and Reserve [Line Items]
Pretax charges related to the Restructuring Program to date	36
Other
Restructuring Cost and Reserve [Line Items]
Pretax charges related to the Restructuring Program to date	$ 807

Restructuring and Related Imp53

Restructuring and Related Implementation Charges - Restructuring Activity and Related Accruals (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Restructuring Reserve [Roll Forward]
Charges	$ 169	$ 105	$ 170
Global Growth and Efficiency Program
Restructuring Reserve [Roll Forward]
Beginning balance	181	215	192
Charges	333	228	254
Cash payments	(244)	(237)	(179)
Charges against assets	(40)	(33)	(42)
Foreign exchange	4	(1)	(10)
Other	0	9	0
Ending balance	234	181	215
Global Growth and Efficiency Program \| Employee-Related Costs
Restructuring Reserve [Roll Forward]
Beginning balance	56	84	85
Charges	163	61	109
Cash payments	(74)	(84)	(85)
Charges against assets	(21)	(4)	(17)
Foreign exchange	3	(1)	(8)
Other	0	0	0
Ending balance	127	56	84
Global Growth and Efficiency Program \| Incremental Depreciation
Restructuring Reserve [Roll Forward]
Beginning balance	0	0	0
Charges	10	9	20
Cash payments	0	0	0
Charges against assets	(10)	(9)	(20)
Foreign exchange	0	0	0
Other	0	0	0
Ending balance	0	0	0
Global Growth and Efficiency Program \| Asset Impairments
Restructuring Reserve [Roll Forward]
Beginning balance	0	0	0
Charges	9	20	5
Cash payments	0	0	0
Charges against assets	(9)	(20)	(5)
Foreign exchange	0	0	0
Other	0	0	0
Ending balance	0	0	0
Global Growth and Efficiency Program \| Other
Restructuring Reserve [Roll Forward]
Beginning balance	125	131	107
Charges	151	138	120
Cash payments	(170)	(153)	(94)
Charges against assets	0	0	0
Foreign exchange	1	0	(2)
Other	0	9	0
Ending balance	$ 107	$ 125	$ 131

Goodwill and Other Intangible54

Goodwill and Other Intangible Assets - Schedule of Goodwill (Details) - USD ($) $ in Millions	Dec. 31, 2017	Dec. 31, 2016
Goodwill [Line Items]
Goodwill	$ 2,218	$ 2,107
Oral, Personal and Home Care
Goodwill [Line Items]
Goodwill	2,203	2,092
Pet Nutrition
Goodwill [Line Items]
Goodwill	15	15
North America \| Oral, Personal and Home Care
Goodwill [Line Items]
Goodwill	343	336
Latin America \| Oral, Personal and Home Care
Goodwill [Line Items]
Goodwill	256	260
Europe \| Oral, Personal and Home Care
Goodwill [Line Items]
Goodwill	1,333	1,233
Asia Pacific \| Oral, Personal and Home Care
Goodwill [Line Items]
Goodwill	190	187
Africa/Eurasia \| Oral, Personal and Home Care
Goodwill [Line Items]
Goodwill	$ 81	$ 76

Goodwill and Other Intangible55

Goodwill and Other Intangible Assets - Summary of Other Intangible Assets (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Finite and indefinite-lived intangible assets [Line Items]
Finite & indefinite lived intangibles, gross	$ 1,781	$ 1,708
Finite-lived intangible assets, accumulated amortization, net	(440)	(395)
Intangible assets, net (excluding goodwill)	1,341	1,313
Amortization of intangible assets	35	33	$ 33
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Future amortization expense - 2018	35
Future amortization expense - 2019	35
Future amortization expense - 2020	35
Future amortization expense - 2021	35
Future amortization expense - 2022	35
Indefinite life intangible assets
Finite and indefinite-lived intangible assets [Line Items]
Indefinite-lived intangible assets (excluding goodwill)	985	938
Trademarks
Finite and indefinite-lived intangible assets [Line Items]
Finite-lived intangible assets, gross	547	539
Finite-lived intangible assets, accumulated amortization, net	(337)	(317)
Finite-lived intangible assets, net	210	222
Other finite life intangible assets
Finite and indefinite-lived intangible assets [Line Items]
Finite-lived intangible assets, gross	249	231
Finite-lived intangible assets, accumulated amortization, net	(103)	(78)
Finite-lived intangible assets, net	$ 146	$ 153

Long-Term Debt and Credit Fac56

Long-Term Debt and Credit Facilities - Components of Long-term Debt (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Debt Instrument [Line Items]
Total Debt	$ 6,566	$ 6,520
Less: Current portion of long-term debt	0	0
Total debt, Excluding current portion of long-term debt	6,566	6,520
Short-term borrowings	$ 11	$ 13
Weighted-average interest rate on short term borrowings	2.80%	1.60%
Scheduled maturities of long-term debt [Abstract]
2,018	$ 0
2,019	1,097
2,020	248
2,021	298
2,022	889
Thereafter	$ 3,311
Notes
Debt Instrument [Line Items]
Weighted average interest rate	2.00%
Maturity date range, start	Dec. 31, 2018
Maturity date range, end	Dec. 31, 2078
Total Debt	$ 6,542	$ 6,225
Commercial paper
Debt Instrument [Line Items]
Weighted average interest rate	1.50%
Maturity date	2,018
Total Debt	$ 24	$ 295

Long-Term Debt and Credit Fac57

Long-Term Debt and Credit Facilities - Debt Issuances (Details) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2017	Sep. 30, 2017
Five Year Notes at 2.25 Percent
Schedule of U.S. dollar and Euro denominated notes [Line Items]
Face amount	$ 400
Notes, term	5 years
Fixed interest rate	2.25%
Thirty Year Notes at 3.70 Percent
Schedule of U.S. dollar and Euro denominated notes [Line Items]
Face amount		$ 500
Notes, term		30 years
Fixed interest rate		3.70%

Long-Term Debt and Credit Fac58

Long-Term Debt and Credit Facilities - Summary of Credit Facilities (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2014
Line of credit facility [Line Items]
Unused borrowing capacity		$ 2,949
Domestic Revolving Credit Facility 1850 Million Capacity
Line of credit facility [Line Items]
Notes, term	5 years
Maximum borrowing capacity	$ 1,850
Amended Domestic Revolving Credit Facility 2370 Million Capacity
Line of credit facility [Line Items]
Maximum borrowing capacity				$ 2,370
Domestic Revolving Credit Facility 165 Million Capacity
Line of credit facility [Line Items]
Maximum borrowing capacity			$ 165

Fair Value Measurements and F59

Fair Value Measurements and Financial Instruments - Additional Information, Foreign Exchange Risk (Details)	12 Months Ended
	Dec. 31, 2017country_and_territory
Financial Instruments and Fair Value Measurements [Abstract]
Minimum number of countries and territories serving consumers (more than) (in countries and territories)	200

Fair Value Measurements and F60

Fair Value Measurements and Financial Instruments - Fair Value of Derivative Instruments and Other Financial Instruments (Details) - USD ($) $ in Millions	Dec. 31, 2017	Dec. 31, 2016
Designated Derivative Instruments [Abstract]
Derivative assets, designated	$ 25	$ 36
Derivative liabilities, designated	73	4
Derivative Instruments Not Designated as Hedging Instruments [Abstract]
Derivative assets not designated	0	0
Derivative liabilities not designated	0	0
Total derivative instruments, Assets	25	36
Total derivative instruments, Liabilities	73	4
Financial Instruments, Owned, at Fair Value [Abstract]
Total other financial instruments	14	23
Other current assets
Financial Instruments, Owned, at Fair Value [Abstract]
Marketable securities	14	23
Interest rate swap contracts \| Other current assets
Designated Derivative Instruments [Abstract]
Derivative assets, designated	0	1
Interest rate swap contracts \| Other accruals
Designated Derivative Instruments [Abstract]
Derivative liabilities, designated	0	0
Interest rate swap contracts \| Other assets
Designated Derivative Instruments [Abstract]
Derivative assets, designated	0	1
Interest rate swap contracts \| Other liabilities
Designated Derivative Instruments [Abstract]
Derivative liabilities, designated	7	0
Foreign currency contracts \| Other current assets
Designated Derivative Instruments [Abstract]
Derivative assets, designated	25	29
Foreign currency contracts \| Other accruals
Designated Derivative Instruments [Abstract]
Derivative liabilities, designated	20	4
Foreign currency contracts \| Other assets
Designated Derivative Instruments [Abstract]
Derivative assets, designated	0	5
Derivative Instruments Not Designated as Hedging Instruments [Abstract]
Derivative assets not designated	0	0
Foreign currency contracts \| Other liabilities
Designated Derivative Instruments [Abstract]
Derivative liabilities, designated	46	0
Derivative Instruments Not Designated as Hedging Instruments [Abstract]
Derivative liabilities not designated	0	0
Commodity contracts \| Other current assets
Designated Derivative Instruments [Abstract]
Derivative assets, designated	0	0
Commodity contracts \| Other accruals
Designated Derivative Instruments [Abstract]
Derivative liabilities, designated	$ 0	$ 0

Fair Value Measurements and F61

Fair Value Measurements and Financial Instruments - Carrying Value and Estimated Fair Value of Long-term Debt (Details) - USD ($) $ in Millions	Dec. 31, 2017	Dec. 31, 2016
Debt Instrument [Line Items]
Carrying value of long-term debt	$ 6,566	$ 6,520
Carrying Value
Debt Instrument [Line Items]
Carrying value of long-term debt	6,566	6,520
Fair Value, Inputs, Level 2
Debt Instrument [Line Items]
Estimated fair value of long-term debt	$ 6,799	$ 6,717

Fair Value Measurements and F62

Fair Value Measurements and Financial Instruments - Schedule of Fair Value Hedges (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Not Designated as Hedging Instrument \| Foreign Currency Contracts
Derivative Instruments, Gain (Loss) [Line Items]
Notional value of derivative	$ 3	$ 4
Activity related to derivatives not designated as hedging instruments [Abstract]
Gain (loss) on instruments	0	5
Gain (loss) on hedged items	0	(5)
Fair Value Hedging
Derivative Instruments, Gain (Loss) [Line Items]
Notional value of derivative	2,231	1,454
Activity related to fair value hedges [Abstract]
Gain (loss) on derivatives	(16)	0
Gain (loss) on hedged items	16	0
Fair Value Hedging \| Foreign currency contracts
Derivative Instruments, Gain (Loss) [Line Items]
Notional value of derivative	1,231	204
Activity related to fair value hedges [Abstract]
Gain (loss) on derivatives	(7)	5
Gain (loss) on hedged items	7	(5)
Fair Value Hedging \| Interest rate swap contracts
Derivative Instruments, Gain (Loss) [Line Items]
Notional value of derivative	1,000	1,250
Activity related to fair value hedges [Abstract]
Gain (loss) on derivatives	(9)	(5)
Gain (loss) on hedged items	9	5
Cash Flow Hedging
Derivative Instruments, Gain (Loss) [Line Items]
Notional value of derivative	702	650
Activity related to cash flow hedges [Abstract]
Gain (loss) recognized in OCI	(25)	11
Cash Flow Hedging \| Foreign currency contracts
Derivative Instruments, Gain (Loss) [Line Items]
Notional value of derivative	702	643
Activity related to cash flow hedges [Abstract]
Gain (loss) recognized in OCI	(25)	12
Cash Flow Hedging \| Commodity contracts
Derivative Instruments, Gain (Loss) [Line Items]
Notional value of derivative	0	7
Activity related to cash flow hedges [Abstract]
Gain (loss) recognized in OCI	0	(1)
Net Investment Hedging
Derivative Instruments, Gain (Loss) [Line Items]
Notional value of derivative	1,079	1,616
Activity related to net investment hedges [Abstract]
Gain (loss) on instruments	(183)	57
Gain (loss) on hedged items	183	(60)
Net Investment Hedging \| Foreign currency contracts
Derivative Instruments, Gain (Loss) [Line Items]
Notional value of derivative	478	498
Activity related to net investment hedges [Abstract]
Gain (loss) on instruments	(71)	22
Gain (loss) on hedged items	71	(25)
Net Investment Hedging \| Foreign Currency Debt
Derivative Instruments, Gain (Loss) [Line Items]
Notional value of derivative	601	1,118
Activity related to net investment hedges [Abstract]
Gain (loss) on instruments	(112)	35
Gain (loss) on hedged items	112	(35)
Reclassification out of Accumulated Other Comprehensive Income \| Cash Flow Hedging
Activity related to cash flow hedges [Abstract]
Gain (loss) reclassified into Cost of sales	(3)	4
Reclassification out of Accumulated Other Comprehensive Income \| Cash Flow Hedging \| Foreign currency contracts
Activity related to cash flow hedges [Abstract]
Gain (loss) reclassified into Cost of sales	(3)	4
Reclassification out of Accumulated Other Comprehensive Income \| Cash Flow Hedging \| Commodity contracts
Activity related to cash flow hedges [Abstract]
Gain (loss) reclassified into Cost of sales	$ 0	$ 0

Fair Value Measurements and F63

Fair Value Measurements and Financial Instruments - Other Financial Instruments (Details) - USD ($) $ in Millions	Dec. 31, 2017	Dec. 31, 2016
Other current assets
Schedule of Available for Sale Securities [Line Items]
Marketable securities	$ 14	$ 23
Assets
Schedule of Available for Sale Securities [Line Items]
Held-to-maturity securities	4	52
Bonds Issued By Argentinian Government \| Other current assets
Schedule of Available for Sale Securities [Line Items]
Marketable securities	4
Fair Value, Inputs, Level 1 \| Deposits \| Other current assets
Schedule of Available for Sale Securities [Line Items]
Marketable securities	14
Fair Value, Inputs, Level 2 \| Assets
Schedule of Available for Sale Securities [Line Items]
Held-to-maturity securities, fair value	$ 4	$ 64

Capital Stock and Stock-Based64

Capital Stock and Stock-Based Compensation Plans (Details) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2017USD ($)$ / sharesshares	Dec. 31, 2016USD ($)$ / sharesshares	Dec. 31, 2015USD ($)$ / sharesshares	Feb. 19, 2015USD ($)	May 10, 2013plan
Preference Stock [Abstract]
Shares authorized (in shares)	50,262,150
Stock Repurchases [Abstract]
Repurchased stock \| $	$ 1,399	$ 1,335	$ 1,551
Summary of common stock activity [Roll Forward]
Common stock balance, January 1 (in shares)	883,108,963	892,738,518	906,712,145
Common stock acquired (in shares)	(19,185,828)	(19,271,304)	(22,802,784)
Shares issued for stock options (in shares)	9,670,988	8,536,639	7,394,839
Shares issued for restricted stock and other (in shares)	1,106,995	1,105,110	1,434,318
Common stock balance, December 31 (in shares)	874,701,118	883,108,963	892,738,518
Summary Of Treasury Stock Activity [Roll Forward]
Treasury stock balance, January 1 (in shares)	582,597,397	572,967,842	558,994,215
Common stock acquired (in shares)	19,185,828	19,271,304	22,802,784
Shares issued for stock options (in shares)	(9,670,988)	(8,536,639)	(7,394,839)
Shares issued for restricted stock and other (in shares)	(1,106,995)	(1,105,110)	(1,434,318)
Treasury stock balance, December 31 (in shares)	591,005,242	582,597,397	572,967,842
Stock-based compensation [Abstract]
Number of stockholder approved plans, current \| plan					1
Total stock-based compensation expense charged against pretax income \| $	$ 127	$ 123	$ 125
Total income tax benefit from stock compensation \| $	$ 42	$ 40	$ 39
Fair Value Assumptions [Abstract]
Weighted-average estimated fair value of stock options granted (in dollars per share) \| $ / shares	$ 8.37	$ 8.10	$ 7.25
Expected term (in years)	4 years 6 months	4 years 6 months	4 years 6 months
Expected volatility rate (in hundredths)	16.00%	16.70%	17.60%
Risk-free rate (in hundredths)	1.80%	1.20%	1.50%
Expected dividend yield (in hundredths)	2.20%	2.10%	2.50%
Summary of restricted stock award activity [Roll Forward]
Restricted stock awards - beginning balance (in shares)	2,945,000
Granted (in shares)	916,000
Vested (in shares)	(1,057,000)
Forfeited (in shares)	(74,000)
Restricted stock awards - ending balance (in shares)	2,730,000	2,945,000
Weighted average grant date fair value per award [Roll Forward]
Weighted average grant date fair value of restricted stock awards - beginning of period (in dollars per share) \| $ / shares	$ 66
Weighted average grant date fair value of restricted stock awards - shares granted (in dollars per share) \| $ / shares	74
Weighted average grant date fair value of restricted stock awards - shares vested (in dollars per share) \| $ / shares	62
Weighted average grant date fair value of restricted stock awards - shares forfeited (in dollars per share) \| $ / shares	67
Weighted average grant date fair value of restricted stock awards - end of period (in dollars per share) \| $ / shares	$ 70	$ 66
Summary of stock option plan activity [Roll Forward]
Options - beginning balance (in shares)	43,692,000
Granted (in shares)	7,798,000
Exercised (in shares)	(10,118,000)
Forfeited or expired (in shares)	(393,000)
Options - ending balance (in shares)	40,979,000	43,692,000
Options exercisable (in shares)	25,349,000
Additional disclosures pertaining to stock options [Abstract]
Weighted average exercise price of options - beginning of period (in dollars per share) \| $ / shares	$ 61
Weighted average exercise price of options - shares granted (in dollars per share) \| $ / shares	73
Weighted average exercise price of options - shares exercised (in dollars per share) \| $ / shares	53
Weighted average exercise price of options - shares forfeited or expired (in dollars per share) \| $ / shares	68
Weighted average exercise price of options - end of period (in dollars per share) \| $ / shares	65	$ 61
Weighted average exercise price of options exercisable - end of period (in dollars per share) \| $ / shares	$ 62
Weighted average remaining contractual life, options outstanding (in years)	4 years
Weighted average remaining contractual life, options exercisable (in years)	3 years
Value of unexercised in-the-money options, options outstanding \| $	$ 420
Value of unexercised in-the-money options, options exercisable \| $	351
Stock-based compensation, additional disclosures [Abstract]
Tax benefit from exercise of stock options and vesting of restricted stock unit awards \| $	47	$ 59	$ 55
Proceeds from exercise of stock options \| $	$ 507	386	299
Incentive Stock Plans
Additional disclosures pertaining to stock based compensation [Abstract]
Vesting period (in years)	3 years
Number of shares available for grant (in shares)	9,870,000
Unrecognized compensation expense \| $	$ 52
Unrecognized compensation expense, weighted-average period of recognition in years	2 years 1 month 6 days
Total fair value of shares vested \| $	$ 66	61	70
Stock Option Plans
Additional disclosures pertaining to stock based compensation [Abstract]
Vesting period (in years)	3 years
Number of shares available for grant (in shares)	20,997,000
Unrecognized compensation expense \| $	$ 45
Unrecognized compensation expense, weighted-average period of recognition in years	1 year 6 months
Stock-based compensation, additional disclosures [Abstract]
Contractual term (in years)	6 years
Total intrinsic value of options exercised \| $	$ 201	$ 221	$ 200
Program 2,015
Stock Repurchases [Abstract]
Stock repurchase program, authorized amount \| $				$ 5,000

Employee Stock Ownership Plan (

Employee Stock Ownership Plan (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Shares in ESOP (in shares)	18,400,412	21,082,162
Outstanding borrowings in the ESOP	$ 5
Common shares released and allocated to participant accounts (in shares)	14,809,986
Common shares available for future allocation to participant accounts (in shares)	3,590,426
Annual ESOP expense	$ 0	$ 0	$ 0
Dividends paid by the Company on shares held by the ESOP	32	35	38
Company contributions to the ESOP	$ 0	$ 0	$ 0

Retirement Plans and Other Re66

Retirement Plans and Other Retiree Benefits - Schedule of Target Asset Allocation (Details)	Dec. 31, 2017
United States
Defined Benefit Plan, Assets, Target Allocations [Abstract]
Target asset allocation	100.00%
United States \| Equity securities
Defined Benefit Plan, Assets, Target Allocations [Abstract]
Target asset allocation	27.00%
United States \| Fixed income securities
Defined Benefit Plan, Assets, Target Allocations [Abstract]
Target asset allocation	53.00%
United States \| Real estate and other investments
Defined Benefit Plan, Assets, Target Allocations [Abstract]
Target asset allocation	20.00%
International
Defined Benefit Plan, Assets, Target Allocations [Abstract]
Target asset allocation	100.00%
International \| Equity securities
Defined Benefit Plan, Assets, Target Allocations [Abstract]
Target asset allocation	39.00%
International \| Fixed income securities
Defined Benefit Plan, Assets, Target Allocations [Abstract]
Target asset allocation	41.00%
International \| Real estate and other investments
Defined Benefit Plan, Assets, Target Allocations [Abstract]
Target asset allocation	20.00%

Retirement Plans and Other Re67

Retirement Plans and Other Retiree Benefits - Allocation of Plan Assets and Level of Valuation Input, by Major Asset Category (Details) - USD ($) $ in Millions	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Defined Benefit Plan Disclosure [Line Items]
Percent of fixed income assets invested in US treasury or agency securities	50.00%	50.00%
Other Retiree Benefit Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	$ 0	$ 0	$ 14
Fair value of plan assets, excluding NAV investments	0	0
NAV investments	0	0
Other Retiree Benefit Plans \| Cash and cash equivalents \| Fair Value, Inputs, Level 1
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Other Retiree Benefit Plans \| U.S. common stocks \| Fair Value, Inputs, Level 1
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Other Retiree Benefit Plans \| International common stocks \| Fair Value, Inputs, Level 1
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Other Retiree Benefit Plans \| Pooled funds \| Fair Value, Inputs, Level 1
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Other Retiree Benefit Plans \| Fixed income securities \| Fair Value, Inputs, Level 2
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Other Retiree Benefit Plans \| Guaranteed investment contracts \| Fair Value, Inputs, Level 2
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Other Retiree Benefit Plans \| Domestic, developed and emerging markets equity funds
Defined Benefit Plan Disclosure [Line Items]
NAV investments	0	0
Other Retiree Benefit Plans \| Fixed income funds
Defined Benefit Plan Disclosure [Line Items]
NAV investments	0	0
Other Retiree Benefit Plans \| Hedge funds
Defined Benefit Plan Disclosure [Line Items]
NAV investments	0	0
Other Retiree Benefit Plans \| Multi-Asset funds
Defined Benefit Plan Disclosure [Line Items]
NAV investments	0	0
Other Retiree Benefit Plans \| Real estate funds
Defined Benefit Plan Disclosure [Line Items]
NAV investments	0	0
Other Retiree Benefit Plans \| Other assets and liabilities, net
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
United States \| Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	1,812	1,646	1,624
Fair value of plan assets, excluding NAV investments	1,130	1,056
NAV investments	707	632
United States \| Pension Plans \| Cash and cash equivalents \| Fair Value, Inputs, Level 1
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	21	27
United States \| Pension Plans \| U.S. common stocks \| Fair Value, Inputs, Level 1
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	127	127
United States \| Pension Plans \| International common stocks \| Fair Value, Inputs, Level 1
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
United States \| Pension Plans \| Pooled funds \| Fair Value, Inputs, Level 1
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	138	134
United States \| Pension Plans \| Fixed income securities \| Fair Value, Inputs, Level 2
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	843	767
United States \| Pension Plans \| Guaranteed investment contracts \| Fair Value, Inputs, Level 2
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	1	1
United States \| Pension Plans \| Domestic, developed and emerging markets equity funds
Defined Benefit Plan Disclosure [Line Items]
NAV investments	350	323
United States \| Pension Plans \| Fixed income funds
Defined Benefit Plan Disclosure [Line Items]
NAV investments	122	118
United States \| Pension Plans \| Hedge funds
Defined Benefit Plan Disclosure [Line Items]
NAV investments	82	96
United States \| Pension Plans \| Multi-Asset funds
Defined Benefit Plan Disclosure [Line Items]
NAV investments	115	52
United States \| Pension Plans \| Real estate funds
Defined Benefit Plan Disclosure [Line Items]
NAV investments	38	43
United States \| Pension Plans \| Other assets and liabilities, net
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	(25)	(42)
International \| Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	575	509	$ 520
Fair value of plan assets, excluding NAV investments	189	174
NAV investments	386	335
International \| Pension Plans \| Cash and cash equivalents \| Fair Value, Inputs, Level 1
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	11	13
International \| Pension Plans \| U.S. common stocks \| Fair Value, Inputs, Level 1
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	4	3
International \| Pension Plans \| International common stocks \| Fair Value, Inputs, Level 1
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	3	3
International \| Pension Plans \| Pooled funds \| Fair Value, Inputs, Level 1
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	94	84
International \| Pension Plans \| Fixed income securities \| Fair Value, Inputs, Level 2
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	24	22
International \| Pension Plans \| Guaranteed investment contracts \| Fair Value, Inputs, Level 2
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	53	49
International \| Pension Plans \| Domestic, developed and emerging markets equity funds
Defined Benefit Plan Disclosure [Line Items]
NAV investments	189	155
International \| Pension Plans \| Fixed income funds
Defined Benefit Plan Disclosure [Line Items]
NAV investments	167	155
International \| Pension Plans \| Hedge funds
Defined Benefit Plan Disclosure [Line Items]
NAV investments	5	3
International \| Pension Plans \| Multi-Asset funds
Defined Benefit Plan Disclosure [Line Items]
NAV investments	3	3
International \| Pension Plans \| Real estate funds
Defined Benefit Plan Disclosure [Line Items]
NAV investments	22	19
International \| Pension Plans \| Other assets and liabilities, net
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	$ 0	$ 0

Retirement Plans and Other Re68

Retirement Plans and Other Retiree Benefits - Additional Information, U.S. Plans (Details) - United States - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Defined Benefit Plan Disclosure [Line Items]
U.S. plans assets purchased/sold to Company	0	0
Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Percentage of investments in Company's common stock	7.00%	7.00%
Dividends received by plans on the Company's common stock	$ 3	$ 3

Retirement Plans and Other Re69

Retirement Plans and Other Retiree Benefits - Summary of Defined Benefit and Other Retiree Benefit Plans (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Amounts Recognized in Balance Sheet
Current liabilities	$ (81)	$ (80)
Other Retiree Benefit Plans
Change in Benefit Obligations
Benefit obligations at beginning of year	923	862
Service cost	13	13	$ 14
Interest cost	40	43	44
Participants’ contributions	0	0
Acquisitions/plan amendments	0	0
Actuarial loss (gain)	21	39
Foreign exchange impact	3	1
Termination benefits	(3)	1
Curtailments and settlements	0	0
Benefit payments	(37)	(36)
Other	0	0
Benefit obligations at end of year	960	923	862
Change in Plan Assets
Fair value of plan assets at beginning of year	0	14
Actual return on plan assets	0	1
Company contributions	37	21
Participants’ contributions	0	0
Foreign exchange impact	0	0
Settlements and acquisitions	0	0
Benefit payments	(37)	(36)
Other	0	0
Fair value of plan assets at end of year	0	0	14
Funded Status
Benefit obligations at end of year	960	923	862
Fair value of plan assets at end of year	0	0	14
Net amount recognized	(960)	(923)
Amounts Recognized in Balance Sheet
Noncurrent assets	0	0
Current liabilities	(44)	(44)
Noncurrent liabilities	(916)	(879)
Net amount recognized	(960)	(923)
Amounts Recognized in Accumulated Other Comprehensive Income (Loss)
Actuarial loss	338	330
Transition/prior service cost	(1)	(2)
Amounts recognized in accumulated other comprehensive income	337	328
Accumulated benefit obligation	$ 0	$ 0
Weighted-Average Assumptions Used to Determine Benefit Obligations
Discount rate	3.80%	4.41%
Long-term rate of return on plan assets		6.80%
Long-term rate of compensation increase	3.50%	0.00%
ESOP growth rate	10.00%	10.00%
Medical cost trend rate of increase	6.00%	6.33%
Assumed medical cost trend rates [Abstract]
Medical cost trend rate assumed for next fiscal year	6.00%
Ultimate medical cost trend rate	4.75%
Year which ultimate medical cost trend rate is reached	2,023
United States \| Pension Plans
Change in Benefit Obligations
Benefit obligations at beginning of year	$ 2,298	$ 2,201
Service cost	1	1	2
Interest cost	94	105	100
Participants’ contributions	0	0
Acquisitions/plan amendments	0	0
Actuarial loss (gain)	110	129
Foreign exchange impact	0	0
Termination benefits	24	3
Curtailments and settlements	0	0
Benefit payments	(164)	(141)
Other	0	0
Benefit obligations at end of year	2,363	2,298	2,201
Change in Plan Assets
Fair value of plan assets at beginning of year	1,646	1,624
Actual return on plan assets	225	88
Company contributions	105	75
Participants’ contributions	0	0
Foreign exchange impact	0	0
Settlements and acquisitions	0	0
Benefit payments	(164)	(141)
Other	0	0
Fair value of plan assets at end of year	1,812	1,646	1,624
Funded Status
Benefit obligations at end of year	2,363	2,298	2,201
Fair value of plan assets at end of year	1,812	1,646	1,624
Net amount recognized	(551)	(652)
Amounts Recognized in Balance Sheet
Noncurrent assets	0	0
Current liabilities	(24)	(24)
Noncurrent liabilities	(527)	(628)
Net amount recognized	(551)	(652)
Amounts Recognized in Accumulated Other Comprehensive Income (Loss)
Actuarial loss	911	962
Transition/prior service cost	1	2
Amounts recognized in accumulated other comprehensive income	912	964
Accumulated benefit obligation	$ 2,293	$ 2,230
Weighted-Average Assumptions Used to Determine Benefit Obligations
Discount rate	3.73%	4.27%
Long-term rate of return on plan assets	6.60%	6.80%
Long-term rate of compensation increase	3.50%	3.50%
ESOP growth rate	0.00%	0.00%
Medical cost trend rate of increase	0.00%	0.00%
Long-term rate of return on plan assets [Abstract]
Average annual rates of return for the most recent 1-year period	14.00%
Average annual rates of return for the most recent 5-year period	8.00%
Average annual rates of return for the most recent 10-year period	6.00%
Average annual rates of return for the most recent 15-year period	8.00%
Average annual rates of return for the most recent 25-year period	8.00%
International \| Pension Plans
Change in Benefit Obligations
Benefit obligations at beginning of year	$ 800	$ 802
Service cost	16	16	20
Interest cost	22	25	28
Participants’ contributions	2	2
Acquisitions/plan amendments	(6)	1
Actuarial loss (gain)	(11)	76
Foreign exchange impact	72	(47)
Termination benefits	0	0
Curtailments and settlements	(11)	(37)
Benefit payments	(36)	(36)
Other	(1)	(2)
Benefit obligations at end of year	847	800	802
Change in Plan Assets
Fair value of plan assets at beginning of year	509	520
Actual return on plan assets	42	46
Company contributions	30	54
Participants’ contributions	2	2
Foreign exchange impact	40	(43)
Settlements and acquisitions	(11)	(33)
Benefit payments	(36)	(36)
Other	(1)	(1)
Fair value of plan assets at end of year	575	509	520
Funded Status
Benefit obligations at end of year	847	800	802
Fair value of plan assets at end of year	575	509	$ 520
Net amount recognized	(272)	(291)
Amounts Recognized in Balance Sheet
Noncurrent assets	22	8
Current liabilities	(13)	(12)
Noncurrent liabilities	(281)	(287)
Net amount recognized	(272)	(291)
Amounts Recognized in Accumulated Other Comprehensive Income (Loss)
Actuarial loss	209	254
Transition/prior service cost	1	5
Amounts recognized in accumulated other comprehensive income	210	259
Accumulated benefit obligation	$ 787	$ 739
Weighted-Average Assumptions Used to Determine Benefit Obligations
Discount rate	2.53%	2.59%
Long-term rate of return on plan assets	4.04%	4.14%
Long-term rate of compensation increase	2.79%	2.58%
ESOP growth rate	0.00%	0.00%
Medical cost trend rate of increase	0.00%	0.00%

Retirement Plans and Other Re70

Retirement Plans and Other Retiree Benefits - Key Assumptions (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Other Retiree Benefit Plans
Defined Benefit Plan Disclosure [Line Items]
Effect of one percentage point increase on accumulated postretirement benefit obligation	$ 123
Effect of one percentage point increase on service and interest cost	9
Effect of one percentage point decrease on accumulated postretirement benefit obligation	(100)
Effect of one percentage point decrease on service and interest cost	$ (7)
Other post-retirement plan, benefit obligation, percent decrease due to expected mortality update in the current year		2.00%	2.00%
United States \| Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan, benefit obligation, percent decrease due to expected mortality update in current year		1.00%	1.00%

Retirement Plans and Other Re71

Retirement Plans and Other Retiree Benefits - Benefit Obligation Exceeds Fair Value of Plan Assets (Details) - Pension Plans - USD ($) $ in Millions	Dec. 31, 2017	Dec. 31, 2016
Defined Benefit Plan Disclosure - Plans with Projected Obligations in Excess of Plan Assets and Plans with Accumulated Benefit Obligations in Excess of Plan Assets [Line Items]
Projected benefit obligation	$ 2,834	$ 2,973
Fair value of plan assets	1,992	2,024
Accumulated benefit obligation	2,641	2,840
Fair value of plan assets	$ 1,905	$ 2,003

Retirement Plans and Other Re72

Retirement Plans and Other Retiree Benefits - Summary of Net Periodic Benefit Costs (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Other Retiree Benefit Plans
Components of Net Periodic Benefit Cost
Service cost	$ 13	$ 13	$ 14
Interest cost	40	43	44
Annual ESOP allocation	0	0	0
Expected return on plan assets	0	(1)	(2)
Amortization of transition and prior service costs (credits)	0	0	0
Amortization of actuarial loss	13	14	25
Net periodic benefit cost	66	69	81
Other postretirement charges	(3)	1	1
Total pension cost	$ 63	$ 70	$ 82
Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost
Discount rate	4.41%	4.97%	4.36%
Long-term rate of return on plan assets	6.80%	6.80%	6.80%
Long-term rate of compensation increase	0.00%	0.00%	0.00%
ESOP growth rate	10.00%	10.00%	10.00%
Medical cost trend rate of increase	6.33%	6.67%	7.00%
United States \| Pension Plans
Components of Net Periodic Benefit Cost
Service cost	$ 1	$ 1	$ 2
Interest cost	94	105	100
Annual ESOP allocation	0	0	0
Expected return on plan assets	(111)	(109)	(117)
Amortization of transition and prior service costs (credits)	0	0	0
Amortization of actuarial loss	48	41	44
Net periodic benefit cost	32	38	29
Other postretirement charges	24	3	16
Total pension cost	$ 56	$ 41	$ 45
Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost
Discount rate	4.27%	4.93%	4.24%
Long-term rate of return on plan assets	6.80%	6.80%	6.80%
Long-term rate of compensation increase	3.50%	3.50%	3.50%
ESOP growth rate	0.00%	0.00%	0.00%
Medical cost trend rate of increase	0.00%	0.00%	0.00%
Defined Benefit Plan Disclosure, Additional Information [Abstract]
Voluntary contributions to postretirement plans	$ 81	$ 53	$ 0
International \| Pension Plans
Components of Net Periodic Benefit Cost
Service cost	16	16	20
Interest cost	22	25	28
Annual ESOP allocation	0	0	0
Expected return on plan assets	(22)	(23)	(28)
Amortization of transition and prior service costs (credits)	0	0	2
Amortization of actuarial loss	10	8	11
Net periodic benefit cost	26	26	33
Other postretirement charges	4	11	(1)
Total pension cost	$ 30	$ 37	$ 32
Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost
Discount rate	2.59%	3.17%	3.06%
Long-term rate of return on plan assets	4.14%	4.62%	5.05%
Long-term rate of compensation increase	2.58%	2.78%	2.83%
ESOP growth rate	0.00%	0.00%	0.00%
Medical cost trend rate of increase	0.00%	0.00%	0.00%
Global Growth and Efficiency Program
Defined Benefit Plan Disclosure, Additional Information [Abstract]
Charges against assets	$ (40)	$ (33)	$ (42)
Global Growth and Efficiency Program \| Employee-Related Costs
Defined Benefit Plan Disclosure, Additional Information [Abstract]
Charges against assets	$ (21)	$ (4)	$ (17)

Retirement Plans and Other Re73

Retirement Plans and Other Retiree Benefits - Summary of Amounts in AOCI (Details) $ in Millions	Dec. 31, 2017USD ($)
Pension Plans
Estimated amounts that will be amortized from accumulated other comprehensive income [Abstract]
Net actuarial loss	$ 54
Net transition and prior service cost	0
Other Retiree Benefit Plans
Estimated amounts that will be amortized from accumulated other comprehensive income [Abstract]
Net actuarial loss	17
Net transition and prior service cost	$ 0

Retirement Plans and Other Re74

Retirement Plans and Other Retiree Benefits - Expected Contributions and Benefit Payments (Details) $ in Millions	12 Months Ended
	Dec. 31, 2017USD ($)
Defined Benefit Plan Disclosure [Line Items]
Estimated future voluntary employer contributions in next fiscal year	$ 75
Expected benefit payments from company assets	82
Total benefit payments [Abstract]
2,018	219
2,019	222
2,020	227
2,021	228
2,022	238
2023-2027	1,209
Other Retiree Benefit Plans
Total benefit payments [Abstract]
2,018	45
2,019	46
2,020	46
2,021	47
2,022	48
2023-2027	250
United States \| Pension Plans
Total benefit payments [Abstract]
2,018	137
2,019	141
2,020	144
2,021	143
2,022	151
2023-2027	737
International \| Pension Plans
Total benefit payments [Abstract]
2,018	37
2,019	35
2,020	37
2,021	38
2,022	39
2023-2027	$ 222

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
Income Taxes (Details) - USD ($) $ in Millions	Dec. 31, 2017	Mar. 31, 2016	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Components of income before income taxes [Abstract]
United States			$ 1,072	$ 1,191	$ 1,118
International			2,415	2,547	1,645
Income before income taxes			3,487	3,738	2,763
Provision for income taxes [Abstract]
United States			338	395	376
International			975	757	839
Total Provision for income taxes			1,313	1,152	1,215
Income tax provision reconciliation [Abstract]
Goodwill and intangible assets			135	18	3
Property, plant and equipment			84	(3)	(25)
Pension and other retiree benefits			(192)	0	36
Stock-based compensation			(28)	15	11
Tax loss and tax credit carryforwards			(4)	5	(4)
Other, net			(103)	(106)	98
Total deferred tax benefit (provision)			$ (108)	$ (71)	$ 119
Effective Tax Rate Reconciliation [Abstract]
Tax at United States statutory rate			35.00%	35.00%	35.00%
State income taxes, net of federal benefit			0.50%	0.50%	1.00%
Earnings taxed at other than United States statutory rate			(3.40%)	(2.70%)	(3.60%)
Charge for U.S. tax reform			7.90%	0.00%	0.00%
Excess tax benefits from stock-based compensation			(1.40%)	0.00%	0.00%
(Benefit) charge for previously disclosed tax matters			0.00%	(0.80%)	0.50%
(Benefit) on Venezuela remeasurement			0.00%	(5.60%)	0.00%
Tax charge on incremental repatriation of foreign earnings			0.00%	5.60%	0.00%
Venezuela deconsolidation			0.00%	0.00%	12.80%
Other, net			(0.90%)	(1.20%)	(1.70%)
Effective tax rate			37.70%	30.80%	44.00%
Tax reform, provisional charge	$ 275		$ 275	$ 0	$ 0
Tax reform, one-time deemed repatriation of accumulated foreign earnings and withholdings	451
Tax reform, remeasurement from change in tax rate	20
Tax reform, taxes and withholdings previously provided for planned repatriations	(196)
Deferred tax liabilities:
Goodwill and intangible assets	(311)		(311)	(451)
Property, plant and equipment	(306)		(306)	(380)
Other	(182)		(182)	(202)
Deferred tax liabilities, total	(799)		(799)	(1,033)
Deferred tax assets:
Pension and other retiree benefits	375		375	599
Tax loss and tax credit carryforwards	39		39	34
Accrued liabilities	197		197	246
Stock-based compensation	90		90	127
Other	82		82	82
Deferred tax assets, total	783		783	1,088
Assets:
Deferred income taxes	188		188	301
Liabilities:
Deferred income taxes	(204)		(204)	(246)
Net deferred income taxes	(16)		(16)
Net deferred income taxes				55
Income tax expense (benefit) allocated directly to equity			(37)	(85)	78
Unrecognized tax benefits:
Balance, January 1		$ 186	201	186	218
Increases as a result of tax positions taken during the current year			13	9	20
Decreases of tax positions taken during prior years			(9)	(45)	(25)
Increases of tax positions taken during prior years			15	71	61
Decreases as a result of settlements with taxing authorities and the expiration of statutes of limitations			(15)	(18)	(79)
Effect of foreign currency rate movements			9	(2)	(9)
Balance, December 31	214		214	201	186
Unrecognized tax benefits that would impact effective tax rate	205		205
Cash outflow from unrecognized tax benefit that would impact effective tax rate	185		185
Interest (income) expense recognized related to unrecognized tax benefits			11	2	2
Accrued interest related to unrecognized tax benefits	$ 28		$ 28	17	$ 16
Minimum
Unrecognized tax benefits:
Statue of limitations on foreign jurisdictions for tax audits			3 years
Maximum
Effective Tax Rate Reconciliation [Abstract]
Excess tax benefits recognized			$ 47
Unrecognized tax benefits:
Statue of limitations on foreign jurisdictions for tax audits			6 years
CP Venezuela
Effective Tax Rate Reconciliation [Abstract]
Income tax benefit, principally related to changes in Venezuela foreign currency regime		210
Foreign earnings repatriated		1,500		$ 1,500
Tax charge resulting from repatriation of earnings of foreign subsidiaries		$ 210

Earnings Per Share (Details)

Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Income [Abstract]
Basic EPS									$ 2,024	$ 2,441	$ 1,384
Diluted EPS									$ 2,024	$ 2,441	$ 1,384
Shares [Abstract]
Basic EPS (in shares)									881,800,000	891,800,000	902,200,000
Stock options and restricted stock units (in shares)									6,000,000	6,600,000	7,500,000
Diluted EPS (in shares)									887,800,000	898,400,000	909,700,000
Earnings Per Share, Basic [Abstract]
Basic EPS (in dollars per share)	$ 0.37	$ 0.69	$ 0.59	$ 0.64	$ 0.68	$ 0.79	$ 0.67	$ 0.60	$ 2.30	$ 2.74	$ 1.53
Earnings Per Share, Diluted [Abstract]
Diluted EPS (in dollars per share)	$ 0.37	$ 0.68	$ 0.59	$ 0.64	$ 0.68	$ 0.78	$ 0.67	$ 0.59	$ 2.28	$ 2.72	$ 1.52
Employee Stock Option
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)									11,056,725	3,187,485	3,228,359
Restricted Stock Units (RSUs)
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)									91	2,693	120

Commitments and Contingencies (

Commitments and Contingencies (Details) $ in Millions	1 Months Ended	12 Months Ended
Commitments and Contingencies (Details) $ in Millions	Dec. 31, 2014USD ($)company	Dec. 31, 2017USD ($)country_and_territorycase	Dec. 31, 2016USD ($)case	Dec. 31, 2015USD ($)	Jul. 31, 2017USD ($)
Operating leases,minimum rental commitments[Abstract]
Minimum rental commitments under noncancellable operating leases due within one year of the balance sheet date		$ 188
Minimum rental commitments under noncancellable operating leases due in two years of the balance sheet date		163
Minimum rental commitments under noncancellable operating leases due in three years of the balance sheet date		143
Minimum rental commitments under noncancellable operating leases due in four years of the balance sheet date		106
Minimum rental commitments under noncancellable operating leases due in five years of the balance sheet date		93
Minimum rental commitments under noncancellable operating leases due after five years of the balance sheet date		44
Operating leases, rental expense [Abstract]
Rental expense		211	$ 204	$ 214
Contractual commitments (Abstract)
Contractual commitments, amount		$ 467
Contingencies [Abstract]
Minimum number of countries and territories serving consumers (more than) (in countries and territories) \| country_and_territory		200
Brazilian internal revenue authority, matter 1		$ 165
Brazilian internal revenue authority, matter 2		$ 74
Number of consumer goods companies \| company	13
Fine imposed French competition authority	$ 57
Fine imposed French competition authority - as a result of Sanex Acquisition	$ 25
Fine imposed by greek competition authority					$ 11
Loss contingency, pending claims, number (in cases) \| case		193	115
Loss contingency, new claims filed, number (in cases) \| case		132
Loss contingency, claims dismissed or settled, number (in cases) \| case		54
Minimum
Contingencies [Abstract]
Range of reasonably possible losses		$ 0
Maximum
Contingencies [Abstract]
Range of reasonably possible losses		$ 250

Venezuela (Details)

Venezuela (Details) $ / shares in Units, $ in Millions	3 Months Ended	12 Months Ended
Venezuela (Details) $ / shares in Units, $ in Millions	Mar. 31, 2016USD ($)	Dec. 31, 2017USD ($)	Dec. 31, 2016USD ($)	Dec. 31, 2015USD ($)bolivar / $$ / shares
Foreign Currency [Line Items]
Pretax charge for Venezuela deconsolidation		$ 0	$ 0	$ 1,084
Pretax remeasurement charges		$ 0	$ 0	34
CP Venezuela
Foreign Currency [Line Items]
Aftertax charge for Venezuela deconsolidation				1,058
Pretax charge for Venezuela deconsolidation				$ 1,084
Aftertax charge for Venezuela deconsolidation (in dollars per share) \| $ / shares				$ 1.16
Charge for Venezuela deconsolidation - portion related to investment in CP Venezuela				$ 952
Reclassification due to Venezuela deconsolidation - cumulative translation adjustment, before-tax				111
Income tax benefit, principally related to changes in Venezuela foreign currency regime	$ 210
Pretax remeasurement charges				34
Aftertax remeasurement charge				$ 22
Impact of aftertax remeasurement charge, diluted (in dollars per share) \| $ / shares				$ 0.02
VENEZUELA
Foreign Currency [Line Items]
SICAD exchange rate (in bolivares per USD) \| bolivar / $				13.50
Official exchange rate (in bolivares per USD) \| bolivar / $				6.30

Segment Information (Details)

Segment Information (Details) $ in Millions	3 Months Ended	12 Months Ended
Segment Information (Details) $ in Millions	Sep. 30, 2016USD ($)	Dec. 31, 2017USD ($)business_segment	Dec. 31, 2016USD ($)	Dec. 31, 2015USD ($)
Segment Reporting Information [Line Items]
Number of product segments (in segments) \| business_segment		2
Number of reportable segments (in segments) \| business_segment		5
Number of operating segments (in segments) \| business_segment		5
Total Global Growth and Efficiency Program charges, pretax		$ 169	$ 105	$ 170
Charges for litigation matters		0	17	14
Gain on sale of land in Mexico		0	97	0
Charge for Venezuela accounting change		0	0	1,084
Venezuela remeasurement charges		0	0	34
Gain on sale of business		0	0	187
Net sales		15,454	15,195	16,034
Operating profit		3,589	3,837	2,789
Capital expenditures		553	593	691
Depreciation and amortization		475	443	449
Identifiable assets		$ 12,676	$ 12,123	$ 11,935
Percentage of corporate identifiable assets consisting of derivative instruments		5.00%	24.00%	76.00%
Percentage of corporate identifiable assets consisting of investments in equity securities		86.00%	68.00%	23.00%
Total long lived assets		$ 7,908	$ 7,642	$ 7,420
Operating Segments \| Oral, Personal and Home Care
Segment Reporting Information [Line Items]
Net sales		13,162	12,931	13,822
Operating profit		3,767	3,814	3,864
Capital expenditures		402	433	490
Depreciation and amortization		323	297	309
Identifiable assets		11,600	11,058	10,751
Operating Segments \| Pet Nutrition
Segment Reporting Information [Line Items]
Net sales		2,292	2,264	2,212
Operating profit		653	653	612
Capital expenditures		33	38	34
Depreciation and amortization		53	53	52
Identifiable assets		1,026	1,009	1,006
Corporate
Segment Reporting Information [Line Items]
Operating profit		(831)	(630)	(1,687)
Capital expenditures		118	122	167
Depreciation and amortization		99	93	88
Identifiable assets		50	56	178
CP Venezuela
Segment Reporting Information [Line Items]
Charge for Venezuela accounting change				1,084
Venezuela remeasurement charges				34
MEXICO
Segment Reporting Information [Line Items]
Gain on sale of land in Mexico	$ 97		97
North America \| Operating Segments \| Oral, Personal and Home Care
Segment Reporting Information [Line Items]
Net sales		3,117	3,183	3,149
Operating profit		986	1,030	974
Capital expenditures		74	151	207
Depreciation and amortization		58	54	47
Identifiable assets		2,608	2,685	2,622
Latin America \| Operating Segments \| Oral, Personal and Home Care
Segment Reporting Information [Line Items]
Net sales		3,887	3,650	4,327
Operating profit		1,162	1,132	1,209
Capital expenditures		127	94	110
Depreciation and amortization		82	76	88
Identifiable assets		2,423	2,314	2,314
Europe \| Operating Segments \| Oral, Personal and Home Care
Segment Reporting Information [Line Items]
Net sales		2,394	2,342	2,411
Operating profit		599	579	615
Capital expenditures		63	51	40
Depreciation and amortization		74	64	67
Identifiable assets		3,781	3,554	3,308
Asia Pacific \| Operating Segments \| Oral, Personal and Home Care
Segment Reporting Information [Line Items]
Net sales		2,781	2,796	2,937
Operating profit		841	887	888
Capital expenditures		125	120	121
Depreciation and amortization		101	96	99
Identifiable assets		2,244	2,006	2,031
Africa/Eurasia \| Operating Segments \| Oral, Personal and Home Care
Segment Reporting Information [Line Items]
Net sales		983	960	998
Operating profit		179	186	178
Capital expenditures		13	17	12
Depreciation and amortization		8	7	8
Identifiable assets		544	499	476
United States \| Oral, Personal and Home Care
Segment Reporting Information [Line Items]
Net sales		2,865	2,932	2,896
United States \| Pet Nutrition
Segment Reporting Information [Line Items]
Net sales		1,246	1,243	1,223
Global Growth and Efficiency Program
Segment Reporting Information [Line Items]
Total Global Growth and Efficiency Program charges, pretax		$ 333	$ 228	254
Home Care \| Europe South Pacific
Segment Reporting Information [Line Items]
Gain on sale of business				$ 187
Sales Revenue, Net
Segment Reporting Information [Line Items]
Percentage of consolidated Net sales represented by sales outside US		75.00%
Percentage of consolidated Net sales coming from emerging markets		50.00%
Percentage of consolidated sales represented by one customer		11.00%

Supplemental Income Statement80

Supplemental Income Statement Information (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Other (income) expense, net
Total Global Growth and Efficiency Program charges, pretax	$ 169	$ 105	$ 170
Amortization of intangible assets	35	33	33
Gain on sale of land in Mexico	0	(97)	0
Charges for litigation matters	0	17	14
Venezuela remeasurement charges	0	0	34
Gain on sale of South Pacific laundry detergent business	0	0	(187)
Equity income	(11)	(10)	(8)
Other, net	1	(11)	6
Total Other (income) expense, net	194	37	62
Interest (income) expense, net
Interest incurred	156	155	139
Interest capitalized	(3)	(6)	(6)
Interest income	(51)	(50)	(107)
Total Interest (income) expense, net	102	99	26
Research and development	285	289	274
Advertising	$ 1,573	$ 1,428	$ 1,491

Supplemental Balance Sheet In81

Supplemental Balance Sheet Information (Details) - USD ($) $ in Millions	Dec. 31, 2017	Dec. 31, 2016
Inventory, Net [Abstract]
Raw materials and supplies	$ 267	$ 266
Work-in-process	42	42
Finished goods	912	863
Total Inventories	1,221	1,171
Inventories valued under LIFO	289	278
Excess of current cost over LIFO cost	63	30
Property, plant and equipment, net
Land	159	147
Buildings	1,655	1,544
Manufacturing machinery and equipment	5,165	4,971
Other equipment	1,481	1,280
Property, plant and equipment, gross	8,460	7,942
Accumulated depreciation	(4,388)	(4,102)
Total Property, plant and equipment, net	4,072	3,840
Other accruals
Accrued advertising and coupon redemption	510	491
Accrued payroll and employee benefits	325	309
Accrued taxes other than income taxes	123	112
Restructuring accrual	181	112
Pension and other retiree benefits	81	80
Accrued interest	34	29
Derivatives	20	4
Other	557	590
Total Other accruals	1,831	1,727
Other liabilities
Pension and other retiree benefits	1,724	1,794
Restructuring accrual	53	69
Other	478	172
Total Other liabilities	$ 2,255	$ 2,035

Supplemental Other Comprehens82

Supplemental Other Comprehensive Income (Loss) Information - Schedule of Comprehensive Income (Loss) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Other Comprehensive Income (Loss), before Tax [Abstract]
Total Other comprehensive income (loss), before-tax	$ 288	$ (259)	$ (314)
Other comprehensive income (loss), net of tax:
Total Other comprehensive income (loss), net-of-tax	325	(230)	(443)
Remeasurement Due To Change in Foreign Exchange Rates [Abstract]
Loss (gain) related to the remeasurement of fixed interest rate and devaluation-protected bonds in Venezuela		50
Cumulative translation adjustments
Other Comprehensive Income (Loss), before Tax [Abstract]
OCI, before reclassifications, before-tax	218	(97)	(721)
Reclassification from accumulated other comprehensive income, before-tax	0	0	111
Total Other comprehensive income (loss), before-tax	218	(97)	(610)
Other comprehensive income (loss), net of tax:
OCI, before reclassifications, net-of-tax	285	(125)	(745)
Reclassification from accumulated other comprehensive income, net-of-tax	0	0	111
Total Other comprehensive income (loss), net-of-tax	285	(125)	(634)
Pension and other benefits
Other Comprehensive Income (Loss), before Tax [Abstract]
Total Other comprehensive income (loss), before-tax	92	(168)	308
Other comprehensive income (loss), net of tax:
Total Other comprehensive income (loss), net-of-tax	54	(109)	196
Net actuarial gain (loss), prior service costs and settlements during the period
Other Comprehensive Income (Loss), before Tax [Abstract]
OCI, before reclassifications, before-tax	21	(231)	182
Other comprehensive income (loss), net of tax:
OCI, before reclassifications, net-of-tax	9	(152)	115
Amortization of net actuarial loss, transition and prior service costs
Other Comprehensive Income (Loss), before Tax [Abstract]
Reclassification from accumulated other comprehensive income, before-tax	(71)	(63)	(82)
Other comprehensive income (loss), net of tax:
Reclassification from accumulated other comprehensive income, net-of-tax	(45)	(43)	(52)
Available-for-sale securities
Other Comprehensive Income (Loss), before Tax [Abstract]
OCI, before reclassifications, before-tax	0	0	(18)
Reclassification from accumulated other comprehensive income, before-tax	0	(1)	14
Total Other comprehensive income (loss), before-tax	0	(1)	(14)
Other comprehensive income (loss), net of tax:
OCI, before reclassifications, net-of-tax	0	0	(12)
Reclassification from accumulated other comprehensive income, net-of-tax	0	(1)	11
Total Other comprehensive income (loss), net-of-tax	0	(1)	(7)
Cash flow hedges
Other Comprehensive Income (Loss), before Tax [Abstract]
OCI, before reclassifications, before-tax	(25)	11	18
Reclassification from accumulated other comprehensive income, before-tax	3	(4)	(16)
Total Other comprehensive income (loss), before-tax	(22)	7	2
Other comprehensive income (loss), net of tax:
OCI, before reclassifications, net-of-tax	(16)	8	12
Reclassification from accumulated other comprehensive income, net-of-tax	2	(3)	(10)
Total Other comprehensive income (loss), net-of-tax	(14)	5	2
Venezuela Deconsolidation \| Reclassification
Other Comprehensive Income (Loss), before Tax [Abstract]
Reclassification from accumulated other comprehensive income, before-tax	0	0	44
Other comprehensive income (loss), net of tax:
Reclassification from accumulated other comprehensive income, net-of-tax	0	0	29
Venezuela Deconsolidation \| Available-for-sale securities
Other Comprehensive Income (Loss), before Tax [Abstract]
Reclassification from accumulated other comprehensive income, before-tax	0	0	(10)
Other comprehensive income (loss), net of tax:
Reclassification from accumulated other comprehensive income, net-of-tax	$ 0	$ 0	$ (6)

Supplemental Other Comprehens83

Supplemental Other Comprehensive Income (Loss) Information - Narrative (Details) - USD ($) $ in Millions	Dec. 31, 2017	Dec. 31, 2016
Equity [Abstract]
Unrecognized pension and other retiree benefit costs, aftertax	$ 923	$ 977
Foreign currency translation adjustments	$ 2,927	$ 3,212

Quarterly Financial Data (Una84

Quarterly Financial Data (Unaudited) (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Quarterly financial data (Unaudited) [Abstract]
Net sales	$ 3,892	$ 3,974	$ 3,826	$ 3,762	$ 3,721	$ 3,867	$ 3,845	$ 3,762	$ 15,454	$ 15,195	$ 16,034
Gross profit	2,328	2,383	2,300	2,269	2,247	2,324	2,304	2,248	9,280	9,123	9,399
Net income including noncontrolling interests	353	650	560	611	628	746	638	574	2,174	2,586	1,548
Net income attributable to Colgate-Palmolive Company	$ 323	$ 607	$ 524	$ 570	$ 606	$ 702	$ 600	$ 533	$ 2,024	$ 2,441	$ 1,384
Earnings (loss) per common share:
Basic EPS (in dollars per share)	$ 0.37	$ 0.69	$ 0.59	$ 0.64	$ 0.68	$ 0.79	$ 0.67	$ 0.60	$ 2.30	$ 2.74	$ 1.53
Diluted EPS (in dollars per share)	$ 0.37	$ 0.68	$ 0.59	$ 0.64	$ 0.68	$ 0.78	$ 0.67	$ 0.59	$ 2.28	$ 2.72	$ 1.52
Quarterly Financial Information Disclosure [Abstract]
Total Global Growth and Efficiency Program charges, pretax									$ 169	$ 105	$ 170
Charge for U.S. tax reform	$ 275								275	0	0
Aftertax charges for litigation matters					$ 7	$ 4				11
Benefit from tax matters						22	$ 13			35
CP Venezuela
Quarterly Financial Information Disclosure [Abstract]
Income tax benefit, principally related to changes in Venezuela foreign currency regime								$ 210
Foreign earnings repatriated								1,500		1,500
Tax charge resulting from repatriation of earnings of foreign subsidiaries								210
MEXICO
Quarterly Financial Information Disclosure [Abstract]
Aftertax gain on sale of land in Mexico						63				63
Global Growth and Efficiency Program
Quarterly Financial Information Disclosure [Abstract]
Total Global Growth and Efficiency Program charges, pretax									333	228	254
Total Global Growth and Efficiency Program charges, aftertax	61	$ 39	$ 115	$ 31	54	32	44	38	246	168	183
Total Global Growth and Efficiency Program charges, including noncontrolling interest, aftertax							45			169
Global Growth and Efficiency Program \| Gross Profit
Quarterly Financial Information Disclosure [Abstract]
Total Global Growth and Efficiency Program charges, pretax	$ 24	$ 16	$ 21	$ 14	$ 15	$ 11	$ 12	$ 8	$ 75	$ 46	$ 20

Schedule II - Valuation and Q85

Schedule II - Valuation and Qualifying Accounts (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Allowance for doubtful accounts and estimated returns
Movement in Valuation Allowances and Reserves [Roll Forward]
Beginning balance of valuation allowance and reserves	$ 73	$ 59	$ 54
Charged to Costs and Expenses, additions	8	18	7
Other, additions	0	0	0
Deductions	4	4	2
Ending balance of valuation allowance and reserves	77	73	59
Valuation allowance for deferred tax assets
Movement in Valuation Allowances and Reserves [Roll Forward]
Beginning balance of valuation allowance and reserves	0	0	0
Charged to Costs and Expenses, additions	9	0	0
Other, additions	0	0	0
Deductions	0	0	0
Ending balance of valuation allowance and reserves	$ 9	$ 0	$ 0